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RNA interference therapeutics are regarded as having a crucial role in gene regulation and 
play an integral role in diseases, e.g. cancer, neurological diseases and heart disease. 
However, the lack of success in using non-coding RNAs as therapeutics lies in the absence of 
efficient, safe and reliable tools for targeted delivery. Although polymeric vectors have 
yielded some success in gene delivery, there are still major downfalls related to toxicity, 
endosomal escape and cytoplasmic delivery.  
Herein, two classes of novel delivery vehicles have been synthesized and their gene 
regulation efficiency tested, in an effort to address the difficulties in endosomal escape and 
cytoplasmic release. The first type of system is a diblock-copolymer conjugated via a pH-
labile linker to enhance endosomal escape. The first block is poly(N-vinylpyrrolidone) (PVP) 
which was synthesized via RAFT–mediated polymerization. The second block is composed of 
either hydrolysable poly(2-(N,N-dimethylamino)ethyl acrylate-co-butylmethacrylate) 
(p(DMAEA-co-BMA)) or non-hydrolysable poly(2-(N,N-dimethylamino)ethyl methacrylate-
co-butylmethacrylate) (p(DMAEMA-co-BMA)), which are both capable of RNA complexation. 
The hydrolysable properties of the p(DMAEA-co-BMA) causes decationization, releasing the 
RNA within the cytoplasm. Neither of the diblock-copolymer conjugates caused significant 
cytotoxicity. Although gene regulation for both systems was greater than or equivalent to 
poly(ethylamine), the gold standard in gene regulation, they do not effectively escape the 
endosome. Interestingly, p(DMAEMA-co-BMA)-b-PVP is more efficient at regulating gene 
expression than p(DMAEA-co-BMA)-b-PVP.  
Ring opened and closed DMAPA-modified poly(styrene-co-maleic anhydride) derivatives 
were synthesized as the second class of zwitterionic polymer vectors. Although the ring-
closed derivative was more efficient in condensing the RNAs, the ring-open analogue is 
more effective at delivering gene regulation. Both systems cause no cytotoxicity, 
erythrocyte aggregation or hemolysis. The ring-opened analogue, in particular, provides a 
platform from which potentially effective and safe gene delivery vectors can be designed.  
 
  




RNA-obtrusieterapeutiesemiddels speel 'n belangrike rol in geenregulering asook in 
behandeling van siektes soos bv. kanker, neurologiesesiektes en hartsiektes. Die gebrek aan 
sukses in die gebruik van nie-koderende-RNAs as terapeutiese middels lê egter in die 
afwesigheid van doeltreffende, veilige en betroubare sisteme vir geteikende-aflewering. 
Alhoewel polimeriesevektore 'n mate van sukses behaal het in geenaflewering, is daar 
steeds groot tekortkominge wat verband hou met toksisiteit, endosomale ontsnappings en 
sitoplasmiese aflewering. 
Hierin is twee klasse nuwe afleweringsvoertuie gesintetiseer en hulle geenregulasie 
doeltreffend getoets in 'n poging om die probleme in endosomale ontsnapping en 
sitoplasmiese vrystelling aan te spreek. Die eerste tipe stelsel is die van 'n diblok-kopolimeer 
wat via 'n pH-sensitiewekoppelaar verbind is om endosomale ontsnapping te verbeter. Die 
eerste blok bestaan uit poli(N-vinielpyrolidoon) (PVP) wat deur RAFT-gemedieerde 
polimerisasie gesintetiseer is. Die tweede blok is saamgestel uit óf hidroliseerbare 
poli(2-(N, N-dimetielamien)etielakrilaat-ko-butielmetakrilaat) (p(DMAEA-ko-BMA)) óf 
nie-hidroliseerbare poli(2-(N,N-dimetielamien)etielmetakrilaat-ko-butielmetakrilaat 
p(DMAEMA-ko-BMA)), wat beide in staat is tot RNA-kompleksasie. Die hidroliseerbare 
eienskappe van die p(DMAEA-ko-BMA) veroorsaak dekationisasie wat die RNA binne die 
sitoplasma vrystel. Nie een van die diblok-kopolimeergekonjugeerde sisteme het 
beduidende sitotoksisiteit veroorsaak nie. Alhoewel geenregulering vir beide stelsels groter 
is as of ekwivalent is aan poli(etielamien) (die goudstandaard in geenregulering) ontsnap 
hulle nie die endosoom effektief genoeg nie. Interessant genoeg is dat 
p(DMAEMA-ko-BMA)-b-PVP meer doeltreffend is om geenuitdrukking te reguleer as 
p(DMAEA-ko-BMA)-b-PVP. 
Ring-oop en ringgeslote DMAPA-gemodifiseerde poli(stireen-ko-maleïenanhidried) 
afgeleides is gesintetiseer as die tweede klas van zwitterioniese polimeervektore. Alhoewel 
die ringgeslote afgeleide meer doeltreffend was om die RNAs te kondenseer, is die ring-oop 
vorm meer doeltreffend in geenregulering. Beide sisteme veroorsaak geen sitotoksisiteit, 
eritrosiete-aggregasie of hemolise nie. Die besondere analoog bied 'n platform waarvan 
potensiële, effektiewe en veilige geenafleweringsvektore ontwerp kan word.  
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Chapter 1: Prologue 
 




Within the field of gene therapy, there is a considerable need for the development of non-
viral vectors that are able to compete with the efficiency obtained by viral vectors, while 
maintaining a good toxicity profile and not inducing an immune response within the body. 
While there have been many reports of possible delivery systems, (1-5) few have made it 
from the bench to a clinical setting due to toxicity, systemic instability or gene regulation 
inefficiency. (6) Figure 1.1 depicts the journey of a delivery system from complexation with 
the nucleotide to gene regulation. 
 
Figure 1.1 The journey of polycationic gene delivery systems, from complexation, to systemic 
delivery and extravasation, endocytosis and cytoplasmic release to the final steps of the formation 
of the RNA-induced silencing complex and mRNA inhibition/degradation 
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There are a number of hurdles a delivery system must conquer on route to delivering its 
payload. Firstly, the polymeric delivery system must be able to condense the gene 
therapeutic. Due to the nucleotide’s negative charge, this has been achieved in the past 
through electrostatic interactions with polycations, such as polyethylenimine (PEI). (7, 8) 
These complexed polymer-nucleotide systems are referred to as polyplexes. During systemic 
delivery, these polyplexes should not interact aspecifically with blood components, or cause 
erythrocyte aggregation or hemolysis. The polymer system should increase the half-life of 
the therapeutic, and allow for passive targeting. Polycations fail in a number of these 
aspects, (9) but all of these issues have been seen to be improved by the addition of a 
hydrophilic polymer, such as poly(ethylene glycol) (PEG). (10-13)  
After extravasation from the blood vessels/capillaries into the extracellular matrix, the 
polyplexes must enter the cell through endocytosis via interactions with the cell membrane. 
(14, 15) This has been reported to be enhanced by the addition of targeting 
ligands/antibodies, i.e. through active targeting. (6, 16) One of the biggest hurdles comes 
next: the polyplex’s endosomal escape. (6, 17) It has been seen that the PEGylation which 
enhances stability and half-life, decreases endosomal escape. (18, 19) Reports have shown 
that by incorporating a pH-labile linker between the PEG group and the polycation, it is 
possible to exploit the decrease in pH within the endosome/lysosome to enhance 
endosomal escape. (19, 20)  
The next obstacle has to do with cytoplasmic release of the RNA therapeutic from the 
complex. Due to the high complexation efficiency of the polycationic systems, this seems to 
be the biggest bottleneck for delivery. (21) The use of decationizing systems, i.e. systems 
which lose their cationic charge by breaking the bond between the cationic moiety and the 
polymer backbone via for example hydrolysis or reduction of disulfides, have been reported 
to enhance this payload release, which in turn allows for the gene regulation to occur. (22, 
23) 
In this dissertation, two types of polymeric delivery systems were designed and 
investigated. The first is a diblock conjugate containing an acid-labile linker to enhance 
endosomal escape. Two different hydrophobic polymers were employed, a non-
hydrolysable p(DMAEMA-co-BMA) system and a hydrolysable, de-cationizing p(DMAEA-co-
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BMA) system. The issues pertaining to the immune response caused by PEG  (24) was 
addressed through the alternative use of poly(N-vinylpyrrolidone) (PVP). Targeting ligands 
were attached to facilitate active targeting. These two systems were analysed in vitro and 
their efficiency was compared. 
The second polymeric delivery system investigated was a zwitterionic poly(styrene-co-
maleic anhydride) derivative, functionalized with 3-(N,N-dimethylamino)propyl-1-amine. 
This novel system was assessed for its complexation efficiency and in vitro application. It 
was compared to its ring-closed (maleimide) analogue, which does not possess the 
zwitterionic properties. 
1.2 Objectives 
The objectives of this study are summarized as follows: 
1. To develop an easy route of obtaining α,ω-heterotelechelic PVP with high chain end 
fidelity. 
2. To design and synthesize a pH-responsive, polymeric gene delivery system by 
conjugating a hydrophobic, cationic block to hydrophilic PVP functionalized with 
targeting ligands. 
3. To test the physiological application of the abovementioned conjugates in terms of 
complexation efficiency, cytotoxicity, cellular uptake and gene regulation efficiency. 
4. To additionally study the use of a zwitterionic copolymer for use as a gene delivery 
vector, including synthesis, characterization, gene complexation efficiency, 
cytotoxicity, cellular uptake and its mechanism, as well as gene regulation efficiency. 
Futhermore, to compare this zwitterionic copolymer to its ring-closed, cationic 
analogue. 
1.3 Layout of dissertation 
The dissertation comprises 7 chapters. 
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Chapter 1: Prologue 
Chapter 1 gives a brief introduction to previous research within the field of gene therapy, as 
well as an overview of the aims and objectives of the study. 
Chapter 2: Literature Review 
Chapter 2 presents a comprehensive literature review in which the focus is on previous 
polymeric systems designed to improve gene delivery. The overview summarizes what has 
been learned from the original gene delivery systems, such as PEI, and how the field has 
developed into the use of “smart” polymeric delivery systems. 
Chapter 3: Facile routes to telechelic poly(N-vinylpyrrolidone) with high chain end fidelity 
Chapter 3 reports a route for synthesizing PVP via RAFT-mediated polymerization with chain 
transfer agents that were previously termed unsuitable. The method offers polymers with 
high chain end fidelity and α,ω-heterotelechelic functionality. 
Chapter 4: Polymer synthesis, characterization and diblock conjugation 
Chapter 4 describes the design, polymerization, conjugation and characterization of pH-
labile polymeric vectors, with both non-hydrolysable and hydrolysable moieties for RNA 
complexation.  
Chapter 5: Packaging of anti-miR-214 for targeted cardiovascular delivery 
Chapter 5 investigates the in vitro use of the conjugates synthesized in Chapter 4 as gene 
delivery vectors. It describes their RNA complexation efficiency, toxicity profiles, cellular 
uptake and gene regulation efficiency. 
Chapter 6: Zwitterionic poly(styrene-co-maleic anhydride) derivatives for application in 
gene therapy  
Chapter 6 describes the synthesis of a zwitterionic poly(styrene-co-maleic anhydride) 
derivative for application as a non-viral vector in gene delivery, and compares the system to 
its cationic analogue. The chapter further addresses the polymer systems’ abilities to 
condense anti-miRNA and their combined cytotoxicity, cellular uptake, uptake mechanism 
and gene regulation efficiency.  
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Chapter 7: Epilogue 
Chapter 7 provides a brief overview of the results discussed within the dissertation, as well 
as giving some recommendations for future improvements and development of gene 
delivery systems.  
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2.1 Gene delivery 
Gene therapy is the delivery of genetic materials in order to modulate diseases. There are 
two approaches for gene therapy, where the first is to deliver a functional copy of a gene 
that is defective/absent, while the second is to deliver RNA interference (RNAi) therapeutics 
that can remove a pathological gene expression. RNAi therapeutics include the following 
nucleic acids: short interfering RNA (siRNA), microRNA (miRNA), short hairpin RNA (shRNA) 
and antisense oligonucleotides (AONs). The work presented in this thesis will focus 
specifically on the second approach.  
RNAi was first discovered by Fire et al. (1), and the importance of RNAi has become a 
recognized fact over the past 20 years, with siRNA and miRNA becoming accepted as having 
a vital role in gene regulation. Their importance therein has been studied extensively and, as 
such, these nucleic acids have been linked, beyond healthy individuals, to playing an integral 
role in diseases such as cancer, neurological diseases and heart disease. (2) However, the 
lack of success in gene therapy, despite the large number of gene therapy-related clinical 
trials, can often be attributed to the absence of a safe, reliable and efficient tool for 
targeted delivery of these RNA molecules into their intracellular locations of diseased cells. 
This lack of success is also due to the RNA molecules’ size, negative charge, instability and 
difficulty in cellular uptake. (3) Although there has been some success in local delivery of 
naked RNA molecules, especially siRNA, (4-6), complications arise when targeting tissue via 
systematic administration. Furthermore, local delivery falls short, as it is not appropriate for 
all diseases. Numerous studies have investigated diverse means of protecting these RNAs 
via delivery systems, with the intention of transporting the therapeutics to reach their site 
of action. Davis et al. reported the first in-human phase 1 clinical trial in 2010, in which they 
showed systemic administration of siRNA via a PEG-coated nanoparticle delivery system. (7) 
Since then, many delivery systems have been developed, including viral vectors, (8-10) 
liposomes, (11, 12) dendrimers, (13-16) peptides (17-19) and polymers (20-22). This chapter 
will focus specifically on polymeric delivery systems, known as polyplexes when the 
polymers are complexed with the gene therapeutic. Polymeric delivery systems do not 
cause an immune response like those seen for viral vectors (23, 24) and, due to the 
development of controlled polymerization techniques, the ease with which polymeric 
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delivery systems can be modified makes them a strong alternative as vectors within gene 
therapy.  
There are a number of factors that are important when designing a polymeric gene delivery 
system, and these factors are based on the end function of the gene therapy vehicle. It is 
vital that the vector protects the pay load from degradation, which can be caused by the 
constituents within the extracellular fluid such as serum components and proteins, while 
not causing an immune response. Moreover, the system should not form non-specific 
aggregates or cause aggregation of blood components, as this can cause capillary occlusions. 
(25) It is also important that the vehicle facilitates cellular uptake, (26) usually through 
endocytosis, (26, 27) where a major obstacle remains the endosomal/lysosomal release of 
the polymeric delivery system into the cytoplasm. (28, 29) Thereafter, one further hurdle is 
the release of the payload from the polyplex in order for it to be able to perform its 
intended purpose of regulating gene expression. (30) 
Thus far, no delivery vehicles have been able to address all of these requirements, but large 
strides have been made over the past decade. More research has been performed 
investigating the delivery of oligo-DNA with polymer vectors, and this knowledge, both 
positive and negative, can be directly applied to non-coding RNA delivery, although the 
system might need some slight refinement in order to achieve its new purpose. Therefore, 
this can be used as a type of shortcut when designing delivery vehicles for non-coding RNAs. 
This chapter will discuss a variety of different systems that have been designed for both 
non-coding RNAs and oligo-DNAs, with an emphasis on their positive and negative 
attributes.  
2.2 Cationic polymeric delivery systems  
Cationic polymers have emerged as highly attractive vehicles for gene therapy and are, by 
far, the most deliberated polymeric gene delivery vehicles for both non-coding RNAs and 
oligo-DNAs. Generally, these polymers are composed of amines that can be protonated, and 
which are thus capable of interacting with the non-coding RNAs and condensing them to 
form polyplexes. By condensing the nucleotides, the polycations protect them from 
degradation by decreasing their interactions with proteins and enzymes, as well as by 
minimizing systemic clearance, transporting them systemically, increasing their half-life, and 
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facilitating cellular uptake through increased interaction with cells. (31) However, the 
disadvantage of polycation systems is the inherent cytotoxicity that they cause due to their 
positive charge. (32) 
The nitrogen to phosphorus charge (N/P) ratio is the ratio of positive charge on the polymer 
to the negative charge on the nucleic acid, and it is an important physicochemical factor to 
consider when forming polyplexes as it has an impact on the size, stability and net charge of 
the system. Higher N/P ratios have been seen to form smaller micelles and enhance gene 
expression in vivo. (33, 34) This enhanced gene expression is due to the presence of free 
polycations which increases intracellular delivery; however, when the charge neutral point is 
surpassed due to these free polycations, the cytotoxicity of the polyplexes increases due to 
non-specific aggregation with constituents within the extracellular fluid. (35) Fischer et al. 
(36) conducted an in vitro study that explored the structural effects of the polymer that 
influenced the polycation’s influence on the cell viability and hemolysis. This study 
highlighted that the cytotoxicity of a polymer directly relates to the cationic charge density 
and the molecular weight. Thus, significance is placed on finding the correct N/P ratio for 
each system, i.e. the balance between transfection efficiency and the toxicity profile. 
One way in which to improve the toxicity profile of polyplexes is to add a hydrophilic 
surface-coating polymer block, e.g. poly(ethylene glycol) (PEG). This also offers other 
advantages such as an increased circulation time in vivo, decreased aggregation, and more 
protection against blood components. (37-40) On the other hand, due to the shielding of 
the positive charge, the PEGylation has been seen to decrease the complexation efficiency 
(41) and cellular interactions, causing a decrease in cellular uptake. This issue has been 
addressed by actively targeting cells by adding targeting ligands or antibodies on the surface 
of the system. (28, 38, 42-46) PEGylation increases the passive targeting of the polyplexes, 
i.e. it increases the chance of polyplexes reaching their targeted site due to the increased 
circulation time. (47) The incorporation of targeting ligands and antibodies allows for active 
targeting by interacting with receptor proteins on specific cell types, which subsequently 
facilitates cellular uptake. (48) For example, Allen et al. (49) synthesized poly(1-vinyl-
imidazole) (PVIM) quaternized with various t-Boc-protected bromoalkylamines (up to 30% 
quaternization) and then, after Boc-deprotection, was functionalized with folic acid. 
Although these polyplexes wholly underachieved in comparison with poly(ethylenimine) 
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(PEI) and SuperFect Transfection Reagent in terms of transfection efficiency, the results 
nevertheless underscore the remarkable impact that folic acid has on the cellular uptake of 
polyplexes. The folic acid functionality increased the luciferase expression up to 250 times 
compared to the unmodified analogues. Thus, this reiterates the importance of targeting 
ligands, such as folic acid, within gene therapy. 
In addition, the transfection efficiency of PEGylated systems decreases due to insufficient 
intracellular release. It has been repeatedly observed that endosomal escape is of greater 
significance than cellular uptake when attempting to achieve efficient gene knockdown. (50-
53) Some evidence shows that, through the use of pH labile, PEGylated polymer systems, it 
is possible to improve the endosomal escape of the delivery systems. (54-59) Depending on 
the delivery system, this enhancement can occur via the collapse of nanoparticles and, in 
the case of polycations, through an increased proton sponge effect that is caused by an 
elevation in osmotic pressure due to the number of products from the broken pH-labile 
bond. Consequently, this increases the pressure within endosomes, which in turn causes the 
swelling and rupture of the endosome. Therefore, the use of these pH-labile linkers can 
facilitate gene regulation through delivering the vector to the cytoplasm. (53, 60-62)  
Because reversible deactivation radical polymerization (RDRP) techniques, such as ATRP and 
RAFT-mediated polymerizations, allow for the synthesis of polymers with predetermined 
molecular weights and architectures, it has been possible to elucidate the effect of 
polymers’ molecular weight and architecture on polyplex transfection efficiency and 
toxicity. The results of numerous studies have shown that, by increasing the molecular 
weight of the polycation, or by increasing the molecular weight of the polycation block 
within a block copolymer, the oligonucleotide condensation capabilities and the transfection 
efficiency of the polyplex are also increased. However, these increases also cause a rise in 
the inherent cytotoxicity. (63-67) This increase in cytotoxicity has been linked to two causes: 
firstly, that the increased molecular weight causes an increase in the polyplex size, which 
thus increases their propensity to bind to negatively charged peptides. Secondly, that they 
interact more with the cell membrane, causing destabilization and, consequently, cell death. 
Hence, it is imperative to consider molecular weight when developing polymers for gene 
delivery applications.  
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Similarly, the polymer backbone architecture, e.g. homopolymers, block copolymers, 
statistical or random copolymers, graft copolymers, and star-shaped polymers, imparts 
important properties that influence gene delivery. Due to a lower charge density, random 
copolymers impart lower cytotoxicity than block copolymers. (68) Furthermore, polyplexes 
produced from grafted and branched copolymers display better toxicity profiles, as well as 
higher transfection efficacy, than those from linear homopolymers. (63, 69, 70) These 
grafted polymers display higher electrostatic interactions with the nucleic acids and cell 
membranes, subsequently improving membrane disruption and increasing uptake.  
Ziebarth and Wang (71) used coarse-grained molecular dynamics simulations to investigate 
the effect of the polymer architecture, as well as the molecular weight of blocks, within 
copolymers on the polyplex structure. These theoretical models revealed that polyplexes 
that consist of longer, linear block copolymers were smaller and possess more well-defined 
core-coronas. This is due to their ability to better condense the RNA/DNA molecules than 
lower molecular weight blocks. Linear copolymers were reported to be homogeneously 
dispersed with RNA/DNA molecules whereas polyplexes, prepared from star-shaped 
polymers, form layered structures. Furthermore, experimental investigations have shown 
that polyplexes from star-shaped polymers display higher transfection efficacy. This is due 
to the enhanced condensation of polyanions than polyplexes from their equivalent linear or 
randomly branched polymers. (72-76)  
Georgiou et al. established that, beyond the importance of the polymer’s architecture, the 
positioning of monomers within the polymer is of equal significance, as the architecture 
impacts the transfection ability of the polyplex. (77, 78) Synatschke et al. (75) suggested that 
the ideal polyplexes are those prepared from branched polymers with intermediate 
molecular weight, as this would help researchers to discover the most optimal balance 
between transfection efficiency and cytotoxicity. 
A number of different polycations have been investigated for use in gene delivery systems. 
A few of these systems will be discussed in more detail in the subsequent sections. The most 
well researched polycation is PEI, see Figure 2.1. (79, 80) 
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2.2.1 Polyethylenimine (PEI) 
 
Figure 2.1 Structural representations of linear and branched polyethylenimine 
 
PEI has been named the “gold standard” of non-viral based delivery systems and, due to 
this, there have been a tremendous number of studies that vary PEI’s architectures, add 
modifications or conjugations, PEGylation and target different cell/tissue types. PEI’s 
success as a gene delivery vehicle can be found in its ability to complex with non-coding 
RNAs and oligo-DNAs due to its amines that can be protonated to bear a strong positive 
charge.  
However, this positive charge also causes its inherent cytotoxic nature. (35, 81) The levels of 
its cytotoxicity have been strongly correlated to the size and structure of PEI. (82) Thus, the 
charge ratio of PEI polyplexes is very important, with increased N/P ratios resulting in 
smaller particles with more positive charge, and hence allow for enhanced permeation into 
cells. (83) Of course, this leads to increased cytotoxicity. In an in vivo study conducted by 
Chollet et al., a clear enhancement in the luciferase activity in the lung was noted with 
systemic injections when the concentration of linear PEI/DNA polyplexes was increased. 
However, an adverse reaction of this accumulation was necrosis in the liver and fatality. (84)  
Fischer et al. (36) discovered that the nature of cell death caused by linear PEI and 
polyplexes was indicative of a nectrotic type of cell death due to the fact that cell apoptosis 
was not detected. Comparatively, a study by Kafil et al. (85) reported that branched PEI is 
capable of eliciting apoptosis in target cells. This study noted that branched PEI (25 kDa) 
caused higher levels of toxicity than linear PEI (25 kDa). The increased cytotoxicity was 
thought to be related to the higher zeta potential of branched PEI compared to linear PEI. 
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Interestingly, subsequent studies have revealed that linear PEI demonstrates higher 
efficiency than branched PEI. (86)  
It has become a well-known phenomenon that, as the molecular weight of PEI increases, so 
too the cytotoxicity rises. However, the transfection efficiency of low molecular weight PEI is 
also notably lower. Therefore, studies have been conducted in which chains of low 
molecular weight PEI are connected via a reducible link, in order to obtain biodegradable 
high molecular weight PEI. (82, 87) This has proven to be effective in obtaining superior 
RNAi activity with lower cytotoxicity. Gosselin et al. incorporated a disulfide bond between 
two low molecular PEI molecules, using dithiobis(succinimidylpropionate) and dimethyl‚3,3′-
dithiobispropionimidate. These polymeric systems showed slightly lower transfection 
efficiencies compared to high molecular weight PEI; however, the cytotoxicity was also 
somewhat reduced via the inclusion of the disulfide bridge. (87) In comparison to this, 
Breunig et al. investigated the viability and efficacy of disulfide crosslinked, low molecular 
weight, linear PEI in numerous cell lines. They obtained a decrease in cytotoxicity (>90% 
viability across all cell lines), while improving the transfection efficacy. Nonetheless, the 
maximum efficacy of these reducible PEI polyplexes required higher N/P ratios relative to 
the non-reducible PEI polyplexes. Thus, one can deduce that, although the use of reducible 
bonds between low molecular weight PEI can somewhat decrease the cytotoxicity, the 
yielded transfection efficiency may be compromised when compared to non-reducible PEI 
of the same ultimate molecular weight. (88, 89) 
As mentioned above, there can be no true RNA delivery without endosomal escape, and 
hence no gene regulation can occur, as the delivered RNA molecule must be able to enter 
the cytosol in order to interact with the targeted RNA. Understanding the mechanism of 
endosomal escape is pertinent in order to improve the actual delivery system; however, this 
mechanism is still rather elusive in terms of PEI. A number of theories abound regarding 
endosomal escape. The most accepted, and most widely debated, theory is the “proton 
sponge” effect. (90) This theory is based on the large buffering capacity of polycations, 
including PEI. It is believed that the endosome will eventually rupture due to an increase in 
osmotic pressure, caused by an uptake of chloride ions that are passively transported into 
the endosome due to the charge gradient. Although popular, this theory has also been 
greatly disputed. A study by Benjaminsen et al. (91) reported evidence that suggested that 
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no decrease in pH occurs within the lysosome, thus shedding doubt on the accuracy of the 
proton sponge effect. Yet, no concrete explanation exists to explain how PEI polyplex causes 
gene regulation, only that they do. 
In elaboration to the abovementioned, PEGylation has become common practice in order to 
address the toxicity, stability and circulation time of PEI polyplexes. (92-94) Due to the 
disadvantages of PEGylation, studies have been conducted in order to investigate the PEG 
chain length, in hope of discovering the optimum architecture for the simultaneous 
protection and maintenance of cellular uptake and transfection efficiency. (92, 93, 95) 
However, due to the proof that a hydrophilic polymer on the external surface decreases 
cellular uptake transfection efficiency, (96, 97) many PEGylated PEI polyplexes have 
included different targeting ligands or antibodies on the surface, with the intent to promote 
active targeting. (98-100) As such, folic acid has become a popular targeting ligand in gene 
therapy due to its selectivity towards cancerous cells which over-express folate receptors, 
thus increasing its internalization efficiency. (99, 101)  
Acid-labile linkers have also been incorporated in order to improve the endosomal escape, 
and consequently the transfection efficacy, of PEGylated PEI polyplexes. (54, 97, 102) Knorr 
et al. (54) synthesized novel PEG-acetal-PEI polyplexes, via a Michael addition, between a 
maleimide moiety on the PEG chain-end and the mercaptan-modified PEI. The resultant 
PEG-acetal-PEI was seen to break down after 3 minutes in pH 5.5 – the pH corresponding to 
that within the endosomal compartment. A 10-fold increase in transfection efficiency was 
obtained, which was notable in comparison to the PEGylated PEI with a stable linkage.  
Other examples have incorporated disulfide links between the hydrophilic polymer and PEI, 
for example Carlisle et al. (103) connected PEI and hydroxypropyl methacrylate (HPMA) via 
a reducible, disulfide bond. They hypothesized that the increase obtained in terms of 
transfection efficiency was caused by the reducing environment in the late-
endosome/lysosome, which thus caused the breakage of the disulfide linker. However, in 
more recent studies, the use of disulfide links has been rendered less effective than a pH-
labile bond. This will be discussed further in Section 2.5. 
Despite all of these investigations, the transfection efficiency of PEI still remains inadequate, 
especially when the toxicity profile is kept in check. Thus, although research on PEI 
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polyplexes remains active, there has been a boom of new research within gene delivery, as 
many no longer consider PEI to be the ultimate vector for these delivery systems. Instead, 
“smart” polymeric systems have become leaders in this field. Their “smart” nature can be 
attributed to a range of different factors, including biodegradability, responsiveness to 
stimulus such as pH, temperature, reducible linkers, etc. But all of these systems have one 
thing in common – they aim to enhance biodistribution, biocompatibility, cellular uptake, 
endosomal escape and cytoplasmic release – and ultimately their main function is the 
delivery of the RNA species in order to control gene expression. Accumulatively, this is an 
attempt to improve what PEI predecessors could not achieve. Few of these “smart” 
polymeric systems, if any, are able to fulfill all of these objectives. Many of them have 
utilized RDRP techniques, e.g. RAFT-mediated polymerization and ATRP, to obtain more 
sophisticated polymers and copolymers with better molecular architecture. A major 
advantage of RDRP techniques is that they enable the synthesis of polymers in a sequential 
manner and allow for facile means of incorporating functional modifications, such as linking 
targeting ligands, fluorescent markers or other imaging modalities, or even the RNA 
molecule itself. 
2.2.2 Poly(2-(N,N-dimethylamino)ethyl methacrylate) (pDMAEMA) 
The anionic nature of RNA remains a simple manner in which to form polyplexes. Poly(2-
(N,N-dimethylamino)ethyl methacrylate (pDMAEMA) is a well-studied polymer for these 
sorts of delivery systems (104). Its complexation is also based on the protonation of amines, 
thus causing endosomal escape to be based on the hypothesis of the debated proton 
sponge effect. Owing to the sterically unhindered and free nature of the amines of 
pDMAEMA, they have a higher capacity of absorbing protons, and thus possess a higher 
proton sponge buffering potential. (89, 105) In a comparative study, pDMAEMA with 
tertiary amines was compared to those with quaternized amines. They found that, although 
the complexation with nucleic acids is higher for quaternized pDMAEMA, the toxicity also 
increases, while the transfection efficiency decreases. They hypothesized that this decrease 
in transfection efficiency is caused by the quaternized amines’ inability to be further 
protonated, which then decreases the buffering capacity of the polymer. (63, 106)  
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Via controlled radical polymerization techniques, many investigations have been conducted 
on the effect of molecular weight on complexation efficiency, toxicity, cellular uptake and 
transfection efficiency of pDMAEMA.  Like PEI, pDMAEMA is inherently cytotoxic due to its 
cationic nature, and this toxicity increases with an increase in the molecular weight. (90, 
107) It has been observed that transfection efficiency rises with an increase in molecular 
weight, and that the only limiting factor is toxicity. It has been possible to study the effect of 
polymer architecture on the polyplex properties and, as such, linear, star-shaped, (66, 74, 
75) grafted copolymers, (63, 69, 108) statistical copolymers (58, 59, 109-111) and block 
copolymers of pDMAEMA (64, 112) have all been investigated. Studies of pDMAEMA grafted 
onto poly(2-hydroxyethyl methacrylate), (69) hydroxypropyl cellulose, (63) dextran (106), 
and chitosan (70) have highlighted that these grafted or branched polymers have better 
toxicity profiles compared to their high molecular weight, linear pDMAEMA counterparts. 
Moreover, their transfection efficiency is also higher, even at lower cation incorporation. 
(63) This same phenomenon was also seen for hyperbranched pDMAEMA of the same 
molecular weight as linear pDMAEMA. (113) Synatschke et al. (75) investigated the effect of 
branched pDMAEMA on transfection efficiency and cytotoxicity by synthesizing linear, 3-
arm and 5-arm pDMAEMA at different molecular weights. They found that a minimum 
threshold molecular weight is required in order to obtain cellular uptake which differs 
according to the polymer architecture. Moreover, in line with other studies, they reported 
that linear pDMAEMA is more cytotoxic than star-shaped polymers. However, they also 
specified that they noticed an upper limit of the dependency of N/P ratio on cellular uptake. 
This is more likely due to a stronger complexation of plasmid DNA to the polycation, which 
causes a shielding effect of the green fluorescent protein encoded in the plasmid, as 
described by Vader et al. (114)  
PEG has been used profusely as a protective block for pDMAEMA in a similar manner to its 
use with PEI. However, as controlled polymerization techniques lend themselves to easy 
incorporation of other comonomers, there have also been investigations into the use of 
other hydrophilic protective blocks. For example, Song et al. (112) synthesized copolymers 
of poly(N-vinylpyrrolidone) (PVP) and pDMAEMA (PVP-g-pDMAEMA), as well as PVP-
pDMAEMA with poly(methyl methacrylate) (PMMA) (PVP-g-pDMAEMA-b-PMMA) via ATRP. 
The PVP-g-pDMAEMA are able to form coils in aqueous medium, while the PVP-g-
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pDMAEMA-b-PMMA form micelles with PMMA in the hydrophobic corona. The 
incorporation of PMMA allowed for better condensation of pDNA, a higher buffering 
capacity and subsequently a higher transfection efficiency. As such, both of these systems 
display an increased transfection efficiency when compared to PEI (25k) at low N/P ratios.  
In order to tackle toxicity, and inspired by reducible PEI, You et al. (115) synthesized 
reducible high molecular weight pDMAEMA by coupling low molecular weight pDMAEMA 
via disulfide bonds. The use of RAFT-mediated polymerization makes synthesis of well-
defined reducible pDMAEMA easier than reducible PEI. You et al. synthesized a bisfunctional 
RAFT agent and, post-polymerization, removed the trithiocarbonate-end groups in order to 
obtain α,ω-dithiol-pDMAEMA. Thereafter, this was oxidized to form the high molecular 
weight product. They obtained lower cytotoxicity than the non-reducible analogue, and 
equivalent transfections efficiency; however, the transfection of PEI remains significantly 
higher.  
In order to further lessen the toxicity, studies have worked towards developing smarter 
pDMAEMA polymers that contain reduced charge, by incorporating a neutral comonomer. 
Methyl methacrylate (MMA), (112, 116) butyl methacrylate (BMA) (109, 117, 118) and butyl 
acrylate (nBA) (60) have all been copolymerized with DMAEMA in order to decrease the 
cytotoxicity and improve the transfection efficiency. Within this scope, they have exhibited 
a good ability to complex the nucleotides. Nonetheless, slightly higher N/P ratios are 
commonly necessary to achieve this. While the incorporation of nBA improves the stability 
and cytotoxicity of the polyplexes, it reduces their pH-dependent disruptive behavior. Thus, 
this leads to a decrease in RNAi activity, which may be due to endosomal entrapment. (109) 
Conversely, the copolymerization of DMAEMA and BMA produced pH tunable polymer 
micelles, with a pH directly related to the percentage of BMA incorporated in the polymer 
chain. In a study conducted by Nelson et al., varied percentages of BMA were incorporated 
into PEGylated copolymers of DMAEMA and BMA. It was found that polymers with a 
content of 50% or more BMA form micelles at pH 7.4. As the pH is lowered, these micelles 
disassociate at a pH inversely proportional to the percentage of BMA. At 70% BMA, the 
micelles are stable – even at pH 4.0. This suggests that they do not gather enough positive 
charge to destabilize the BMA’s increased hydrophobic interactions. (109) The investigation 
revealed that the cellular uptake of the polyplexes increases as the percentage of BMA 
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decreases; however, 50% BMA conveys the highest luciferase silencing relative to all other 
copolymers. This indicates that the polyplexes, based on the 50% BMA, show better 
endosomal release as a result of their pH dependent profile. Stayton et al. (111) 
incorporated propylacrylic acid (PAA) into this system, forming poly(DMAEMA-b-[DMAEMA-
s-PAA-s-BMA]) via RAFT-mediated polymerization. This system enhances serum stability 
and, most importantly, the endosomal escape of the polyplex is enhanced due to the tuning 
of the polyplex’s pH-dependent membrane disruptive behavior. They later incorporated a 
folate targeting ligand through a folate-containing RAFT agent. This system was reported to 
further facilitate specific cellular uptake through folate-receptor interaction. (110) 
To improve the endosomal escape, pH-labile linkers have been incorporated between the 
hydrophilic surface polymer and pDMAEMA. Lin et al. (119) incorporated a pH labile, ortho-
ester, linker between pDMAEMA and PEG. Unfortunately, they found that the ortho ester 
linker is not the ideal bond type for a gene therapy system as it is stable around pH 6.5. 
Thus, this means that the deshielding effect of PEG was not complete.  
2.2.3 Poly(L-lysine) 
Poly(L-lysine) was one of the first cationic polymers to be used for the complexation of 
nucleotides due to its biodegradable nature. (120, 121) Nevertheless, it was judged to be a 
second rate choice due to its poor transfection efficiency, which was caused by a lack of 
buffering capability, short circulatory half-life and high cytotoxicity. (122) In fact, it has been 
revealed to possess an equivalent toxicity to branched PEI. (36) Nonetheless, it has been 
possible to incorporate other polymer blocks with poly(L-lysine) in order to improve 
transfection efficiency and/or toxicity. (123, 124) One such example was investigated by 
Patil et al., (125) whereby they synthesized triblock poly((amido amine)-b-(ethylene glycol)-
b-(L-lysine)) nanocarriers. The poly(L-lysine) provides the polycationic nature required for 
the condensation of RNAs, as well as encourages cellular uptake. Conversely, the 
poly(amido amine) enhances endosomal escape and cytosplasmic delivery of RNAs due to 
the presence of its tertiary amine groups, i.e. it functions as the proton sponge. The gene 
knockdown is substantially decreased when poly(amido amine) is not present in the 
nanocarrier, thus confirming its essential role in making the delivery system effective.  
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Another such example was the investigation into the use of PEG-b-poly(L-lysine)-b-(L-
leucine) for gene delivery. (126) It was observed that, only by tuning the poly(L-lysine) and 
poly(L-leucine) segments, was it possible to obtain better transfection efficiency than poly(L-
lysine). A similar study incorporated poly(aspartamide) derivatives into PEGylated poly(L-
lysine). (124) The poly(aspartamide) was introduced with the intention of enhancing in vivo 
micelle stability, which was previously seen to be lacking in polyplexes that spontaneously 
assemble due to electrostatic interactions. The presence of both hydrophilic nucleotides and 
hydrophobic polycations is believed to cause some destabilization in vivo. (124, 127, 128) 
These stabilized polyanion micelles were compared to “randomly” hydrophobic control 
micelles, as well as non-PEGylated diblock copolymer micelles. They reported that the non–
PEGylated micelles are more readily taken up by cells, while the “randomly” hydrophobic 
control micelles are taken up the least. But the cellular uptake did not tally with efficient 
gene silencing, as the non-PEGylated micelles’ performance were the least successful. This 
was determined to be due to the fact that these micelles are unable to release the siRNA in 
the cells, whereas the triblock micelles release their payload more effectively. The triblock 
micelles also outperformed the “randomly” hydrophobic control micelles, which was 
correlated to their balance between serum stability and RNA release. (124) 
Matsumoto et al. (129) developed environmentally responsive core shell-type polyion 
complex micelles containing PEG-b-poly(L-lysine) with iminothilane modification, in order 
cross-link the core with disulfide bonds. This crosslinking was utilized in an attempt to 
stabilize the structure of the micelles in physiological conditions, while also allowing for 
cytoplasmic release of RNAs due to the reductive nature within the cell. These responsive 
systems are able to achieve a 100-fold increase in siRNA activity compared to the 
unmodified PEG-b-poly(L-lysine). 
Oishi et al. (130) conjugated siRNA and lactocylated PEG via a β-thiopropionate acid-labile 
linkage, and subsequently complexed it with poly(L-lysine), in order to infuse pH-sensitivity 
into their novel polyion complex micelles. Since the β-thiopropionate bond is stable at 
physiological pH, but readily cleaves at the pH of the intracellular endosomal compartment 
(pH = 5.5), the smart complexes are able to release the siRNA from the lactocylated PEG. 
This allowed them to achieve enhanced gene silencing in hepatoma cells at extremely low 
siRNA concentrations compared to Lac-PEI-siRNA complexes. In fact, they obtained almost a 
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100 times enhancement in RNAi activity for their pH sensitive PIC micelles when compared 
to the Lac-PEG-siRNA conjugate. Very notably, these PIC conjugates retained their RNAi 
activity even when incubated with 50% serum for 30 minutes prior to transfection. Oishi et 
al. (130) investigated the importance of the pH-labile linker to the RNAi activity by inhibiting 
the endosomal acidification. This was achieved by adding nifericin to their culture medium. 
As a result, they saw a significant decrease in the RNAi activity, while no change was seen in 
the RNAi activity for the Lac-PEG-siRNA conjugates. This suggests that the cleavage of the 
acid-labile linker indeed occurs within the intracellular endosomal compartment, and that it 
is probable that the free PEG increases the osmotic pressure within the endosomal 
compartment, which causes swelling and disruption within the compartment. Ultimately, 
this allows for the release of the siRNA into the cytoplasm.  
 
 
Scheme 2.1 A schematic illustration of the synthesis of HPMA-oligolysine polymers containing a 
reducible or non-reducible linker between the polymer backbone and the RNA-complexing, 
oligolysine side-chains 
 
An interesting trend was observed when comparing HPMA-oligolysine polymers synthesized 
via RAFT-mediated polymerization and via conventional free radical polymerization, Scheme 
2.1. (131) The transfection efficiency was seen to be similar in both systems; however, the 
IC50 values (the polymer concentration at which there is 50% cell survival) for the 
conventional free radical polymers were 10-fold lower than those of the RAFT-mediated 
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polymers, indicating that the conventional free radical polymers cause far greater 
cytotoxicity.  
2.2.4 Polyester delivery systems 
Poly(lactic acid-co-glycolic acid) (PLGA) is a biodegradable polyester synthesized through 
copolymerization of lactic acid and glycolic acid. It has found many applications within the 
medical field as its biodegradation time (depending on molecular weight and copolymer 
ratio) can be tailored, and also due to its biocompatibility and FDA approval. PLGA enhances 
the transfection efficiency because it is able to facilitate the continuous intracellular release 
of its payload. Within drug delivery, this has the ability to improve drug release from mere 
days to weeks. (132) Results indicated that this endosomal escape of PLGA nanoparticles is 
not due to the proton sponge mechanism, but rather due to a selective charge reversal, 
from anionic to cationic, on the surface of the nanoparticles within the acidic 
endosome/lysosome, causing the nanoparticles to adhere to the endo-lysosomal 
membranes. (133)  The nanoparticles were reported to not adhere to membranes of early 
endosomal membranes, thus underscoring the need for a decrease in pH in order to 
facilitate endo-lysosomal escape. That said, the drawback of utilizing PLGA for gene therapy 
is that it cannot effectively condense nucleotides. Arora et al. (134) attempted to overcome 
this disadvantage by incorporating PEI into the PLGA delivery system. However, the zeta 
potential of the nanoparticles is not as high as expected, even with the incorporation of PEI. 
Although a slow, sustained release of the miRNA in vitro was reported, a very significant 
increase in the time of release in the presence of serum was also noted. This is most likely a 
result of inefficient complexation of the miRNA. Since then, similar studies have been 
performed with poly(L-lysine) (135); however, the necessity of using non-degradable 
polycations as copolymers reduces the allure of utilizing biodegradable polymers.  
However, the hydrolytic degradability and biocompatibility of polyesters make them highly 
attractive polymers in biological applications – and certainly in gene delivery. (136-138) 
Although polyesters are very structurally diverse, there are synthetic challenges inherent in 
generating new monomers, such as linear step-growth polymerization necessitating 
monomers containing less than 1% impurity. Regardless of this obstacle, Nelson et al. (139) 
recently published their investigation into water soluble polyesters functionalized with 
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imidazolium groups as possible vehicles within gene delivery. Via catalyst and solvent free 
melt polycondensation reactions, they obtained a collection of cationic polyesters of 
imidazolium diol, neopentylglycol and adipic acid with tunable hydrophobicity and thermal 
transitions. The range of polymers acquired included polyesters with 10-75 mol% ionic 
content, imidazolium homopolyester and poly(neopentylene adipate) (neutral), which 
allowed them to investigate the role of charge content and structure on transfection 
efficiency. The polyplexes achieve DNA complexation at very low N/P ratios (N/P of 4 
completely complexes DNA) and show insignificant toxicity in HeLa cells; however, the 
transfection efficiency of all of the polyester systems are orders of magnitude lower than 
PEI and Superfect. Although these results are seemingly disappointing, very few studies 
have investigated these sorts of polycations, compared to the tremendous number of 
studies that focus on polycations based on nitrogen ions, e.g. PEI. As these polymers are 
able to show transfection at low N/P ratios, by adjusting the cationic charge and structure, it 
is plausible that there is still some hope that these polyesters have potential applications in 
gene delivery. 
Kozielski et al. (140) optimized the production of a bio-reducible, linear poly(β-amino ester) 
by incorporating disulfide bonds into the polymeric backbone. These polymers are capable 
of condensing the siRNA into nanoparticles, which subsequently release their payload into 
the cytoplasm of the cells within minutes. This is achieved due to the presence of 
glutathione in the cytosol. In comparison to their non-reducible counterparts, they are able 
to obtain efficient GFP knockdown with decreased cytotoxicity in human brain cancer cells. 
However, the bio-reducible nanoparticles display some instability. Thus, in their later work, 
(141) Kozielski et al. endeavored to address these issues by balancing the bioreducibility of 
the polymer backbone with the hydrophobicity from the poly(β-amino ester). A balance was 
found between the cytotoxicity (lowered by a higher level of bioreducibility and increased 
with a rise in hydrophobicity), and the enhanced delivery and stability of the nanoparticles 
affiliated with hydrophobicity. This was achieved while still maintaining the cytoplasmic 
targeting imparted by the bioreducible nature of the nanoparticles. They were able to 
obtain nanoparticles with enhanced properties and gene knockdown. The nanoparticles also 
display cell specific knockdown, whereby human primary glioblastomas show higher gene 
knockdown (97 ± 4%) than human primary non-cancer brain cells (27 ±9%). 
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2.2.5 Phosphonium-containing polymers 
There has been some interest in polyplexes that are prepared from phosphonium-
containing polymers. (142-144) Clément and coworkers were the first to investigate lipids 
containing phosphonium and arsenium, in comparison to ammonium, for use in gene 
therapy, with respect to the effect that the cationic core plays on structure and 
properties/function. (145-147) They discovered that by replacing the ammonium core with 
phosphonium or arsenium, they were able to achieve an improved toxicity profile, as well as 
higher levels of stability in the solution – both in vitro and in vivo.  
Hemp et al. (143) used conventional free radical polymerization in order to synthesize 
styrenic-based ammonium and phosphonium containing polymers. They varied the length of 
the alkyl substituent attached to the cation in order to elucidate structure’s impact on 
transfection efficiency. They synthesized poly(triethyl-(4-vinylbenzyl)ammonium chloride 
(PTEA), poly(tributyl-(4-vinylbenzyl)ammonium chloride (PTBA), poly(triethyl-(4-
vinylbenzyl)phosphonium chloride (PTEP) and poly(tributyl-(4-vinylbenzyl)phosphonium 
chloride (PTBP). The transfection efficiency of the four polymers was compared to that of 
Superfect and Jet-PEI, and it was seen that PTBP has better transfection efficiency than 
Superfect. Moreover, they observed that PTBA’s transfection efficiency is equivalent to that 
of Superfect. In comparison, the ethyl moiety seems to affect the transfection efficiency of 
the polyplexes, as both of these were inferior to Superfect. As cellular uptake of the ethyl 
containing polyplexes was seen via fluorescent markers on the polyplexes, it was 
hypothesized that the poor transfection efficiencies are due to intracellular mechanisms. 
The consideration was that perhaps the longer alkyl chain in the butyl derivatives aid in 
membrane disruption and endosomal escape, as has been reported in the past. (111, 148) 
Further hypothesizing led them to consider that the shorter alkyl chain may have caused 
stronger electrostatic interactions with the DNA, thus decreasing the release of the DNA and 
inhibiting the end function, as was reported by Song et al. (149) This study stresses that it is 
not only the type of cation used, but also the immediate structural environment around that 
cation that impacts the transfection efficiency of the polyplex delivery system. However, 
these polyplex systems are completely ineffective in serum. Therefore, Hemp et al. (144) 
have subsequently developed a phosphonium-containing diblock copolymer based on their 
previous work, containing a 4-vinylbenzyltributylphosphonium chloride (TBP) block and a 
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colloidal protecting block of either oligo(ethylene glycol)9 methyl ether methacrylate 
(OEGMA) or 2-(methacryloxy)ethyl phosphorylcholine (MPC), all of which demonstrate 
steric shielding of nanoparticles that led to a resistance towards proteins and prolonged 
circulation times. (150, 151) Using RAFT-mediated polymerization, they synthesized their 
diblock copolymer from a macroCTA containing the stabilizing polymer, which then allowed 
them to target TBP with three different molecular weights (DP 25, 50, 75). This enabled 
them to determine the optimal AB block ratio for gene transfection for this system. In order 
to establish the effect of the protecting block, they also synthesized a homopolymer of TBP 
via RAFT-mediated polymerization, with a molecular weight equal to the intermediate 
diblock copolymers. As expected, all MPC87TBPy and OEG52TBPy polymers show an increased 
resistance towards serum proteins, as well as a heightened stability at physiological salt 
concentrations. The diblock copolymers exhibit cell specific uptake in HepaRG cells, with 
poor cellular uptake, and therefore low transfection, in COS-7 and HeLa cells. The 
transfection efficiency in HepaRG cells is equivalent to Jet-PEI; however, the phoshonium 
diblock copolymers cause lower cytotoxicity than the Jet-PEI polyplexes.  
A study by Ornelas-Megiatto et al. (142) was published at around the same time as the 
abovementioned research by Hemp et al. (143, 144), and it showed similar results. In this 
study they synthesized poly(acrylic acid) modified with triethylene glycol monochlorohydrin 
via a hydrolyzable ester linkage. A second post-polymerization modification via a 
nucleophilic substitution of the chloride produced five different polycations containing 
triethylphosphine, tri(tert-butyl)phosphine, tris(3-hydroxy-propyl)phosphine, 
triphenylphosphine and triethylammonium, respectively. After eliminating the 
triphenylphosphine–containing polymer due to low aqueous solubility, the tri(tert-
butyl)phosphine–containing polymer because of high cytotoxicity and the tris(3-hydroxy-
propyl)phosphine–containing polymer for poor transfection efficiency (even though it was 
less cytotoxic than the triethylammonium–containing polymer), it was ascertained that the 
triethylphosphine–containing polymer exhibits lower cytotoxicity than the 
triethylammonium–containing polymer. In addition, it also displays a higher transfection 
efficiency. A notable result from this study was the superior transfection efficiency for the 
triethylphosphine–containing polymer in the presence of serum. Thus, this indicates that 
the polymer is more stable in physiological conditions than the ammonium analog.  
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2.2.6 Amphiphilic polymers 
A few studies have investigated the use of amphiphilic polymers as vectors for gene 
delivery. (152, 153) Due to their amphiphilic nature, these polymers incorporate some 
liposome-like characteristics; however, as they are still synthetic polymers, they are also 
easily modified. Their dual-hydrophilic-hydrophobic nature suggests that they would be less 
cytotoxic than polycations, while still facilitating cellular uptake. (154) 
 
 
Scheme 2.2 A schematic representation of the pH-response hydrolysis causing a transition from hydrophobic 
to hydrophilic form, inducing a breakdown of the self-assembled structure. 
 
Recently, Du et al. (53) developed pH responsive, amphiphilic nanomicelles from 
poly(ethylene glycol)-b-poly[(2,4,6-trimethoxybenzylidene-1,1,1-tris(hydroxymethyl)] 
ethane methacrylate-b-poly(dimethylamino glycidyl methacrylate). These are the first 2,4,6-
trimethoxybenzylidene-1,1,1-tris(hydroxymethyl) ethane methacrylate (TTMA)-based siRNA 
delivery systems to be developed. The hydrolysis of the acetal group in acidic pH causes a 
hydrophobic to hydrophilic transition of the pTTMA, Scheme 2.2. Since the hydrophobicity 
induces self-assembly, this transition causes a breakdown of these self-assembled 
structures. Furthermore, there is evidence showing that this transition promotes endosomal 
escape; thus, this improves the gene knockdown efficiency of the delivery system (at N/P 
ratios ≥ 20) compared to Lipofectamine 2000. Importantly, they reported no significant 
cytotoxicity caused by the nanomicelles. By inhibiting the mechanisms of clathrin and 
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caveolae-mediated endocytosis, as well as micropinocytosis, they showed that nanomicelles 
enter the cell via both clathrin and caveolae-mediated endocytotic pathways. These results 
indicated that the nanomicelles exhibit improved half-life (30 min) in the body compared to 
naked siRNA (<5 minutes). They also investigated the biodistribution of the amphiphilic 
nanomicelles in mice and saw majority accumulation in the liver, spleen and lungs.  
2.3 Decationizing polymers  
The problems associated with the use of polycations are not limited to a systematic issue, 
i.e. the issues associated with systemic cytotoxicity, blood aggregation and hemolysis, as 
well as biodistribution and renal clearance, but also expand to the cellular level. Although, 
PEGylation addresses the systemic toxicity, the cellular toxicity remains a major limiting 
factor due to disturbances it presents to the cell membrane, (36, 81, 155) interferences with 
physiological polyanions, such as enzymes, cell receptors, non-targeted RNA or DNA, etc., 
(156) and their possible implications in cancer formation through the activation of 
oncogenes, which also induces apoptosis. (157) Therefore, there has been a redirect of 
research towards neutral RNAi delivery systems. One such system, developed by Hennink 
and co-workers, (158) employs a decationized polyplex system for the delivery of siRNA, 
Scheme 2.3. RAFT-mediated polymerization was employed to obtain poly(hydroxypropyl 
methacrylate-N,N′-dimethylaminoethanol-b-N-[2-(2-pyridyldithio)]ethyl methacrylamide)-b-
PEG, with folic acid targeting functionality from a (folic acid-PEG5000)2-(4,4′-azobis(4-
cyanovaleric acid)) macroinitiator. Complexation with siRNA was attained by employing 
electrostatic interactions between the cationic polymer with the negatively charged nucleic 
acid, in the same manner as the polycationic systems mentioned above. However, post-
complexation, crosslinking of the polyplexes was obtained via disulfide bonds causing a 
physical entrapment of the RNAs. The polycations were then decationized via cleavage of 
the carbonate ester group through hydrolysis, releasing the positively charged side chains 
from the poly(hydroxypropyl methacrylate) backbone. After cellular internalization of the 
decationized, reducibly cross-linked polyplexes, the disulfide bonds were reduced in the 
cytosol, due to the presence of glutathione, allowing for the payload to be deposited. These 
polyplexes impart lower cytotoxicity compared to their cationic counterparts. 




Scheme 2.3 Schematic illustration of the complexation of poly(hydroxypropyl methacrylate-N,N′-
dimethylaminoethanol-b-N-[2-(2-pyridyldithio)]ethyl methacrylamide)-b-PEG via electrostatic interaction 
between the RNA and the hydroxypropyl methacrylate-N,N′-dimethylaminoethanol moiety, and crosslinking 
via disulfide formation. Subsequent  de-complexation is also shown caused by hydrolysis-induced de-
cationization 
 
Monteiro and coworkers (159) developed poly(2-(N,N-dimethylamino)ethyl acrylate) which 
strongly resembles pDMAEMA; however, they were able to undergo self-catalyzed 
hydrolysis in aqueous medium into poly(acrylic acid) and 2-(N,N-dimethylamino)ethanol. 
This degradation occurs over 10 hours, but is independent of pH and other external cues. 
These de-cationizing polymers behave similarly to pDMAEMA, with the marked difference of 
being able to release their payload within the cytoplasm due to their degradative behavior. 
(111, 160) Werfel et al. (161) compared PEGylated copolymers of DMAEA and BMA  to their 
DMAEMA analogue and noted an enhanced cytosol delivery of the degrading species. It is 
important to note that the hydrophilic protection, e.g. PEGylation, remains an important 
Stellenbosch University  https://scholar.sun.ac.za
31 
 
component for polyplexes regardless of the charged nature of the polymer backbone. (162, 
163)  
2.4 Polymers directly bonded to RNA 
There have been some attempts in connecting neutral polymers directly to nucleotides via 
labile linkers, e.g. disulfide (164) or pH-labile (102) bonds. This means that the nucleotide is 
modified, usually on the 5’-end, for this functionalization to be possible. Maynard and 
coworkers (164) synthesized RAFT-polymerized poly(PEG acrylate), a polymer similar to PEG, 
using a pyridyl disulfide (activated disulfide) RAFT agent. Poly(PEG acrylate) has been shown 
to facilitate passive targeting through increased circulation time. Post-polymerization, this 
polymer was conjugated to a thiol-modified siRNA. They obtained efficient binding, as well 
as reversibility of the bond. In a later publication, (165) they combined the polymer-siRNA 
conjugates with a fusogenic peptide KALA, which is able to facilitate endosplasmic escape, in 
order to assess the in vitro efficiency of the system. They reported that transfection 
efficiency was comparable, but slightly lower, than that of Lipofectamine complexed siRNA. 
Low and high molecular weight poly(PEG acrylate), 6000 and 17 400 g·mol-1, respectively, 
exhibited little impact on transfection efficiency, while the presence of both KALA and 
poly(PEG acrylate) components was of utmost importance, with transfection efficiency 
decreasing significantly with the absence of either of the components. 
Recently, Lin and Maynard (166) described, for the first time, a study in which the polymer 
was grafted from siRNA, although the strategy had previously been used for DNA. (167)  The 
ATRP initiator was attached to the siRNA via a disulfide bond, thus introducing a reducible 
link between the polymer and siRNA for later cleavage within the cytoplasm. Poly(ethylene 
glycol) methyl ether methacrylate (PEGMA) and di(ethylene glycol) methyl ether 
methacrylate (DEGMA) were grafted from the siRNA via AGET ATRP. These monomers were 
chosen based on having previously exhibited a nuclease stabilizing effect on siRNA. (165) 
They reported some low initiator efficiency, causing some siRNA to remain unreacted; 
however, they obtained good control over molar mass and its distribution. This technique 
represents a possible future alternative for the introduction of polymeric delivery.  
However, no in vitro or in vivo results have been published to date.  
Stellenbosch University  https://scholar.sun.ac.za
32 
 
Perrier and coworkers (168) used surfactant-free emulsion polymerization to synthesize 2-
(2-pyridyldithio)ethylamine modified, carboxyl-α-end HOOC-poly(acrylamide)-stabilized 
polystyrene latex particles. The disulfide ligand was then conjugated to a miRNA duplex via a 
reducible disulfide bond. Thereafter, they successfully characterized the conjugation as well 
as subsequent release of miRNA via incubation in glutathione. No in vitro results were 
shown, and therefore further investigation would be required in order to evaluate the true 
potential that these nanoparticles have within gene delivery, especially focusing on possible 
aggregation and serum stability. 
The direct chemical modification of nucleotides can cause some difficulties, as possible side 
reactions may occur, and because stimulation of premature degradation of the nucleotide 
may take place. Furthermore, purification of a polymer-nucleotide can be challenging. To 
combat this, Averick et al. (169) reported the use of three covalently bonded, biocompatible 
polymers (PEG-methacrylate-pOEOMA; pOEOMA-co-MEO2MA and pOEOMA-co-DMAEMA) 
to a passenger siRNA via click chemistry, in order to obtain a polymer-escort siRNA. The 
passenger siRNA was complementary to the guide siRNA (the biologically active 
therapeutic), enabling the guide strand to be annealed to the polymer-escort siRNA. This 
system allowed the polymers to provide nuclease resistance and facilitate cellular uptake, 
while the guide siRNA remained unmodified. Unfortunately, a limiting factor in this system 
remains, as the guide strand needs to dissociate from the passenger strand in order for it to 
form the RISC complex, and in so doing allowing the gene expression to be regulated. That 
said, in vitro experiments resulted in efficient luciferase knockdown for all three polymer 
escort systems.   
2.5 Nanoparticles 
As polyplex formation is dependent on electrostatic interactions, the polyplex’s 
superstructure is thus reliant on its anionic payload, which, in this case, is the RNA/DNA 
molecule. Because siRNA and miRNAs are too small to guarantee stability resulting from 
charge, the polyplexes have an inherent flaw in their make-up. This also means that the -
potential of the polyplex is dependent on the siRNA and, subsequently, the aggregation 
behavior of the system differs depending on the payload. As mentioned before, polyplex 
aggregation is of grave concern. As the physiochemical properties of the superstructure are 
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conditional on the RNA payload, this competitive interaction with other polyanions in the 
physiological environment is also at the mercy of the payload. In a dynamic system, for 
example within the physiological environment, the polyplex’s superstructure may be 
compromised or weakened due to this dependence on the payload. For this reason, some 
researchers have shifted their attention towards nanoparticles and nanogels (170) with a 
superstructure independent of their payloads. Nanoparticles and nanogels possess stable 
size and morphology, as well as stability that is independent of their load. The first siRNA 
clinical trial using nanoparticles as gene delivery tools was published in 2010. (7) The 
nanoparticles were formulated from PEG that had been conjugated to adamantine, making 
it able to form inclusion complexes with cyclodextrin. The nanoparticles were functionalized 
with transferrin protein targeting ligands in order to facilitate specific cellular uptake, due to 
the overexpression of transferrin protein receptors on cancer cells. Thereafter, the particles 
were administered intravenously and a gene knockdown effect was seen in tumor cells.  
Siegwart et al. (171) developed a library of cationic core shell nanoparticles, with various 
hydrophilic surface polymers, to protrude from the nanoparticles and protect the shell. They 
used crosslinkers with secondary and tertiary amine functionalities in order for these 
nanoparticles to be able to complex with nucleotides, while still ensuring that the particle 
formation was not based on polymer-nucleotide interactions. Successful in vivo delivery of 
cholesterol-protected siRNA to liver hepatocytes in mice was reported, while naked siRNA 
was reported to be distributed to the liver, kidneys and lung.  
Zentel and coworkers (172) developed cationic nanogels from amphiphilic ester precursor 
polymers, which show a tendency towards aggregation in polar aprotic solvents such as 
DMSO. They followed Siegwart’s example (171) and cross-linked the hydrophobic inner core 
with amine functionalized cross-linkers, allowing them to obtain a cationic core for siRNA 
interaction. Due to a low knock-down efficiency of these nanogels, they then adapted these 
crosslinker molecules to contain disulfides or ketal (pH labile) linkers (173) in order to obtain 
second generation, degradable nanoparticles. This, in turn, produced stimuli responsive 
nanogels that can be destabilized under specific conditions, such as the reductive 
environment in the cytosol or acidic conditions in the endosome. The particle size and 
stability is independent of their payload. After in vitro analysis of these nanogels, it was 
ascertained that the disulfide containing cross-linker required relatively high N/P ratios 
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compared to the ketal-containing cross-linker. This corresponded to their previously 
published results. (174) This was due to the need for elevated concentrations of glutathione 
to be present in order for the disulfide bond to break. Such levels of glutathione are 
predominantly present within the cytoplasm; (175) thus, the nanogels had to be transported 
into the cytoplasm in order to disassemble. Predominantly, this does not seem to 
successfully occur. (51, 176) Therefore, they continued their in vivo work with the ketal-
containing cross-linker and saw a significant improvement in knock-down compared to their 
previously unresponsive nanogels. In fact, the in vitro knockdown, caused by these 
nanoparticles being capable of effectively delivering their payload, was comparable to that 
of Lipofectamine. The nanoparticles were tested on different cell lines for cytotoxicity, and 
no significant toxicity was detected in cells after transfection with concentrations of up to 
400 nM. Subsequently, Zentel and coworkers conducted consecutive injections in order to 
establish more information of the clearance capabilities of the degradable nanoparticles 
compared to the non-degradable, spermine crosslinked analogues. They discovered that the 
biodegradable ketal-modified particles reported superior clearance properties. The 
biodegradable property of these nanoparticles, as well as the high in vitro and in vivo 
transfection efficiency, make these nanoparticles stand out as true contenders in the race 
for gene therapeutic delivery systems. Of course, one area of concern is the fact that, 
although the particles themselves are degradable due to the cleavage of the crosslinker, 
their polymer components are not. This means that, while the nanoparticles degrade, the 
cationic polymers are still present within the cells post-degradation. These polycations may 
destabilize the endosomal membrane allowing for endosomal release; however, they are 
still able to interact with the RNA therapeutics and decrease the knockdown efficiency of 
the therapeutics. Furthermore, the presence of these polymers poses the same cytotoxic 
threat as the original polyplex systems.   
Klinker et al. (177) recently published a study describing the formation of bio-responsive 
polypept(o)ide nanohydrogels synthesized from polypeptoid polysarcosine and S-
alkylsulfonyl-protected cysteine N-carboxyanhydrides. The S-alkylsulfonyl cysteine promotes 
micelle self-assembly and provides a chemoselective reactivity towards thiols, allowing for 
reductive disulfide crosslinking. They demonstrated that these nanohydrogels are able to 
complex with cholesterol-modified siRNA, while still maintaining their size and morphology 
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and exhibiting an almost neutral -potential. This provides an interesting new platform for 
gene therapy. However, they did not show any results describing the nanohydrogel’s 
transfection efficiency. It is plausible that they will suffer the same challenges as Zentel’s 
disulfide nanogels described above. Thus, further investigation is necessary in order to truly 
assess these nanohydrogel’s future potential in the field of gene therapy. 
2.6 Future outlooks 
Extensive work has been conducted within the development of non-viral, polymeric delivery 
system for gene therapy. Nonetheless, despite all efforts, the challenges of the past decade 
remain prevalent. Although cationic polyplexes allow for efficient uptake, they lack 
biocompatibility and efficiency in knockdown effects. The issues of endosomal escape and 
cytosolic release are still very real and are, therefore, the limiting factor within any delivery 
system. Thus, they should remain the focal point when designing gene delivery systems in 
the future, while also keeping cytotoxicity in mind. It is probable that future research will 
see a marked shift towards vectors in the form of neutral or amphiphilic 
nanoparticles/nanogels or polymeric-RNA escort systems.   
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α,ω-Heterotelechelic vinyl polymers with high chain-end fidelity, 
and their block copolymers, have attracted much attention for 
applications in drug delivery. However, their synthesis requires 
multiple steps of protection, deprotection and/or activation. In 
this chapter, a facile route of obtaining poly(N-vinylpyrrolidone) 
using chain transfer agents (CTAs) that were previously believed 
to be ‘unsuitable’ was designed. This method resulted in 
difunctional PVP with high chain end fidelity, as well as PVP 
polymerized using a bromine functional xanthate CTA in order to 
produce PVP macroATRP initiators for later chain extension with 
activated monomers.  




Precision polymers have played an integral role in the advancement of drug delivery by 
providing a platform for targeted delivery of drugs, controlled release and increased 
circulation, leading to lowered overall dosages and reduced side-effects. (1-4) These 
polymeric drug delivery systems have developed into responsive structures with the not-so-
improbable hope of tailor-making them for specific applications. As such, it can be very 
beneficial to couple bioactive compounds or biomacromolecules to telechelic polymers 
containing complementary functional end-groups. (5-10) Therefore, there is growing 
interest in producing α,ω-heterotelechelic polymers, whereby the end-groups can react 
orthogonally to produce “smarter” systems. The advancement of reversible deactivation 
radical polymerization techniques (RDRP), such as reversible addition–fragmentation chain 
transfer (RAFT) mediated polymerization (11-15) and atom–transfer radical polymerization 
(ATRP) (16, 17), has provided a simplistic route to obtain polymers with controlled 
molecular weight, narrow molecular weight distributions and defined end-groups available 
for bioconjugation. RAFT–mediated polymerization utilizes a chain transfer agent in order to 
control the polymerization. These chain transfer agents employed in RAFT–mediated 
polymerization are made up of a leaving (R–) group and a thiocarbonyl thio (Z–) group, 
which form the α– and ω–chain ends of the final polymer, respectively, Scheme 3.1 (12-15, 
18) Therefore, through careful selection of functional R– and Z–groups, it is possible to 
impart desired α– and ω–end group functionalities. 
 
 
Scheme 3.1 General representation of a RAFT–mediated polymerization using chain transfer 
agents containing an R and Z group, resulting in polymers with α– and ω–chain ends, respectively 
ω-chain end
α-chain end
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The instability of the Z–group to nucleophiles allows for a simple route in which the ω-chain 
end can be modified, post-polymerization, in order to obtain useful functional groups, 
including via aminolysis, hydrolysis, thermolysis, oxidation and reduction. (19, 20) The 
production of thiols and disulfides through aminolysis is particularly useful, since thiols 
readily react in a Michael addition with acrylate, vinylsulfone and maleimide functionalities 
(21-24), while disulfides are useful to produce biologically reducible bonds with peptides or 
proteins. (25) 
Several studies imparted α-chain end functionality on polymers by designing RAFT agents 
with R-groups that contain functional groups such as activated disulfides (26), activated 
esters  (27), biotin (6) or azides. (28) These can be used post-polymerization for further 
modification to yield α-end functional polymers. However, the use of reactive functional R–
groups causes difficulties for the polymerization of many monomers, especially true for (less 
activated) vinyl monomers such as NVP. (29-32) It has previously been reported by our 
group that NVP can undergo many side reactions during xanthate–mediated polymerization, 
which negatively influence the control over the polymerization. (33) Pound et al. previously 
reported that the presence of certain functional groups on the RAFT agent enhances the 
formation of side products during the polymerization of NVP. This was especially true in the 
presence of xanthates containing R-groups with carboxylic acid and hydroxyl functionalities, 
which were shown to cause significant dimer formation of NVP. (33) Therefore, restrictions 
are placed on the type of functional groups that can be present during RAFT–mediated 
polymerization of NVP. Of course, this means that if any of these ‘restricted’ functionalities 
are desired, post-polymerization functionalization is necessary, which is not always 
straightforward or facile.  
In order to obtain α,ω-heterotelechelic PVP, the restrictions caused by R-group functionality 
must be circumvented. Different RAFT agents have been designed whereby functional 
groups have been protected, and are subsequently deprotected post-polymerization, or 
altered post-polymerization. (34-36) Shimoni et al. (34), for example, polymerized NVP in 
the presence of O-ethyl S-(phthalimidomethyl) xanthate. Post-polymerization they used 
hydrazine, which aminolyzed the xanthate into a thiol and hydrazinolyzed the 
phthalamidomethyl R-group, in order to obtain a primary amine. Another such example has 
been described in our group, where Reader et al. (36) designed a linear acetal functionalized 
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RAFT agent, O-{1-[1-(3,3-diethoxypropyl)-1H-1,2,3-triazol-4-yl]ethyl} O-ethyl 
carbonodithioate, whereby a one-pot orthogonal end-group modification procedure was 
employed to obtain α,ω-heterotelechelic polymer. In this case, the linear acetal functional 
α-end group was converted into an aldehyde group and the xanthate ω-chain end was 
converted into a thiol. However, very high CTA:AIBN (4:1) ratios were necessary in order to 
achieve reasonable monomer conversion. This high ratio is known to lead to loss of end-
groups, yielding lower functionality, which is defying the ultimate goal of using this RAFT 
agent.  
The common method of xanthate–mediated polymerization of NVP is at 60 °C in bulk or in 
organic solvents. (29, 30, 32, 33, 37-47) Via this method, it is accepted that up to 10% of the 
polymer chain ends are unsaturated. (33) Anything above this temperature increases the 
formation of unsaturated chain ends. These unsaturated chain ends lead to a loss of ω-chain 
end functionality. Furthermore, water, as a rule, has been avoided as a solvent, as it is 
known to react with NVP, thus causing numerous side-reactions to occur. (33, 48-51) 
However, there are many advantages of using an aqueous medium in a polymerization 
process, the most important of these being that it is non-toxic and environmentally friendly. 
Due to the high viscosity within the reaction mixture that occurs during bulk polymerization, 
complications arise, such as increased dispersity, unsaturated chain ends, and ultimately 
decreased control over the polymerization. This is especially true at high monomer 
conversion. Destarac et al. (52, 53) successfully polymerized NVP in aqueous medium at low 
temperatures using redox initiators (ascorbic acid/t-BuOOH and Na2SO3/t-BuOOH) in the 
presence of a xanthate CTA. The byproducts of hydrolysis and dimer formation that are 
typically present during xanthate–mediated polymerizations of NVP at elevated 
temperature in organic media were shown to be absent under these conditions and, due to 
the low temperature, no formation of unsaturated chain ends seemed to occur.  
Due to the low activity of NVP, it requires the use of a RAFT agent with a poorly stabilizing Z-
group, such as a xanthate or dithiocarbamate. (14, 18, 30, 37) However, this presents 
challenges in preparing block copolymers containing PVP, since these Z-groups are 
unsuitable for more activated monomers. (14, 15) The idea of block copolymers containing 
PVP remains appealing; hence, several studies have investigated ways in which to obtain 
such block copolymers, including the use of ‘switchable’-CTAs. (43) Others have separately 
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synthesized homopolymers and conjugated the blocks through click chemistry. (54) More 
recently, there have been some studies investigating the use of dual RAFT/ATRP 
chloroxanthate CTAs. (44, 55) Matyjaszewski and coworkers (44) reported that the presence 
of small amounts of bromoxanthate polyfunctional initiator-transfer agents, or inifers, leads 
to almost quantitative dimerization of NVP, and therefore, they employed a chloroxanthate 
inifer with decreased electrophilicity compared to the bromoxanthate inifer. Despite the 
success of the polymerization using the chloroxanthate CTA, they faced problems when 
chain extending the PVP macroinitiators, possibly due to the single methyl substituent on 
the R-group of the CTA, but also possibly due to the chloro– rather than bromo– ATRP 
intiator. Employing a similar system containing two methyl substituents on the R-group, 
Jumeaux et al., (55) showed successful RAFT–mediated polymerization of NVP and ATRP–
mediated chain extension of triethylene glycol methacrylate (TEGMA), Scheme 3.2. 
However, if it were conceivable to use bromoxanthate CTA, the possible applications of the 
block copolymers are endless. 
 
 
Scheme 3.2 RAFT-mediated polymerization of NVP using chloroxanthate chain transfer agent and 
further chain extention of the macroinitiator with triethylene glycol methacrylate, as described by 
Jumeaux et al. (55) 
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Since the commercial applications of functional PVP are widespread, the ideal 
polymerization method is one that allows for the facile production of α,ω-heterotelechelic 
polymers with high chain-end fidelity. Furthermore, simple preparation of block copolymers 
of PVP holds exciting possibilities. In this study, a method is presented whereby unpurified 
NVP is polymerized to high monomer conversion and with good control over molecular 
weight in the presence of CTAs containing functionalities that were previously deemed 
unsuitable. Through NMR spectroscopic analysis, high chain-end fidelity is illustrated. 
Furthermore, the ability of polymerizing NVP with a bromoxanthate CTA, previously 
reported to cause dimerization of NVP and thus cause retardation of the polymerization, is 
shown. (44) This allows for the formation of PVP macro-ATRP initiators for future chain 
extension with activated monomers. 
3.2 Results and Discussion 
3.2.1 Polymerization of NVP 
The three CTAs (R3.1-3) seen in Figure 3.1 were synthesized for this study. CTAs R3.1 and 
R3.2 were synthesized according to protocols previously reported by Pound et al. (33) R3.2 
has previously been used in the polymerization of NVP in our group; however, the results 
showed large fractions of unsaturated chain ends and poor monomer conversions. (56) 
Pound et al. (33) showed that the use of R3.1 and R3.2 as CTAs in the RAFT–mediated 
polymerization of NVP resulted in dimer formation, and retardation of conversion to PVP. 
R3.3 is a novel CTA, where 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) was used 
to couple R3.1 and 2-hydroxybenzaldehyde via a carbodiimide coupling reaction. R3.3, the 
benzaldehyde functional CTA, provides a novel way to introduce a benzaldehyde functional 
group pre-polymerization. According to 1H NMR spectrum, two isomers of R3.3 are present 
in the final product; approximately 30% of the benzaldehyde group is in the meta-position 
while the rest is in the ortho-position, Figure 3.6 (a) in Section 3.2.2. The isomeric 
positioning of the benzaldehyde is of no consequence to the end-application as the 
importance simply lies in the presence of the functional group for end group conjugation. 
There is an unassigned quartet peak in the 1H NMR spectrum at 9.91 ppm, possibly due to 
an impurity. However, purification via column chromatography was unsuccessful. R3.3 was 
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used, as is, for the polymerization of NVP, discussed further in Section 3.2.2. The use of an 
aldehyde functional CTA has, to our knowledge, never been reported in literature.  
 
 
Figure 3.1 Chemical structures of chain transfer agents R3.1-3 used for the RAFT-mediated 
polymerization of NVP 
 
Table 3.1 A summary of results from RAFT–mediated polymerization of NVP using R3.1-3 
















































AIBN distilled R3.1 60 24 48 2400 900 1700 1.9 












undistilled R3.3 25 24 89 4450 4300 5400 1.3 
§ - Determined by SEC in DMAc relative to PMMA standards.  
‡  - Conversion obtained through gravimetric analysis. 
 
Distilled and undistilled NVP was polymerized in the presence of R3.1-3 using different 
polymerization methods, including a slightly modified version of the redox initiated 
conditions described by Destarac et al. (52, 53) and standard thermally initiated RAFT–
mediated polymerization at 60 °C, (P3.1-9, Table 3.1). The polymers were analyzed using 
SEC calibrated using PMMA standards, and the SEC chromatograms of polymers synthesized 
using R3.1-3 can be seen in Figure 3.2. As expected from literature, the polymerization of 
distilled NVP with R3.1 as CTA was retarded in organic solvent at 60 °C, and thus, relatively 
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low molar mass polymer was obtained with poor control (Đ = 1.90) (P3.5). (33) Under redox 
initiated polymerization conditions, it was possible to suppress the formation of dimers, 
previously attributed to the presence of carboxylic acid and hydroxyl R-group functionalities 
of CTAs, and thereby obtain polymers with predetermined molar masses and with relatively 
low dispersities (Đ < 1.3) (P3.1-4; P3.7). It can be noted that the use of distilled NVP 
compared to undistilled NVP yielded only slight improvements in the control over molecular 
weight and its distribution (P3.2 and P3.3). Thus, this method eliminates the need for 
tedious purification of NVP pre-polymerization. Often, during the distillation of NVP, 
hydration of the vinyl bond occurs to a large extent.(33,46) Although reversible, this retards 
the polymerization, which consequently leads to further problems due to the formation of 
unsaturated chain ends. Typically, vacuum distillation is employed during purification; 
however, the temperature required for efficient distillation can reach 60 °C, thus inducing 
oligomer formation. The process of distillation ultimately results in cost implications, and, as 
such, should preferably be avoided.  
 
 
Figure 3.2 (a): Molar mass distribution for the RAFT–mediated polymerization of NVP with R3.1-3 
using thermally initiated and redox initiated methods in water and 1,4-dioxane and (b): Molar 
mass distribution for the RAFT mediated polymerization of NVP with R3.1 using the redox method 
targeting different molar masses 
 
The redox initiated and thermally initiated RAFT–mediated polymerization of NVP differ in 
two parameters: temperature and solvent (water). Thus, it is possible that either of these 















Stellenbosch University  https://scholar.sun.ac.za
61 
 
parameters is responsible for the flexibility of this method towards CTAs with protic 
functionalities. It is possible that the lower temperature decreases the dimer formation, 
thus, allowing the polymerization to occur, or it is possible that the presence of water 
interferes with the interaction between NVP and the CTA containing protic functionalities, 
thus allowing for the polymerization to take place. In order to further understand this, 
polymerizations were conducted where only one of these parameters was varied, i.e. the 
solvent. Polymerization of undistilled NVP in water at 60 °C using a water soluble initiator, 
4,4’-azobis(4-cyanovaleric acid) (ACVA) and R3.1 as CTA yielded no polymer. When the 
polymerization was performed with distilled NVP, 5% monomer conversion was achieved 
and polymer with high dispersity (Đ = 2.87) was obtained. These results lead us to believe 
that the temperature of the polymerization method plays a crucial role in the mechanism of 
the polymerization, allowing for use of previously believed to be unsuitable CTAs. 
 
 
Figure 3.3 Molar mass as a function of conversion plot for the redox initiated polymerization of 
NVP using RAFT agent R3.1. Dotted lines represent the theoretical Mn curve 
 
A kinetic study of the polymerization of NVP with R3.1 was performed using the redox 
initiated method in water. Samples were taken hourly, until the reaction mixture was too 
viscous to continue stirring (ca. 4 hours). The evolution of Mn and Đ as a function of 
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monomer conversion is depicted in Figure 3.3. From Figure 3.3, it is worth noting that 70% 
of the monomer is converted to PVP within a quarter of the reaction time. Figure 3.3 depicts 
a linear evolution of Mn with monomer conversion up to about 80% conversion values, 
before slightly tapering off as would be expected at relatively high monomer conversion. 
Figure 3.3 is thus sufficient in exemplifying the level of control over NVP polymerization 
using R3.1. 
3.2.2 End-group analysis and post-polymerization functionalization 
As mentioned above, the formation of unsaturated chain ends is prevalent in thermally 
initiated RAFT–mediated polymerizations of NVP due to the thermally labile nature of the 
xanthate moiety adjacent to the terminal NVP unit. This unsaturation not only decreases the 
control over the polymerization, it also causes problems with post-polymerization 
functionalization, as the chain ends necessary for functionalization are no longer present. 
For certain applications of the polymer, especially for biological applications where 
telechelic polymers are desired, the significant loss of end groups may cause a noteworthy 
disadvantage. Pound et al. showed that 1H NMR spectroscopy can be used to quantify the 
presence of these unsaturated chain-ends. (33) The signal representing protons attached to 
the unsaturated carbons a and b (Figure 3.4a) can be seen at approximately 4.7 ppm and 6.8 
ppm, respectively. The polymers obtained from the thermally initiated conventional RAFT–
mediated polymerization method with R3.2 (P3.8) shown in the NMR spectrum in Figure 
3.4a exhibit a very high percentage of unsaturation, which is in agreement with the 
observation of a high dispersity. These signals are absent in the 1H NMR spectrum of the 
PVP synthesized using the redox initiated method (P3.7), see Figure 3.4b, indicating that no 
unsaturated end groups are formed under these conditions. This lack of unsaturation is due 
to the polymerization taking place at a lower temperature, as was noted in the case for 
Destarac et al. (52,53) The absence of unsaturated chain ends makes this technique ideal for 
polymerization where chain end fidelity is important, such as in the production of telechelic 
polymers. 
 




Figure 3.4 Depiction of unsaturated chain ends analysed by 1H NMR spectroscopy. Spectra of (a): 
PVP synthesized using thermally initiated conventional RAFT–mediated polymerization (P3.8) and 
(b): PVP synthesized using redox initiated RAFT–mediated polymerization conditions (P3.7). Labels 
a and b indicate protons belonging to the unsaturated chain ends, while c and d indicate the 
protons present when the ω-end group is still present  
 
It has been shown numerous times that aldehydes readily react with amine functionalities, 
such as those found in biological compounds, e.g. proteins and peptides. This occurs under 
mild reaction conditions using reductive amination via Schiff base formation. (57, 58) It has 
also been previously reported that it is possible to obtain α-aldehyde functionalized poly(2-
hydroxyethyl methacrylate) by oxidizing the brush side chain hydroxyl groups (59) via the 
Albright-Goldman oxidation. (60, 61) This reaction employs a mixture of dimethyl sulfoxide 
and acetic acid in order to oxidize alcohols under mild reaction conditions. After aminolysis 
of P3.7, which was prepared using R3.2 and therefore contains a hydroxyl-functional α-chain 
end, the Albright-Goldman oxidation was employed. Although this oxidation is not as 
quantitative as, for example, the Swern oxidation, (62) it has no effect on the backbone of 
PVP. Figure 3.5 confirmed that the Albright-Goldman method converted some of the 
hydroxyl groups to aldehyde moieties. The observed aldehyde proton is characteristically 
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broad compared to aldehyde protons in small molecules, due to the slightly varying 
chemical environment inherent in polymeric systems. Although, the conversion efficiency 
was not quantified, this method is a very convenient protocol to obtain aldehyde functional 
PVP, underscored by the CTA synthesis being relatively straightforward and inexpensive.  
 
 
Figure 3.5 1H NMR spectra of (a): P3.7 after aminolysis with 2-aminoethan-1-ol, where it is possible 
to see the peak corresponding to the protons of the hydroxyl chain end, a, and (b): after oxidation 
via the Albright-Goldman method, where it is possible to see the peaks representing the aldehydic 
proton, b and residual hydroxyl protons a’. 
 
Since this redox initiated method tolerated the use of unpurified NVP and the presence of 
protic functional groups, it was plausible to believe that it might also be more tolerant to 
the presence of a reactive moiety such as a benzaldehyde functional group. The redox 
method of polymerization of NVP using R3.3 yielded PVP with good control over the 
molecular weight and its distribution (P3.9), while thermally initiated conventional RAFT–
mediated polymerization with R3.3 yielded no conversion of NVP. Using 1H NMRit is 
possible to see that the benzaldehyde proton is present on the polymer, with no need for 
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further post-polymerization modification. However, the aldehyde proton peak in the 
spectrum looks slightly unusual since it is not one single, broad peak which is generally 
obtained for polymeric, aldehyde proton end-groups. This could be attributed to the 
isomeric forms of R3.3, and thus two different benzaldehyde proton chemical environments 
are present. It is also possible that some of the ω-chain end has been converted to an 
aldehyde moiety. However, more investigation in the future is necessary to further 
characterize this polymer, including through MALDI-TOF. It would also be interesting to 
further conjugate the aldehyde moiety with an amine via reductive amination followed by a 




Figure 3.6 1H NMR spectrum of PVP polymerized with R3.3 using the redox method (P3.9) 
 
Due to the nature of initiation, deactivation and re-initiation of RAFT–mediated 
polymerizations, it is expected that some initiator derived “I” end groups are formed in 
competition with the reinitiating leaving groups of the original CTA. However, the majority 
of the α–chain ends are usually derived from the original CTA’s R group; therefore, making it 
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possible to quantify the ω–chain ends relative to the α–chain end to establish how many of 
the polymer chains are living, i.e. the fraction of chains carrying the RAFT chain end. For an 
ideal RAFT–mediated polymerization in which initiator–derived chains are neglected, the 
theoretical ratio of α– to ω–chain ends should be 1. (64, 65) Since the chemical shift of the 
protons belonging to the α– and ω–chain ends of P3.9 are resolved, Figure 3.6, it was 
possible to compare the integrations corresponding to the ω–chain end protons (b) with 
those of the benzaldehyde protons on the α-chain end (k, m, and n). These results indicated 
that there was high chain-end fidelity, since the number of protons of the α– and ω– chain 
ends correlated to 0.96 relative to each other. Due to an overlay between the solvent peak 
(CDCl3) and the peaks corresponding to i and j, these were not used for this correlation 
analysis.  
This emphasizes the robust nature of the redox initiated polymerization in comparison to 
thermally initiated conventional RAFT–mediated polymerization. This means that long 
purification procedures during the synthesis of the CTA, for example column 
chromatography, are not necessary in order to gain control over the polymerization. 
Moreover, any impurities can be removed easily during the precipitation of the polymer. 
Most importantly, it opens new avenues for the production of telechelic PVP. 
Further, we report an example whereby α,ω-heterotelechelic PVP was produced through 
facile post-polymerization functionalization of P3.2, seen in Scheme 3.3. This post-
polymerization functionalization is only possible due to the tolerance for protic functional 
groups on the CTA. The xanthate was converted into an aldehyde moiety (P3.10) via the 
method previously published by Pound et al. (57) In short, the xanthate end group is 
converted to a hydroxyl group by hydrolysis, which was subsequently converted to an 
aldehyde functional group by heating at 120 ˚C under reduced pressure. Subsequently, the 
carboxylic acid on the α-chain end was reacted with 2-hydroxyethyl acrylate via a 
carbodiimide coupling using N,N'-dicyclohexylcarbodiimide (DCC) (P3.11). 




Scheme 3.3 Post-polymerization modification of P3.2’s α-chain end into aldehyde end-groups and 
ω-chain end into an acrylate end group, ready for application as a α,ω-heterotelechelic polymer  
 
Via 1H NMR spectroscopic analysis, Figure 3.7, it was possible to quantify the ω–chain end 
functionality relative to that of the α–chain end of P3.12, in the same manner as P3.9 above. 
High chain-end fidelity was retained as the proton integrations on the α–chain ends (k and l 
in Figure 3.7) and ω–chain ends (f in Figure 3.7) correspond to a ratio of 0.97. The peak 
corresponding to the aldehyde proton is characteristically broad for a polymeric system due 
to the slightly varying chemical environments. This example of post-polymerization 
functionalization further underscores the beneficial nature of the capability of this 
technique to accommodate CTAs containing reactive functional moieties in the production 
of α,ω–heterotelechelic PVP. P3.11 is capable of reacting with bioactive compounds or 
biomacromolecules containing amine functional moieties on the ω-chain end, as well as via 
a Michael addition on the α-chain end. Thus, making it capable of orthogonal chain end 
functionalization reactions. 




Figure 3.7 1H NMR spectrum of P3.12 after post-polymerization modification of α and ω-chain 
ends. 
 
3.2.3 Polymerization of NVP using bromoxanthate CTAs and subsequent ATRP chain 
extension 
As mentioned above, Matyjaszewski and co-workers showed that the use of a 
bromoxanthate CTA caused dimer formation during NVP polymerization. R3.4 and R3.5, 
Figure 3.8, were synthesized according to literature, and the resulting structures were 
confirmed by 1H NMR spectroscopy, which correlated well to literature. (44, 55) The CTAs 
were subsequently used for the polymerization of NVP using the redox initiation method.  
 
 
Figure 3.8 Chemical structures of bromoxanthate chain transfer agents, R3.4 and R3.5, used for the 
RAFT-mediated polymerization of NVP 
 
The use of ascorbic acid/t-BuOOH resulted in low conversion of monomer; however when  
Na2SO3/t-BuOOH was employed instead, the polymerization yielded polymers (P3.12 & 
P3.13) with good control over the molecular weight and dispersity (Ð = 1.3), especially in the 
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case where R3.5 was used as the CTA, as summarized in Table 3.2. This means that it could 
be possible to chain extend these PVP macro-ATRP initiators with more active monomers, 
such as methyl methacrylate and styrene, etc. This will be further pursued in the near 
future.  
 
Table 3.2 Tabulation of results from RAFT–mediated polymerization of NVP using R3.4-5 





































undistilled R3.5 25 24 88 8800 8200 10 600 1.3 
§  - Determined by SEC in DMAc relative to PMMA standards.  
‡  - Conversion obtained through gravimetric analysis. 
3.3 Conclusion 
Based on the technique described by Destarac et al., we have been able to polymerize 
unpurified NVP in the presence of CTAs with functionalities that were previously deemed 
incompatible. With the availability of more reactive ω-end groups, we have proven that easy 
and valuable chain end modifications are possible, e.g. the introduction of an aldehyde 
functionality via the Albright-Goldman oxidation. Due to the robust nature of the redox 
initiated method, it was possible to polymerize NVP in the presence of an benzaldehyde 
functional CTA, thus, this method leads to facile production of α,ω-heterotelechelic PVP. 
Furthermore, it was possible to use this method to polymerize NVP in the presence of 
bromoxanthate CTAs, thus producing a PVP-macroinitiator for ATRP chain extensions with 
active monomers. Due to previous difficulties in polymerizing PVP block copolymers of this 
nature, the field is almost uncharted. This method opens opportunities to produce PVP 
block copolymers that would be of particular interest for application in controlled drug 
delivery.  




3.4.1 General Experimental Details 
Unless stated otherwise, all of the chemicals used were purchased from commercial sources 
and used without further purification. 2,2’-Azobis(isobutyronitrile) (AIBN) (Riedel-de Haën) 
was recrystallized from methanol. Subsequently it was dried under vacuum at room 
temperature. Solvents and monomers were dried and distilled before use, unless stated 
otherwise. The progress of the reactions were monitored using thin layer chromatography 
(TLC) with Machery-Nagel Silica gel 60 plates with a UV 254 fluorescent indicator.  
1H and 13C NMR spectra were measured on a Varian VXR-Unity (400 MHz) spectrometer and 
spectra were analyzed using MestreNova 9.0 and chemical shifts were reported in parts-per-
million (ppm) which was referenced to the residual solvent protons. The samples were 
prepared in deuterated solvents (Cambridge Isotope Labs).  
Size exclusion chromatography (SEC) was measured on a Shamdzu LC-10AT isocratic pump, 
a column fitted with a PSS guard column (50 x8 mm) in series with three PPS GRAM columns 
(300 x 8 mm, 10 µm, 2 x 3000 Å and 1 x 100 Å) kept at a constant temperature of 40 °C, a 
Waters 717+ auto-sampler, a Waters 2487 dual wavelength UV detector and a Waters 2414 
differential refractive index (DRI) detector. The samples were measured in 
dimethylacetamide (DMAc) as the eluent stabilized with 0.05% BHT (w/v) and 0.03% LiCl 
(w/v), at a flow rate of 1 mL.min-1. Sample preparation included filtering the sample 
solutions through a 0.45 µm GHP filter to remove impurities. The results were calibrated 
against PMMA standards (Polymer Laboratories) ranging from 690 to 1.2 x 106 g.mol-1. Data 
acquisition was performed using Millenium32 software, v4. 
3.4.2 Experimental methods 
Synthesis of S-(2-propionic acid) O-ethyl xanthate (R3.1) 
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Method was followed according to procedure published by Pound et al. (33) In short, 
potassium ethyl xanthate (5.00 g, 31.2 mmol) was dissolved in water (15 mL) and NaOH (7.5 
mL, 3.3M) was added while the solution was stirring. The solution was then cooled in an ice 
bath, and bromopropionic acid (4.34 g, 28.4 mmol) was added dropwise. The solution was 
stirred for 8 h. The pH was adjusted to pH 1 by the addition of HCl (1 M). The product was 
extracted with Et2O (3 x 50 mL) and then with aq. Na2CO3 (3 x 50 mL). The pH was adjusted 
to pH 3 by the addition of HCl (1 M) and the product was extracted with Et2O (3 x 100 mL) to 
yield R3.1 as a white solid (4.4 g, 80%). 1H NMR spectrum corresponded well to that in 
literature. (33) 
1H NMR (400 MHz, chloroform-d) δ 4.64 (qd, J = 7.1, 1.8 Hz, 2H), 4.41 (q, J = 7.4 Hz, 1H), 1.60 
(d, J = 7.4 Hz, 3H), 1.41 (t, J = 7.1 Hz, 3H). 
Synthesis of S-(4-hydroxyethyl(2-ethyl propionate)) O-ethyl xanthate (R3.2) 
 
R3.1 (3.0 g, 15 mmol), ethylene glycol (1.12 mL, 77.2 mmol) and 4-dimethylaminopyridine 
(DMAP) (188.6 mg, 1.544 mmol) were dissolved in CH2Cl2 (50 mL) in a 100 mL RBF, and 
cooled to 0 °C in an ice bath. EDC (3.26 g, 17.0 mmol) was added portion-wise. The mixture 
was stirred for 12 hours, while reaching room temperature on its own accord. The solution 
was concentrated and re-dissolved in 100 mL EtOAc, and washed with (3 x 50 mL) water and 
(3 x 50 mL) brine. The organic layer was collected and dried over MgSO4, and then filtered 
and concentrated. The crude product was purified via column chromatography (eluent: 10% 
EtOAC in pentane slowly increased to 40% EtOAc in pentane) (Rf = 0.2 in 40% EtOAc in 
pentane) to yield R3.2 as a light yellow, oily liquid (2.3 g, 65%). 1H NMR spectrum 
corresponded well to that in literature. (56) 
1H NMR (400 MHz, chloroform-d) δ 4.61 (q, J = 7.1 Hz, 2H), 4.39 (q, J = 7.4 Hz, 1H), 4.30 – 
4.20 (m, 2H), 3.85 – 3.76 (m, 2H), 2.17 (s, 1H), 1.57 (d, J = 7.4 Hz, 3H), 1.39 (t, J = 7.1 Hz, 3H). 
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Synthesis of S-(2-salicylaldehyde propionate) O-ethyl xanthate (R3.3) 
 
2-Hydroxylbenzaldehyde (0.63 g, 5.2 mmol) and R3.1 (1.0 g, 5.2 mmol) were dissolved in 
CH2Cl2 (30 mL). DMAP (69.3 mg, 0.567 mmol) was added, and the solution was cooled to 0 
°C in an ice bath. Thereafter, the solution was degassed with argon for 20 min. EDC (0.879 g, 
5.67 mmol) was added portion-wise over 10 minutes. Solution was stirred for 8 hours, and 
allowed to reach rt on its own accord. Solvent was removed under vacuum. Crude product 
was re-dissolved in EtOAc (50 mL) and then washed with water (3 x 50 mL) and brine (3 x 50 
mL). Combined organic fractions were dried over anhydrous MgSO4, filtered and 
concentrated under vacuum. The RAFT agent was used without further purification. Its 
purity was determined to be 70% by 1H NMR. 
1H NMR (300 MHz, chloroform-d) δ 11.03 (s, 0.3H), 10.17 (s, 1H), 9.92-9.90 (m, 0.2H, 
impurity), 7.91 (dd, J = 7.7, 1.8 Hz, 1H), 7.65 (tp, J = 8.1, 1.8 Hz, 1H), 7.60-7.50 (m, 0.6H) 7.42 
(td, J = 8.2, 1.2 Hz, 1H), 7.23 (dd, J = 8.2, 1.2 Hz, 1H), 7.06-6.97 (m, 0.6H), 4.79 – 4.63 (m, 4H), 
1.80 (dd, J = 7.1, 0.5 Hz, 3H), 1.45 (td, J = 7.1, 0.5 Hz, 3H).  
13C NMR (75 MHz, chloroform-d) δ 211.80, 196.61, 188.45, 169.78, 161.62, 151.61, 136.99, 
135.32, 133.74, 130.71, 128.09, 126.72, 123.15, 119.85, 117.59, 70.71, 47.25, 16.50, 13.72. 
Synthesis of (R3.4) and (R3.5) 
Method modified from that described by Huang et al. (44) and Jumeaux et al. (55), as 
follows: 
Synthesis of 2-hydroxyethyl 2’-bromopropionate  
A solution of ethylene glycol (43 g, 0.69 mol) and triethylamine (8.4 g, 0.083 mol) in CH2Cl2 
(250 mL) was placed in a two-neck round bottom flask equipped with a condenser. After 
cooling to 0 °C, 2-bromopropionyl bromide (15 g, 0.069 mol) in dry CH2Cl2 (50 mL) was 
added dropwise over 20 min under an inert argon atmosphere. The reaction mixture was 
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stirred at 25 °C under argon for 24 h. The reaction mixture was then filtered to remove any 
precipitate and the solvent was evaporated under reduced pressure. The mixture was 
dissolved in distilled water (100 mL) and extracted with chloroform (3 x 300 mL). The 
combined organic phases were dried over anhydrous MgSO4, filtered and concentrated 
under vacuum. Pure 2-hydroxyethyl 2’-bromopropionate was isolated by vacuum distillation 
(bp 70 °C at 1.0 mmHg) (8.6 g, 63%). 1H NMR spectrum corresponded well to that in 
literature. (44) 
1H NMR (600 MHz, chloroform-d) δ 4.37 (q, J= 7.0 Hz, 1H), 4.24 (t, J= 4.7 Hz, 2H), 3.88 (t, J = 
4.7 Hz, 2H), 2.35 (s (broad), 1H), 1.78 (d, J = 7.0 Hz). 
Synthesis of S-[1-methyl-4-(6-bromopropionate)ethyl acetate] O-ethyl dithiocarbonate (R3.4) 
 
R3.2 (2.0 g, 8.8 mmol) and trimethylamine (0.934 mL, 6.70 mmol) were dissolved in dry THF 
(10 mL) under an inert argon atmosphere. The reaction mixture was cooled to 0 °C and a 
solution of 2-bromopropionyl bromide (1.1 mL, 11 mmol) in dry THF (5 mL) was added 
slowly while stirring. The mixture was stirred in the cooling bath for 1 h and then at 25 °C for 
17 h. Excess 2-bromopropionyl bromide was neutralized with 0.1 mL of water and the 
reaction mixture was poured into a solution of hydrochloric acid (80 mL, pH 2), and 
extracted with CH2Cl2 (3 x 100 mL). The organic layers were combined and washed with a 
solution of sodium hydroxide (80 mL, 0.3 M) and (3 x 100 mL) brine, dried over anhydrous 
magnesium sulphate and concentrated under vacuum. The product was purified by column 
chromatography (eluent: hexane/ethyl acetate, 8:2) to yield R3.4 as a yellow, viscous liquid 
(2.5 g, 76%). 1H NMR spectrum corresponded well to that in literature. (44) 
1H NMR (400 MHz, chloroform-d) δ 4.63 (q, J = 7.1 Hz, 2H), 4.47 – 4.31 (overlapped m, 6H, 
1.83 (d, J = 7.0 Hz, 3H), 1.58 (d, J = 7.4 Hz, 3H), 1.41 (t, J = 7.1 Hz). 
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Synthesis of S-[1-methyl-4-(6-bromoisobutyrate)ethyl acetate] O-ethyl dithiocarbonate 
(R3.5) 
 
R3.2 (2.00 g, 8.80 mmol) and TEA (0.934 mL, 6.70 mmol) were dissolved in dry THF (10 mL) 
under an inert argon atmosphere. The reaction mixture was cooled to 0 °C and a solution of 
α-isobutyryl bromide (1.1 mL, 8.9 mmol) in dry THF (5 mL) was added slowly while stirring. 
The mixture was stirred in the cooling bath for 1 h and then at 25 °C for 17 h. Excess α-
isobutyryl bromide was neutralized with 0.1 mL of water and the reaction mixture was 
poured into a solution of hydrochloric acid (80 mL, pH 2) and extracted with CH2Cl2 (3 x 100 
mL). The organic layers were combined and washed with a solution of sodium hydroxide (80 
mL, 0.3 M) and (3 x 100 mL) brine, dried over anhydrous magnesium sulphate and 
concentrated under vacuum. The product was purified by column chromatography (eluent: 
hexane/ethyl acetate, 8:2) to yield R3.5 as a yellow viscous liquid (2.4 g, 70%). 1H NMR 
spectrum corresponded well to that in literature. (44) 
1H NMR (400 MHz, chloroform-d) δ 4.64 (q, 2H, J = 7.4 Hz), 4.47 – 4.32 (overlapped m, 5H, 
1.94 (s, 6H), 1.58 (d, J = 7.4 Hz, 3H), 1.42 (td, J = 7.1, 1.1 Hz, 3H). 
A typical polymerization of undistilled NVP 
Polymerization was altered from the procedure by Desterac et al. (52) NVP (straight from 
the bottle) (2.52 g, 22.7 mmol), water (1.83 g), R3.2 (0.1 g, 0.4 mmol) and t-BuOOH (15.38 
mg, 0.1194 mmol) were added to a pear-shaped flask. Argon was bubbled through the 
solution for 20 minutes. Thereafter, ascorbic acid (19.28 mg, 0.1095 mmol) was added in 
one portion to the pear-shaped flask, with argon still flowing into the flask. The reaction 
solution was then stirred in a water bath, preheated to 25 °C, for 24 h, or until too viscous to 
continue stirring. Then, the solution was freeze-dried for 24 h, re-dissolved in chloroform (1 
mL), and precipitated in cold Et2O (45 mL) thrice. Finally, the polymer was re-dissolved in 
CH2Cl2 (1 mL) precipitated in Et2O (45 mL) and centrifuged again. This process was repeated 
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twice. Finally, the polymer was dried under reduced pressure for 24 hours at room 
temperature to yield P3.7. 
Conventional RAFT-mediated polymerization of NVP 
Distilled NVP (2.56 g, 23.0 mmol), AIBN (8.446 mg, 0.052 mmol), R3.1 (0.1 g, 0.52 mmol) and 
1,4 dioxane (2.6 mL) were added to a pear-shaped flask fitted with a Schlenk tap. The 
reaction flask underwent 3 freeze-pump-thaw cycles, and filled with argon. The flask was 
then immersed in an oil bath, preheated to 60 °C, in order to start the polymerization. When 
the polymerization was finished, the solution was precipitated into Et2O (45 mL) and 
centrifuged. The precipitate was re-dissolved in CH2Cl2 (1 mL), precipitated in Et2O (45 mL) 
and centrifuged again. This process was repeated twice. Finally, the polymer was dried 
under reduced pressure for 24 hours at room temperature. (57) 
Xanthate end-group removal 
PVP (0.5 g, 0.1 mmol) was dissolved in THF (10 mL) and 2-aminoethan-1-ol (61 mg, 1.0 
mmol) was added drop-wise. The reaction mixture was stirred at room temperature for 24 
hours, and then the solution was precipitated into Et2O (150 mL) and centrifuged. The 
precipitate was re-dissolved in CH2Cl2 (1 mL), precipitated in Et2O (45 mL) and centrifuged 
again. This process was repeated twice. Finally, the polymer was dried under reduced 
pressure in an oven for 24 hours at room temperature. 
Albright-Goldman oxidation of PVP 
The method was altered from literature. (59) PVP (200 mg) was dissolved in DMSO (1.5 mL) 
and stirred for 18 hours at room temperature. Solution was degassed with argon for 30 
minutes. Acetic anhydride (1.5 mL) was added drop-wise and the mixture was stirred for a 
further 48 hours at room temperature. The polymer was precipitated in Et2O and 
centrifuged. The precipitate was re-dissolved in CH2Cl2 (1 mL), precipitated in Et2O (45 mL) 
and centrifuged again. This process was repeated twice. Finally, the polymer was dried 
under reduced pressure in an oven for 24 hours at room temperature. 
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Chapter 4:  Polymer synthesis, characterization and diblock conjugation  
 
Synopsis 
Polymeric drug delivery systems containing “smart” responses 
based on physiological triggers have gained enormous interest 
recently due to their potential in solving the Achilles’ heel of gene 
therapy: endosomal escape and cytoplasmic release of RNA 
therapeutics. In this chapter, a novel pH-sensitive diblock 
copolymer is reported as a potential gene delivery system. The 
synthesis and characterization of the diblock copolymer systems 
containing hydrolysable poly(2-(N,N-dimethylamino)ethyl 
acrylate) (pDMAEA) or  non-hydrolysable poly(2-(N,N-
dimethylamino)ethyl methacrylate) (pDMAEMA) conjugated to 
poly(N-vinylpyrrolidone) (PVP) via a β-thiopropionate linker, are 
described. 
 




As mentioned earlier in Chapter 2, applications of non-coding RNA therapeutics in gene 
therapy, e.g. short interfering RNA (siRNA) and microRNA (miRNA), are limited due to 
difficulties in their systemic and cellular delivery. (1) During systemic delivery, these naked 
RNAs are rapidly cleared via the kidneys. (2, 3) If these therapeutics do reach the cells, they 
are incapable of crossing the cellular membrane and do not undergo endosomal escape 
because of their small size and negative charge. (3, 4) This has led to many investigations 
towards developing systems that assist in gene delivery. As discussed in Chapter 2, 
polycations, e.g. polyethyleimine (PEI) (5-10) and pDMAEMA (11-15), have become a 
popular choice for such delivery systems due to their ability to condense the negatively 
charged RNAs. (3, 16, 17) However, because of the positive zeta potential of the polyplex 
systems, they possess inherent toxicity. They also readily aggregate and lack stability due to 
interactions with serum components. PEGylation, the addition of poly(ethylene glycol), has 
become a standard method of shielding the polyplexes of their positive charge, 
consequently reducing these negative traits and increasing the stealth behavior of the 
delivery systems as a whole. (18-22)  
The PEGylated polyplexes have previously been shown to exhibit instability when applied in 
vivo, as they were seen to be cleared by the kidneys after disassembly at the glomerular 
basement membrane. (23, 24) The PEGylation only caused a small increase in the circulation 
time and a small improvement in bio-distribution compared to naked RNAs. Nelson et al. 
(25) developed polycationic systems with increased hydrophobicity by adding a hydrophobic 
comonomer component. They copolymerized 2-(N,N-dimethylamino)ethyl methacrylate 
(DMAEMA) and butyl methacrylate (BMA), optimizing the monomer feed ratio, and 
obtained an increase in polyplex circulation time in vivo, as well as improved endosomal 
escape (intracellular delivery) because of the pH dependent membrane disruption behavior.  
In their study, they synthesized polycations composed of 0 – 75% BMA and found that the 
75% BMA polyplexes displayed reduced RNA condensation properties, since only 38% of the 
siRNA was complexed by the 75% BMA at an N/P ratio of 10:1, while the 40 and 50% BMA 
polycations were able to fully condense the RNAs. (25) 
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While investigating the cellular uptake and transfection efficacy of the polyplex systems, 
Nelson et al. (25) reported that although the polyplexes with 0% BMA were most readily 
internalized by cells, and that polyplexes with 50% BMA showed the best transfection 
efficacy, with a 94% luciferase silencing compared to 20% silencing of 0% BMA. They 
proposed that this was due to the polyplexes containing 50% BMA being more capable of 
facilitating cellular membrane disruption, thus, enhancing the cytoplasmic release of the 
RNAs. This was substantiated with hemolysis experiments, where they found that 50% BMA 
provided the polyplexes with the optimal pH-responsive behavior at the pH corresponding 
to that of early and late endosomes, while remaining stable at physiological pH. 
The greatest challenge in polyplex delivery has been narrowed down to endosomal escape 
and cytoplasmic release of RNAs. (26-28) The pH responsive behavior of p(DMAEMA-co-
BMA) (50:50) addresses the endosomal escape; however, the cytoplasmic release remains a 
hurdle, thus, decreasing the efficacy of the systems. If the RNA is not released, it is unable to 
interact with the endoribonuclease DICER, and subsequently form part of the RNA-
interfering silencing complex (RISC). (29-31) The use of polycation complexes is a double-
edged sword, since the cationic nature is necessary for condensation and packaging of the 
RNAs; however, this electrostatic interaction also means that the RNAs have difficulties 
being released. (32, 33) Monteiro and coworkers developed hydrolytically degrading 
polyplexes from pDMAEA which de-cationized over time via hydrolysis of the ester linkage in 
aqueous medium into poly(acrylic acid) and N,N’-dimethylamino ethyl ethanol. (33) The 
advantage of this degradative behavior is that it does not depend on external cues or 
environmental changes within the cell, but is rather self-catalyzed, occurring after just 10 
hours. They discovered a dependency of transfection on molecular weight, whereby higher 
molecular weight pDMAEA resulted in greater transfection efficiency. They further reported 
complexation occurring from N/P ratio of 10, although some smudging on the retardation 
gel indicated that partial complexation was occurring. In their various studies, they obtained 
improved transfection efficiencies, indicating that the hydrolytic degradation was allowing 
for RNA/oligo-DNA cytosolic release. Werfel et al. (34) further investigated these hydrolytic 
charge-reversing polyplexes by copolymerizing 2-(N,N-dimethylamino)ethyl acrylate 
(DMAEA) with BMA in order to obtain enhanced pH responsive behavior for endosomal 
escape, via PEGylation. They compared p(DMAEA-co-BMA)-b-PEG (50:50) to p(DMAEMA-co-
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BMA)-b-PEG (50:50), and found that siRNA was delivered to the cytosol more completely for 
p(DMAEA-co-BMA)-b-PEG polyplexes than the non-charge–reversing p(DMAEMA-co-BMA)-
b-PEG system, thus showing improved intracellular bioavailability produced from the de-
cationizing system. 
Although PEGylation imparts many positive characteristics in the polyplex delivery systems, 
it has been associated with a decreased endosomal release, impeding RNA bioavailability in 
the cell due to core stabilization. (35-37) Therefore, a number of studies have looked at 
reversible PEGylation, e.g. through reducible linkers, (38) biotin-triggered linkers, (39) acid-
labile linkers (40-44) and matrix metalloproteinases (MMP)-cleavable peptides. (13, 45) The 
various studies that incorporate an acid-labile linker take advantage of the pH change 
between serum (pH 7.4) and endosomes (pH 5.0). (46, 47) 
Although PEG is by far the most researched protecting polymer in gene therapy, there are a 
number of drawbacks associated with the use of PEG in drug delivery. It has been known 
since 1950s that non-specific interactions between PEG and blood, induced blood clotting. 
(48) PEG has also been shown to cause a non-specific response by the immune system, 
which in the case of polyplex systems could lead to an immune response after intravenous 
administration. (49) There are a number of alternatives to PEG, which are less well 
investigated for polyplex systems. One such alternative is poly(N-vinylpyrrolidone) (PVP). It 
is a commercially available polymer that is frequently used in cosmetic and pharmaceutical 
products. Its chemical structure allows for a highly hydrated polymer, suppressing any 
immune responses. (50-52) PVP is easily synthesized via RAFT–mediated polymerization, 
(53-57) which produces a polymer readily modified for further use in applications such as 
drug delivery and gene therapy. (58) 
We investigated the effect of adding an acid-labile linker between p(DMAEA-co-BMA) 
(50:50) and PVPas well as between p(DMAEMA-co-BMA) (50:50) and PVP, Figure 4.1,  to 
assess whether we can obtain improved endosomal escape, while comparing the 
hydrolysable and non-hydrolysable systems. Oishi et al. (44, 59) demonstrated the ability of 
β-thiopropionate to be hydrolyzed under mild acidic conditions. By taking advantage of the 
pH change within the endosome, the β-thiopropionate has been shown to break, while an 
orthogonal ester linker has been demonstrated to not be sensitive enough. (60) 




Figure 4.1 General structure of the diblock polymer system containing a hydrophobic polymer 
system, either p(DMAEMA-co-BMA) or p(DMAEA-co-BMA), capable of complexing with RNAs, 
conjugated via a β-thiopropionate linker to PVP. The PVP was pre-conjugated with targeting 
ligands and a fluorescent marker. 
4.2 Results and discussion: 
Figure 4.2 depicts the chemical structures of the reversible-addition fragmentation chain-
transfer (RAFT) agents that have been utilized in the current study to prepare the respective 
polymer. RAFT agent R4.1 was used to prepare well controlled PVP, while R4.2 and R4.3 
were used to prepare p(DMAE(M)A-co-BMA). The details of the synthetic protocols and the 
choice of each RAFT agent are explained in more detail in Sections 4.2.1 and Section 4.2.2 
for the hydrophilic block and hydrophobic blocks, respectively. 
 
 
Figure 4.2 Chemical structures of chain transfer agents used within this chapter (R4.1-3) 
 
Each block was separately synthesized and subsequently conjugated via a Michael addition 
(61-63) in order to obtain the β-thiopropionate linker in the manner seen in Scheme 4.1. 
Therefore, the synthesis and characterization of each block will be individually discussed 
below, as well as the subsequent conjugation experiments. 
PVP is attached to 
targeting ligand and 
fluorescent marker
Acid-labile linker p(DMAEMA-co-BMA) or
p(DMAEA-co-BMA)




Scheme 4.1 Schematic representation of the reaction between the hydrophobic and hydrophilic 
polymer blocks via a Michael addition in order to obtain the pH-sensitive, diblock copolymer 
conjugates (P4.12-17) 
 
4.2.1 Synthesis of the hydrophilic block: PVP 
 
 
Scheme 4.2 A schematic illustration of post-polymerization modification of PVP synthesized using 
R4.1 (See Figure 4.1); first the one-pot deprotection of the linear acetal into an aldehyde and a 
subsequent xanthate conversion to a thiol, followed by the conjugation of the aldehyde with an 
amine (targeting ligand, fluorescent marker, or n-propylamine quenching reagent) via reductive 
amination 
 
A recent publication in our group described the RAFT–mediated polymerization of NVP using 
a xanthate as a chain transfer agent (CTA) (R4.1, Figure 4.2), containing a linear acetal 
leaving group functionality. The polymerization was shown to produce PVP with controlled 
molecular weight and low Ð. (64) The RAFT agent R4.1 is a very convenient CTA for the 
polymerization of NVP, especially due to the ease with which α,ω-heterotelechelic polymer 
can be obtained via a one-pot, orthogonal end-group modification procedure. Thus, it is an 
ideal CTA for this study as it allows for the post-polymerization functionalization necessary 
X – Targeting ligand or fluorescent marker 
or n-propylamine 
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to link the PVP to the targeting ligand/fluorescent marker on the α-end group, and the acid-
labile linker, connected to the hydrophobic polymer, on the ω-end group. R4.1 was 
synthesized according to the method previously described by Reader et al. (64)  
 


















P4.1 5000 25 R4.1 NVP 
Ascorbic 
acid &  
t-BuOOH 
water 60 4600 5500 1.2 
§Determined by SEC in DMAc relative to PMMA standards.  
‡Conversion obtained through gravimetric analysis. 
 
    
Figure 4.3 MMDs of RAFT–mediated polymerized PVP before (P4.1) and after (P4.2) the one-pot 
deprotection: (a): Molecular weight distribution (RI) of P4.1-2, whereby the bimodal distribution 
can be seen owing to the disulfide formation due to xanthate removal of P4.2. (b): UV-vis 
absorbance of the polymers at 290 nm with a disappearance of the absorbance due to xanthate 
end group removal of P4.2  
 
Although conventional RAFT–mediated polymerization techniques, initiated with AIBN at  
60 °C in 1,4-dioxane, using R4.1 results in polymers with controlled molecular weight and 
molecular weight distribution, the AIBN:CTA ratio (1:4) needed in order to obtain 60% 
conversion of NVP was higher than desired. (64) The relatively high levels of AIBN mean that 
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opposed to the leaving group of the chain transfer agent. In addition, the relatively high 
temperature leads to unsaturated chain ends. This of course, leads to a percentage of 
unmodifiable α- and ω-chain ends. Therefore, the aqueous redox method developed in 
Chapter 3 was used to polymerize NVP. Using this technique, PVP (P4.1) was obtained with 
good control over molecular weight and its distribution (Ð = 1.2), as seen in Table 4.1, while 
mitigating the chance of loss of xanthate end-groups. The one-pot method previously 
described (64) was used in order to simultaneously generate the deprotected aldehyde end-
group and the thiol end-group to obtain the deprotected PVP (P4.2). The removal of the 
xanthate end-group was verified by both 1H NMR spectroscopy and SEC analysis. Using 1H 
NMR spectroscopy, the focus is on the disappearance of the protons belonging to the 
xanthate moiety (f in Figure 4.4a). While using SEC, Figure 4.3b, it is possible to see the 
disappearance of the UV-vis absorbance due to the xanthate group at 290 nm, as well as a 
bimodal distribution caused by the partial formation of disulfides, as previously described. 
(64) The aldehyde deprotection was confirmed by the appearance of a characteristic peak in 
the 1H NMR spectrum at 9.7 ppm (i in Figure 4.4b), as well as the disappearance of the 
protons corresponding to the linear acetal protecting group (h in Figure 4.4a). 
 
 
Figure 4.4 1H NMR spectra of (a): protected PVP (P4.1), (b): unprotected PVP (P4.2) and (c): 
CardioTL modified PVP (P4.4) 
10 8 6 4 2 0
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4.2.2 Targeting ligand modification of PVP 
Next, the deprotected PVP was split up into three batches, two batches were modified with 
two targeting ligands (2% modification), ACDCRGDCFGG (hereafter referred to as RGD) 
(P4.3) and CSTSMLKAC (hereafter referred to as CardioTL) (P4.4), respectively, and the final 
batch was left without a targeting ligand modification (P4.5). Each batch containing the 
targeting ligand was also modified with amino-fluorescein (2% modification) and n-propyl 
amine (in excess) was used to quench the remaining aldehyde moieties in all three batches. 
These modifications were performed via a Schiff base formation and subsequent reductive 
amination to form secondary amines using sodium cyanoborohydride, as described in 
literature. (64) RGDs are known to assist with cellular uptake in a broad spectrum of cell 
types. (65, 66) Therefore, this targeting ligand was attached in order to obtain a more 
general polyplex system. In Chapter 5, the polymer conjugates will be used to complex anti-
miR-214, which is known to regulate miRNA-214 expression, an inhibitor of angiogenesis via 
targeting Quaking and the reduction of angiogenic growth factor release. (67, 68) This will 
be discussed further in Chapter 5. However, due to the objective of targeting cardiovascular 
illnesses, and thus cardiovascular cell types, a known targeting ligand for cardiovascular 
cells, CardioTL, was attached to the PVP. The success of the Schiff base-reductive amination 
was confirmed via 1H NMR spectroscopy, as seen in Figure 4.4c, with the disappearance of 
the representative aldehydic proton peak and a slight up-field shift of the protons belonging 
to g, due to the change in the protonic environment caused by the targeting ligands. Due to 
the low percentage of targeting ligand functionalization (2%) and amino-fluorescein (2%), 
and the comparatively large molecular weight of the PVP, it is not possible to precisely 
assign protons of these moieties. However, there are some small changes in the 1H NMR 
spectra in the regions (4.8-5.3 ppm) where we expect protons corresponding to the 
targeting ligand, as well as in the region (7.25-7.5 ppm) in which we expect to find the 
targeting ligand’s amide protons. Similarly, the protons corresponding to n-propyl amine 
overlap with the polymer’s lactam protons, therefore, these peaks cannot be identified in 
the spectra. However, in order to confirm the fluorescence of the modified PVP, the samples 
were re-dissolved in water at a known concentration. Using a fluorescent plate reader, the 
samples were excited at 485 nm and the emission was measured at 535 nm. Figure 4.5 
conclusively shows the strong emission of the amino-fluorescein modified polymers, while 
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the aldehyde precursor polymer does not show any fluorescence. This clearly indicates the 
successful attachment of the fluorescent marker via Schiff base-reductive amination.  
 
 
Figure 4.5 Fluorescence of amino-fluorescein modified and unmodified PVP at 485/535 nm 
 
4.2.3 Synthesis of the hydrophobic blocks: p(DMAEMA-co-BMA) and p(DMAEA-co-BMA) 
It was our desire to obtain a polycation block with an end group that could be functionalized 
post-polymerization to contain an acrylate moiety, with which the PVP could react via a 
Michael addition to obtain the β-thiopropionate acid-labile linkage. DMAEMA and DMAEA 
have been previously copolymerized with BMA using trithiocarbonate RAFT agents with 
good control over molecular weight and Ð. (25, 34) In order to stabilize the acid-labile linker, 
we used an ethylene glycol spacer between the carboxylic acid R-group and the potential β-
thiopropionate acid-labile linkage. Therefore, we chose to synthesize 2-hydroxyethyl 4-
{[(butylthio)carbonothioyl]thio}-4-cyanopentanoate (R4.3, Figure 4.2), with R4.2 as an 
intermediate RAFT agent (the reaction is shown in Scheme S4.2). The synthesis was 
modified from a method previously described in literature. (69) The copolymerization and 
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Scheme 4.3 (a): Copolymerization of DMAE(M)A and BMA, where R represents H (P4.6) or methyl 
(P4.7) moieties, (b): post-polymerization functionalization of end-groups on p(DMAE(M)A-co-
BMA) in order to obtain an acrylate moiety for further conjugation via a Michael addition 
 
As mentioned earlier in the chapter, the monomer feed ratio has previously been 
investigated, and a 1:1 ratio of DMAE(M)A:BMA seems to represent the best balance 
between the cationic nature of the copolymer for the complexation of RNAs and polyplex 
functionality, e.g. circulation time, pH-dependent membrane disruption leading to cellular 
uptake and enhanced endosomal escape. (25, 34) Therefore a 1:1 monomer feed ratio was 
chosen and using RAFT–mediated copolymerization of DMAEMA or DMAEA with BMA, 
p(DMAEMA-co-BMA) (P4.6) and p(DMAEA-co-BMA) (P4.7) were obtained with good control 
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91 16800 19900 1.1 
§Determined by SEC in DMAc relative to PMMA standards.  
‡Conversion obtained through gravimetric analysis. 
 
Post-polymerization modification of the copolymers was necessary in order to prepare them 
for the Michael addition to the PVP moieties. In order for this to be possible, Scheme 4.3 
was followed, whereby the trithiocarbonate was first removed via a reaction with N-
ethylpiperidine hypophosphite to form P4.8-9, according to literature. (70) The 
trithiocarbonate removal was confirmed by the disappearance of the characteristic 
trithiocarbonate UV-vis absorbance at 320 nm using SEC analysis, see Figure 4.6b and Figure 
4.7b for p(DMAEMA-co-BMA) and p(PDMAEA-co-BMA), respectively. Subsequently, the 
acrylate moiety was added to the α-end group. At first, we tried to react the polymer with 
acryloyl chloride; however, this seemed to have an effect on the backbone of the 
p(DMAE(M)A-co-BMA). Thus, the acrylate was supplied via a 1-ethyl-3-(-3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC) coupling reaction between the 
polymer’s hydroxyl end group and the carboxylic acid functional group of acrylic acid (P4.10-
11). Confirming the success of this reaction was slightly problematic, since the molecular 
weights of the polymers were relatively high to rely on NMR or FT-IR spectroscopic analyses. 
The integrity of the polymer backbone was established using SEC analysis. However, no 
significant changes could be observed, Figure 4.6 (a) and Figure 4.7 (a), unlike after the 
previous method with acryloyl chloride. Therefore, we decided to continue with the Michael 
addition step. The Michael addition is completely dependent on the success of the EDC 
coupling; therefore, it could be quickly confirmed whether this was successful or not, 
through the realization of the diblock conjugation. 




Figure 4.6 MMDs of p(DMAEMA-co-BMA) synthesized via RAFT–mediated polymerization before 
and after modification: Left: Molecular weight distribution (RI) of P4.6, P4.8 and P4.10. Right: UV-
vis absorbance at 320 nm of P4.6 and P4.8 with a disappearance of the absorbance due to the 
trithiocarbonate-end group removal of P4.6  
 
 
Figure 4.7 MMDs of p(DMAEA-co-BMA) synthesized via RAFT–mediated polymerization before and 
after modification: Left: Molecular weight distribution (RI) of P4.7, P4.9 and P4.11. Right: UV-vis 
absorbance at 320 nm of P4.7 and P4.9 with a disappearance of the absorbance due to the 
trithiocarbonate-end group removal of P4.7 
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4.2.4 Conjugation of PVP and p(DMAE(M)A-co-BMA) via the acid-labile linker 
 
Table 4.3 Conjugation of p(DMAE(M)A-co-BMA) with three differently modified PVP blocks 
produced 6 conjugate diblock polymers 
Conjugate Hydrophobic block Hydrophilic block 
P4.12 p(DMAEMA-co-BMA) (P4.10) PVP (P4.3) 
P4.13 p(DMAEMA-co-BMA) (P4.10) PVP-CardioTL (P4.4) 
P4.14 p(DMAEMA-co-BMA) (P4.10) PVP-RGD (P4.5) 
P4.15 p(DMAEA-co-BMA) (P4.11) PVP (P4.3) 
P4.16 p(DMAEA-co-BMA) (P4.11) PVP-CardioTL (P4.4) 
P4.17 p(DMAEA-co-BMA) (P4.11) PVP-RGF (P4.5) 
 
PVP was added in a two-fold excess compared to p(DMAE(M)A-co-BMA)-acrylate. The Michael 
addition was performed by dissolving the variously modified PVPs (P4.3-5) and sodium 
borohydride in dry DMF under inert conditions. The sodium borohydride ensured that all of the 
PVP-disulfides are reduced to thiols. This was especially essential due to PVP’s propensity 
towards disulfide formation after xanthate removal. The p(DMAE(M)A-co-BMA)-acrylate (P4.10-
11) was separately dissolved in DMF and trimethylamine was added in catalytic amounts. The 
two solutions were then quickly added together and stirred for 12 hours, while maintaining inert 
conditions as to ensure disulfide formation was prevented. Six conjugates were obtained, as 
summarized in Table 4.3: p(DMAEMA-co-BMA)-b-PVP without a targeting ligand or fluorescent 
marker (P4.12),  with a cardiovascular targeting ligand (CardioTL) and fluorescent marker 
(P4.13), and one with an RGD targeting ligand and fluorescent marker (P4.14); and then 
p(DMAEA-co-BMA)-b-PVP without a targeting ligand or fluorescent marker (P4.15), with a 
cardiovascular targeting ligand (CardioTL) and fluorescent marker (P4.16), and one with a RGD 
targeting ligand and fluorescent marker (P4.17). The conversion of the polymers into the 
conjugates was confirmed by a shift in the molecular weight distributions from SEC 
measurements in accordance to the sum of the molecular weights of the respective precursor 
blocks. This shift was observed for all 6 conjugates, refer to Figure 4.8. It is possible to see some 
residual, unconjugated PVP present in all of the samples. This is due to the excess of PVP used in 
the Michael addition. However, the shift of the molecular weight distribution of the precursor 
blocks towards higher molecular weight was sufficient evidence of the conjugation process.  
                    




Figure 4.8 MMDs of p(DMAE(M)A-co-BMA)-b-PVP conjugates, where the conjugates contain (a): 
p(DMAEMA-co-BMA) and PVP without a targeting ligand (P4.12), (b): p(DMAEMA-co-BMA) and 
PVP with a cardiovascular targeting ligand (P4.13), (c): p(DMAEMA-co-BMA) and PVP with an RGD 
targeting ligand (P4.14), (d): p(DMAEA-co-BMA) and PVP without a targeting ligand (P4.15), (e): 
p(DMAEA-co-BMA) and PVP with a cardiovascular targeting ligand (P4.16) and (f): p(DMAEA-co-
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The efficiency of the conjugation process could not be evaluated from the current set of 
data, as the close proximity of the distribution of the precursor blocks and the resultant 
conjugate meant even the process of deconvolution of peaks would not provide conclusive 
evidence.  For the purpose of the current study, the presence of either precursor block 
should not affect the formation of the polyplexes. Additionally, due to the sensitivity of the 
acid-labile, β-thiopropionate linker, we were cautious of further purification of the 
conjugates. Since the presence of free PVP in the samples should not affect the polyplex 
formation or function, it was decided to not pursue any further efforts towards purification 
of the conjugates. 
4.3 Conclusion 
α,ω-Heterotelechelic PVP was obtained by RAFT–mediated polymerization of NVP with the 
synthesized bifunctional CTA, R4.1 via the polymerization technique developed in Chapter 3. 
A one-pot post-polymerization functionalization was then used to convert the protecting 
acetal into an aldehyde moiety, while the xanthate was converted to a thiol (disulfide). 
Thereafter, the PVP was split into three batches and reacted with various targeting ligands 
(2%), amino-fluorescein (2%), and finally quenched with n-propylamine.  
p(DMAE(M)A-co-BMA) were prepared via RAFT–mediated polymerization with 2-
hydroxyethyl 4-{[(butylthio)carbonothioyl]thio}-4-cyanopentanoate. After trithiocarbonate 
end-group removal, acrylate end-groups were added via an EDC-coupling between the 
hydroxyl α-end group of the polymer and acrylic acid.  
The modified polymers were then conjugated together using a Michael addition, allowing 
for the incorporation of an acid-labile, β-thiopropionate linker between the two polymers. 
The success of the conjugation was confirmed using SEC analysis, and a shift in the 
molecular weight was observed. Due to the sensitivity of the acid-labile linker, no further 
purification techniques were used in order to purify the conjugates to rid them of excess 
free PVP. These conjugates were used for further experiments in Chapter 5. 




4.4.1 General Experimental Details  
Unless stated otherwise, all of the chemicals used were purchased from commercial sources 
and used without further purification. 2,2’-Azobis(isobutyronitrile) (AIBN) (Riedel-de Haën) 
was recrystallized from methanol. Subsequently it was dried under vacuum at room 
temperature. Solvents and monomers were dried and distilled before use, unless stated 
otherwise. The progress of the reactions were monitored using thin layer chromatography 
(TLC) with Machery-Nagel Silica gel 60 plates with a UV 254 fluorescent indicator.  
1H and 13C NMR spectroscopy were measured on a Varian VXR-Unity (400 MHz) 
spectrometer and spectra were analyzed using MestreNova 9.0 and chemical shifts were 
reported in parts-per-million (ppm) which was referenced to the residual solvent protons. 
The samples were prepared in deuterated solvents (Cambridge Isotope Labs).  
Size exclusion chromatography (SEC) was measured on a Shamdzu LC-10AT isocratic pump, 
a column fitted with a PSS guard column (50 x8 mm) in series with three PPS GRAM columns 
(300 x 8 mm, 10 µm, 2 x 3000 Å and 1 x 100 Å) kept at a constant temperature of 40 °C, a 
Waters 717+ auto-sampler, a Waters 2487 dual wavelength UV detector and a Waters 2414 
differential refractive index (DRI) detector. The samples were measured in 
dimethylacetamide (DMAc) as the eluent stabilized with 0.05% BHT (w/v) and 0.03% LiCl 
(w/v), at a flow rate of 1 mL.min-1. Sample preparation included filtering the sample 
solutions through a 0.45 µm GHP filter to remove impurities. The results were calibrated 
against PMMA standards (Polymer Laboratories) ranging from 690 to 1.2 x 106 g.mol-1. Data 
acquisition was performed using Millenium32 software, v4. 
Fluorescent signal was measured using a SpectraMax M2 microplate-based multi-detector 
reader (Molecular Devices). 
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4.4.2 Experimental methods 
S-{1-[10(3,3-diethoxypropyl)-1H-1,2,3-triazol-4-yl]ethyl} O-ethyl carbonodithioate (R4.1) 
Method was followed according to procedure published by Reader et al. (64) 1H NMR 
spectra for all steps corresponded well to that in literature. The synthesis steps were 
performed according to Scheme S4.1 and the methods are described in short below. 
 
 
Scheme S4.1 schematic of synthetic pathway to obtain RAFT agents R4.1 
 
Step 1: Imidazole-1-sulfonyl azide hydrochloride (R4.1.1) 
Sulfuryl chloride (16.1 mL, 200 mmol) was added drop-wise to an ice-cooled suspension of 
sodium azide (13.0 g, 200 mmol) in dry acetonitrile (200 mL) and the mixture was stirred at 
rt for 12 h. The reaction mixture was cooled in an ice bath and imidazole (25.9 g, 380 mmol) 
added portion-wise and the resulting slurry was stirred for 3 h at rt. The reaction mixture 
was diluted with EtOAc (400 mL) and then washed with water (2 x 400 mL) and then with 
sat. NaHCO3 (2 x 400 mL). The organic portion was isolated and dried over MgSO4 and then 
filtered. A solution of HCl in ethyl acetate (4 M) (21.3 mL) was added drop-wise to the 
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filtrate while stirring in an ice bath. The precipitate was collected via filtration and washed 
with EtOAC (3 x 100 mL) to yield the activated azide product (R4.1.1) (23.4 g, 68%). Crude 
product used immediately in step 2 without any further purification.  
Step 2: 3-Azido-1,1-diethoxypropane (R4.1.2) 
1-amino-2,2-diethylpropane (5.00 g, 34.0 mmol), potassium carbonate (9.39 g, 68.0 mmol), 
Cu(II)-sulfate·5H2O (84.9 mg, 0.340 mmol) and MeOH (30 mL) were introduced into a RBF 
(100 mL). The activated azide (synthesized above) (8.50 g, 40.1 mmol) was dissolved in 
MeOH (20 mL) and added to the reaction mixture, and the solution was stirred for 10 h at rt. 
The mixture was then diluted with water (30 mL) and acidified to pH 6 using acetic acid and 
extracted with Et2O (4 x 50 mL). The combined organic layers were washed with water (2 x 
50 mL) and brine (2 x 50 mL), dried over anhydrous MgSO4, filtered and concentrated to 
yield product as a dark yellow oil (R4.1.2) (3.8 g, 65%). 
1H NMR (400 MHz, CDCl3) δ 4.61 (t, J = 5.6 Hz, 1H), 3.74 – 3.62 (m, 2H), 3.59 – 3.45 (m, 2H), 
3.38 (t, J = 6.8 Hz, 2H), 1.89 (td, J = 6.8, 5.6 Hz, 2H), 1.28 – 1.17 (m, 6H). 
Step 3: O-(But-3-yn-2-yl) 4-methylbenzenesulfonate (R4.1.3) 
But-3-yn-2-ol (10.0 g, 142 mmol), Tosyl chloride (32.6 g, 171 mmol) and dry THF (100 mL) 
were added to a 250 mL RBF, and the mixture was cooled to 0 ˚C in a NaCl/ice bath. 
Potassium hydroxide (20.2 g, 360 mmol) was added portion-wise over 20 min, after which 
the suspension was stirred for 2 h, warming to rt on its own accord. The reaction mixture 
was filtered, washed with water (2 x 50 mL), dried over anhydrous MgSO4 and concentrated 
to yield crude, crystalline product R4.1.3. Product was used immediately in next step 
without further purification. 
1H NMR (400 MHz, DMSO-d6) δ
 7.78 (d, J = 7.7 Hz, 2H), 7.46 (d, J = 7.7 Hz, 2H), 5.23 (qd, J = 
6.6, 2.1 Hz, 1H), 3.64 (d, J = 2.1 Hz, 1H), 2.40 (s, 3H), 1.40 (d, J = 6.6 Hz, 3H). 
Step 4: O-(But-3-yn-2-yl) O-ethyl carbonodithioate (R4.1.4) 
R4.1.3 (7.81g, 34.8 mmol) was dissolved in dry THF (100 mL) and cooled in an ice bath. 
Potassium ethyl xanthate (7.81 g, 48.7 mmol) was added portion-wise to the solution in an 
inert environment. The solution was stirred for 2 h in an ice bath. The mixture was filtered, 
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concentrated and purified via column chromatography (eluent: 100% pentane) to yield 
product as a light yellow oil (2.88 g, 47%). 
1H NMR (400 MHz, CDCl3) δ 4.68 (q, J = 7.1 Hz, 2H), 4.49 (qd, J = 7.1, 2.5 Hz, 1H), 2.35 (d, J = 
2.5 Hz, 1H), 1.64 (d, J = 7.1 Hz, 3H), 1.45 (t, J = 7.1 Hz, 3H). 
Step 5: O-(1-(1-(3,3-Diethoxypropyl)-1H-1,2,3-triazol-4-yl)ethyl) O-ethyl carbonodithioate 
(R4.1) 
R4.1.2 (1.0 g, 5.8 mmol), R4.1.4 (1.51 g, 8.66 mmol), CuSO4·5H2O (144 mg, 0.577 mmol) and 
sodium ascorbate (285 mg, 1.44 mmol) were introduced into a small, pear-shaped flask (5 
mL). Dry DMF (5 mL) was added and the solution was stirred at rt for 6 h. The solution was 
then filtered through celite and the filter was washed with CH2Cl2 (1 mL). The combined 
filtrate was purified via column chromatography (eluent: gradient eluent from 100 % hexane 
to 40 % EtOAc in Hexane) to yield product (R4.1) as a yellow oil (1.2 g, 3.48 mmol) 
1H NMR (400 MHz, CDCl3) δ 7.52 (s, 1H), 5.08 (q, J = 7.2 Hz, 1H), 4.63 (q, J = 7.1 Hz, 2H), 4.47 
(t, J = 5.4 Hz, 1H), 4.42 (t, J = 7.1 Hz, 2H), 3.71 – 3.60 (m, 2H), 3.53 – 3.40 (m, 2H),  
2.20 (td, J = 7.0, 5.5 Hz, 2H), 1.81 (d, J = 7.2 Hz, 3H), 1.41 (t, J = 7.1 Hz, 3H), 1.20 (t, J = 7.0 Hz, 
6H).  
Procedure for polymerizing NVP using R4.1 
Method as described in Chapter 3. 
One-pot removal of xanthate and aldehyde deprotection 
Method was followed according to procedure published by Reader et al. (64) 
In short, PVP (P4.1) (2.50 g, 0.543 mmol aldehyde), hexylamine (0.165 g, 1.63 mmol) and 
acetone (14 mL) were introduce into a RBF and the solution was stirred for 4h at rt. 
Thereafter, HCl in 1,4-dioxane (14 mL, 4M) was added dropwise. The solution was stirred for 
an additional 4 h at rt. The polymer was precipitated in Et2O (3 x 200 mL) before redissolving 
in CH2Cl2 (5 mL) and purified via dialysis (3500 Da MWCO) against water/MeOH (1:1) for 2 
days and then pure water for a further 2 days. The polymer was isolated as a white solid by 
freeze-drying it. End-group analysis was performed via 1H NMR spectroscopy and SEC was 
performed in order to determine molar mass and dispersity. 
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Targeting ligand and amino-fluorescent functionalization of PVP 
Method was followed according to procedure published by Reader et al. (64) 
In short, deprotected PVP (1.00 g, 0.375 mmol aldehyde), Ala-Cys-Asp-Cys-Gly-Asp-Cys-Phe-
Cys-Gly (8.6 mg, 0.0075 mmol), aminofluorescein (2.6 mg, 0.0075 mmol), NaBH3CN (235.65 
mg, 3.75 mmol) and sodium borate buffer (5 mL, pH 10.4) were introduced into a pear-
shaped flask. The solution was stirred at rt for 12 h and then purified via dialysis (3500 Da 
MWCO) against water for 2 days. The solution was then freeze-dried in order to obtain P4.5 
as a white powder. End-group analysis was performed via 1H NMR spectroscopy. 
Peptides used:  
Cys-Ser-Thr-Ser-Met-Leu-Lys-Ala-Cys – Cardio TL 
Ala-Cys-Asp-Cys-Gly-Asp-Cys-Phe-Cys-Gly – RGD TL 
Synthesis of 2-hydroxyethyl 4-(((butylthio)carbonothioyl)thio)-4-cyanopentanoate (R4.3) 
Synthesized according to method modified from a combination of Eur. Polym. J. 2015, 66, 
543-557, (71) Polymer 2005, 46, 8458-8468 (72) and Eur. Polym. J. 2014, 50, 9-17. (69) The 
synthesis was performed according to Scheme S4.2 and the method is summarized below. 
1H NMR spectra for all steps corresponded well to that in literature. 
 
Scheme S4.2 schematic of synthetic pathway to obtain RAFT agents R4.2 and R4.3 




Synthesis of 4-cyano-4-(ethylthiocarbonothioylthio) pentanoic acid (R4.2) 
NaH (3.15 g, 79.0 mmol) was suspended in 100 mL diisopropyl ether (100 mL) at 0 ˚C. 
Butane thiol (6.84 g, 76.0 mmol) was added drop-wise over 10 min, and a white slurry 
formed. The solution was kept at 0 ˚C while CS2 (6.0 g, 79 mmol) was added slowly and an 
orange/yellow precipitate formed. The precipitate was filtered and washed with diisopropyl 
ether (3 x 100 mL) and then resuspended in 100 mL diisopropyl ether (100 mL). Iodine (9.77 
g, 38.8 mmol) was added and the solution was stirred for 1 h at rt. The solution was filtered 
and washed with 0.5 M aq. sodium thiosulphate solution, dried over anhydrous MgSO4, 
filtered and concentrated to yield the corresponding disulphide as a yellow oil (R4.2.1), 
which was used for the next reaction without further purification. 
R4.2.1 (7.0 g, 21 mmol) was redissolved in EtOAc (50 mL) and AIVA (8.90 g, 31.8 mmol) was 
added. The solution was refluxed for 18 h. Solution was concentrated and purified by 
column chromatography (eluent: 100% pentane gradient to 1:1 pentane: EtOAc) to yield 
R4.2 as a yellow oil (5.45 g, 89%). 
1H NMR (300 MHz, CDCl3) δ 3.36 (t, J = 7.2 Hz, 2H), 2.74 – 2.66 (m, 2H), 2.62 – 2.34 (m, 2H), 
1.90 (s, 3H), 1.78 – 1.62 (m, 2H), 1.52 – 1.36 (m, 2H), 0.95 (t, J = 7.3 Hz, 3H)  
Step 2: 2-hydroxyethyl 4-{[(butylthio)carbonothioyl]thio}-4-cyanopentanoate (R4.3) 
R4.2 (8.45 g, 29.0 mmol), ethylene glycol (8.11 mL, 145 mmol) and DMAP (0.35 g, 2.9 mmol) 
were dissolved in CH2Cl2 (50 mL) and cooled to 0 ˚C. EDC (6.11 g, 31.9 mmol) was added 
portion-wise at 0 ˚C. The solution was stirred for 12 hours and allowed to reach rt on its own 
accord. The solution was concentrated under vacuum and redissolved in EtOAc (150 mL). 
Solution was washed with water (3 x 100 mL) and brine (3 x 100 mL), dried over MgSO4, 
filtered and concentrated under vaccum. The crude product was purified by column 
chromatography (eluent: 1:1 EtOAc:pentane gradient to 100% EtOAc) to yield R4.3 as an 
orange oil (7.9 g, 81%). 
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1H NMR (300 MHz, CDCl3) δ 4.30 – 4.21 (m, 2H), 3.89 – 3.79 (m, 2H), 3.41 – 3.29 (m, 2H), 
2.73 – 2.65 (m, 2H), 2.64 – 2.33 (m, 2H), 1.89 (s, 3H), 1.74 – 1.60 (m, 2H), 1.51 – 1.37 (m, 
2H), 0.95 (t, J = 7.3 Hz, 3H) 
General procedure for synthesis of p(DMAEMA-co-BMA) and p(DMAEA-co-BMA): 
DMAEMA (9.4 g, 59 mmol), BMA (8.5 g, 59 mmol), R4.3 (0.455 g, 1.19 mmol) and AIBN  
(28 mg, 0.17 mmol) were dissolved in 1,4-dioxane (17.88 mL). The solution was degassed 
with argon for 30 min and placed in a preheated bath at 70 ˚C. The reaction mixture was 
stirred for 24 h. The reaction was terminated by exposing it to oxygen, and the resulting 
polymer was precipitated in cold 1:1 pentane:diisopropyl ether (200 mL). After redissolving 
the polymer in CH2Cl2 (5 mL), it was again precipitated in 1:1 pentane:diisopropyl ether (200 
mL). This was repeated twice to yield the polymer as a yellow solid (P4.6).  
General procedure for removal of trithiocarbonate end group of p(DMEA(M)A-co-BMA): 
p(DMAEMA-co-BMA) (P4.6) (2.0 g), ACHN (10.4, 0.043 mmol) and N-ethylpiperidine 
hypophosphite (0.120 g, 0.667 mmol) were dissolved in toluene (3 mL) and the solution was 
degassed with argon for 20 min. It was then heat to 100 ˚C for 2 h. The polymer was 
precipitated in cold 1:1 pentane:diisopropyl ether (3 x 200 mL) to obtain p(DMAEMA-co-
BMA)-H (P4.8) (1.9 g). 
General procedure for end-group functionalization of polymer with acrylic acid: 
p(DMAEMA-co-BMA)-H (P4.8) (1.35 g), acrylic acid (69 mg, 0.96 mmol), DMAP (12 mg, 0.096 
mmol) were dissolved in CH2Cl2 (5 mL) and cooled to 0 °C. EDC (277 mg, 1.45 mmol) was 
added portion-wise. Mixture was stirred at 0 °C for 30 minutes and then at rt for a further 
12 hours. Precipitated in pentane and re-dissolved in MeOH. Solution was dialyzed against 
MeOH/water (1:1) for 2 days. MeOH was removed on the rotor evaporator under vacuum, 
and the remaining water was removed using the freeze dryer in order to obtain p(DMAEMA-
co-BMA)-acrylate (P4.10) (1.3 g). 
General procedure for conjugation of hydrophobic and hydrophilic blocks: 
PVP-RGD (P4.4) (100 mg, 0.0217 mmol, 2 eq) and NaBH4 (15 mg) were dissolved in DMF (2 
mL) and degassed for 20 minutes. p(DMAEMA-co-BMA)-acrylate (P4.10)  (190 mg, 0.0114 
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mmol, 1 eq) was dissolved in 2 mL DMF and TEA (60 mg) was added. The solution was added 
in one shot to the PVP solution. The resulting mixture was stirred for 12 hours. Water was 
added to the solution and then freeze dried to remove the water and DMF mixture in order 
to obtain the conjugate (P4.14) (202 mg).  
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Chapter 5: Packaging of anti-miR-214 for targeted cardiovascular delivery 
 
Synopsis 
pH-responsive polyplexes have been reported for their use as carriers in 
modulation of gene regulation through improved facilitation of endosomal 
escape. In this study, the use of novel PVPylated pDMAEMA and pDMAEA 
conjugates, linked via a β-thiopropionate linker were tested for complexation 
efficiency with anti-microRNA (miRNA) therapeutics, their cytotoxicity and 
serum and blood stability, cellular uptake and finally efficiency regulation in 
luciferase expression. 
 




New blood vessels, crucial for embryonic organ development and adult tissue repair, are 
formed from pre-existing endothelium during angiogenesis as a response to angiogenic 
stimuli. Lack of control over the growth of blood vessels is a side-effect of several disorders, 
and can either be in the form of an excessive increase or decrease in angiogenesis. Examples 
of overexpressed angiogenesis can lead to cancer, diabetic blindness or age-related macular 
degeneration, while endothelial dysfunction can lead to coronary artery disease and 
strokes. (1) Non-coding microRNAs (miRNAs) are known to play an important role in 
regulating gene expression by inhibiting or degrading messenger RNAs (mRNAs). One miRNA 
has been seen to be capable of targeting numerous mRNA with similar functions or within 
related pathways, thus, making them master regulators of gene expression. (2-4) Research 
into microRNA-214 has linked it to the inhibition of angiogenesis. It does this by directly 
targeting a protein that is critical for vascular development and remodeling, Quaking (QKI), 
probably by regulating the secretion of growth factors such as VEGF, bFGF and PDGF. (5)  
QKI has been identified as an RNA-binding protein, which has an impact on vasculature 
development and remodeling. (6-8)  
When a disease originates from abnormal inhibition of mRNAs triggered by an 
overexpression of miRNAs, it is possible to use synthetically designed, complementary anti-
miRNAs in order to inhibit the expression of the miRNA through direct binding. (9) Anti-
miRNAs can be modified with e.g. 2’O methyl, phosphorothioate linkages and 3’cholesterol, 
for enhanced stability, nuclease resistance and cellular uptake, as well as improved binding 
affinity to target miRNAs, and are then known as antagomiRs, see Figure 5.1. (10)  
Antagomirs and anti-miRNAs are thought to be powerful therapeutic tools for the silencing 
of miRNAs in disease. (9) Van Mil et al. (5) showed that anti-miRNA-214 can be used in the 
downregulation of miRNA-214, and thus, is a possible therapeutic in the upregulation of 
QKI. 
 




Figure 5.1 Schematic representation of anti-miRNA and antagomiR structures and the chemical 
modifications of antagomiRs which provide stability and protection against nucleases 
 
However, the challenge of the therapeutic applications of anti-miRNAs remains in their 
specific targeted delivery. They face the same problems with stability, circulation time and 
uptake as miRNAs and siRNAs, unless in their modified, antagomiR form. However, 
antagomiRs are only plausible for local delivery. Since anti-miRNAs share the same basic 
properties, including small size and negative charge, with miRNA and siRNA, the previously 
provided extensive research into their delivery, discussed in Chapter 2 and 4, can also be 
applied to anti-miRNAs. 
In this chapter, we have used the di-block polymeric system designed in Chapter 4 to test its 
feasibility as a delivery vehicle for anti-miRNA-214. In order to do this, the complexation 
ability, cytotoxicity, cellular uptake and transfection efficiency of the polyplex systems were 
tested.  
5.2 Results and Discussion 
5.2.1 Polyplex formation and characterization 
The block copolymer conjugates synthesized in Chapter 4 and anti-miRNA-214/antagomiR-
214 were combined to form polyplexes at different N/P ratios. The successful complexation 
with Cy3-labelled antagomiR-214 was confirmed by agarose gel electrophoresis, as seen in 
Figure 5.2. Complexation of the antagomiR with all polymer combinations (no targeting 
ligand, CSTSMLKAC-cardiovascular targeting ligand (CardioTL) (11, 12) and the integrin 
targeting peptide ACDCRGDCFGG (RGD) (13, 14)) was tested. Complexed RNA is unable to 
move through the gel, whereas free RNA moves from the negative electrode towards the 
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positive due to its negative charge and smaller size. Therefore, the free RNA is close to the 
positive electrode (right hand side), while the formation of polyplexes can be visualized by 
the RNA not moving towards the positive electrode, and instead remaining in the wells 
where it was plated (left hand side). Since, antagomiR-214 is single stranded, ethidium 
bromide, a DNA interchelator and a common staining technique cannot be used to visualize 
it. Therefore, a fluorescent scanner was used in order to visualize the Cy-3 fluorescent label 
attached to antagomiR-214. All polymers are seen to condense antagomiR-214 at N/P ratios 
as low as 3, with no free RNA molecules present. These complexation N/P ratios are 
somewhat lower than those previously reported for pDMAEA polyplexes. (15) In Figure 5.2, it 
is possible to see an increase in the complexation efficiency from a low N/P ratio towards a 
higher N/P ratio by the increase in the fluorescent signal at higher N/P ratios. 
 
  
Figure 5.2 Agarose gel retardation of polyplexes containing Cy3-labeled antagomiR-214 at 
different N/P ratios, where a) shows complexes composed of p(DMAEMA-co-BMA)-b-PVP (P4.12-
P4.14) and b) shows complexes composed of p(DMAEA-co-BMA)-b-PVP (P4.15-P4.17). Successful 
complexation can be observed at all N/P ratios for all six polymer systems. 
 
As discussed in Chapter 4, pDMAEA is known to hydrolyze to nontoxic poly(acrylic acid) in 
aqueous environments over a few hours without any influence from triggers such as a 
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allows for the release of the RNA payload, we wanted to ensure that it was not inhibited in 
anyway by the PVPylation or presence of the acid-labile linker. Thus, the polyplexes were 
incubated in HEPES buffer for 2 days and subsequently agarose gel electrophoresis was 
employed to visualize the complexation efficiency, see Figure 5.3. The polyplexes formed 
from p(DMAEMA-co-BMA)-b-PVP are stable after 2 days of incubation in an aqueous 
environment, whereas those polyplexes formed from p(DMAEA-co-BMA)-b-PVP had 
released some of the RNAs, observed by the presence of free RNA on the positive region of 
the gel. The fluorescent intensity of the agarose gels in Figure 5.3 is somewhat lower than 
that in Figure 5.2, which is most probably due to the time-frame of the experiment causing 
the fluorescent marker to exhibit lower emission. 
 
 
Scheme 5.1 Hydrolysis of pDMAEA into poly(acrylic acid), causing decationization of the polymer 
block. 
 
Figure 5.3 Agarose gel retardation of polyplexes after 2 days of incubation in HEPES buffer. The 
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while polyplexes composed of b) p(DMAEA-co-BMA)-b-PVP are starting to decompose releasing 
some of the antagomiRs 
p(DMAEMA-co-BMA)-b-PVP polyplexes were then incubated for a period of 5 days, and it 
was observed that some antagomiR was starting to be released from the polyplex, indicating 
some possible polyplex degradation, seen in Figure 5.4. 
 
Figure 5.4 After 5 days of incubation in HEPES buffer, the polyplexes containing P(DMAEMA-co-
BMA)-b-PVP are also starting to release some of the RNAs 
 
Nanoparticle tracking analysis (NTA) was employed to determine the mean size of the 
polyplexes at N/P ratios of 10 and 20. As expected, the size is inversely proportional to the 
N/P ratio, with N/P ratios of 20 producing marginally smaller polyplexes. All polyplexes are 
between 44 and 58 nm in size with narrow dispersities, as can be seen in Table 5.1.   
 
Table 5.1 Complex size measured by NTA reported in nm. Results are shown as mean ± SD where 
n=3. 
Polyplex polymer N/P 10 N/P 20 
p(DMAEMA-co-BMA)-b-PVP 51.4 ± 1.1 46.7 ± 2.2 
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To subsequently visualize the polyplexes we used TEM, however, a large amount of 
aggregation was observed in the obtained images, see Figure 5.5. Uranyl acetate, frequently 
used to stain TEM samples, was employed during the sample preparation. As the staining 
solution has a pH below 6, it is possible that the acid-labile linker hydrolyzed during the 
staining procedure. Polyplexes without a hydrophilic block are known to aggregate, while 
the PEGylation of polyplexes is reported to decrease this aggregation. (16) The aggregation 
in the TEM results was not consistent with the results obtained via nanoparticle tracker 
analysis (NTA). A different, neutral stain, methylamine tungstate, was attempted; however, 
this resulted in micrographs with poor contrast (results not shown).  
 
 
Figure 5.5 Transmission electron micrographs of polyplexes composed of P4.12 and anti-miRNA-
214 at various N/P ratios. Samples were stained with uranyl acetate. 
 
The zeta-potential (-potential) of the polyplexes was measured at N/P 10, 20 and 40 with a 
linear relationship observed  between -potential and N/P ratio for all of the polyplexes, see 
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Figure 5.6. The obtained results show that, in general, the complexes containing 
p(DMAEMA-co-BMA)-b-PVP (P4.12-14) contain a higher negative charge at N/P 10 than 
those containing p(DMAEA-co-BMA)-b-PVP (P4.15-17). However at an N/P ratio of 40, the 
complexes also contained a similar higher positive charge than the p(DMAEA-co-BMA)-b-
PVP complexes.  
 
 
Figure 5.6 Zeta potential measured in polyplexes at different N/P ratios. Results are shown as 
mean ± SD where n=3. 
 
5.2.2 Serum stability 
When the polyplexes are used intravenously, they will be exposed to blood, where it is 
possible for them to interact with serum proteins, erythrocytes and other blood cells. This 
can cause aggregation which would ultimately lead to polyplex clearance by the reticulo-
endothelial system (RES) as well as to cellular toxicity. (17) The instability of polyplexes in 
the presence of serum is a rather large setback in most polyplex systems. It has been shown 
that conjugation of the polyplexes with PEG improves biocompatibility and stability. (16) 
The stability of PVPylated polyplexes at N/P 10 and N/P 20 was determined by incubating 
them in the presence of varying concentrations of fetal bovine serum (FBS) for 4 hours, and 
subsequently running agarose gel electrophoresis, see Figure 5.7. No significant polyplex 
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degradation was observed as evidenced by the strong bands in the agarose gel 
corresponding to undamaged polyplexes. An additional band can be observed, which is 
characteristic of the presence of serum. Therefore, the polyplexes exhibit excellent serum 
stability in these conditions, which indicates that the presence of PVP on the surface of the 
polyplexes prevent nonspecific protein adsorption. Interestingly, the polyplexes containing 
p(DMAEA-co-BMA)-b-PVP incubated in the absence of FBS,  see Figure 5.7 (b), exhibit some 
decomplexation probably due to decationization via hydrolysis in the aqueous medium. 
However, in the presence of FBS, this decationization is reduced. Consequently, 
decationizing polyplexes will potentially show enhanced stability in the presence of serum, 
i.e. during systemic circulation, which would improve their half-life and passive targeting, 
while after cellular uptake they provide a mechanism to release their payload. Further, in 
vivo investigations will be necessary to confirm this. 
 
 
Figure 5.7 Agarose gel retardation of polyplexes incubated in the presence of varying 
concentrations of fetal bovine serum, where polyplexes are composed of a) P4.13 and b) P4.15 
 
Erythrocytes are negatively charged blood cells and have previously been shown to interact 
with polyplexes. Ultimately, this leads to aggregate formation and systemic toxicity. (18) In 
order to predict the possibility of erythrocyte hemolysis induced by the polyplexes, 
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(N/P 10, 20, 40, 100 and 500) for 1 hour at 37 °C. Subsequently, the concentration of 
released haemoglobin in the supernatant after centrifugation was measured by UV-vis 
absorbance at 550 nm, see Figure 5.8. The pellet was redissolved in PBS and visualized for 
aggregation under the microscope, Figure 5.9.  
The hemolysis caused by polyplexes was compared to the hemolysis effect caused by 
Lipofectamine and PEI, Figure 5.8. It is clear that polyplexes from p(DMAEA-co-BMA)-b-PVP 
(P4.15-17) induce hemolysis to a greater extent than those from p(DMAEMA-co-BMA)-b-
PVP (P4.12-14). The N/P ratio also impacts the hemolysis, with higher N/P ratios causing 
more hemolysis. Lipofectamine 2000 induced a large degree of hemolysis, only surpassed by 
the polyplexes investigated in this study at extremely high N/P ratios (>100). 
 
 
Figure 5.8 Polyplex-induced erythrocyte hemolysis. Polyplexes were incubated with erythrocytes 
for 1 hour at 37 °C. PEI polyplex and Lipofectamine 2000 were used as controls. The graph 
represents the degree of erythrocyte hemolysis determined by absorbance detection at 550 nm. 








































































Figure 5.9 Polyplex-induced erythrocyte aggregation. Polyplexes were incubated with erythrocytes 
for 1 hour at 37 °C. PEI polyplex and naked anti-miRNAs were used as controls. Representative 
microscopic images of erythrocyte aggregation, whereby aggregates are indicated using arrows. 
Erythrocytes were incubated with anti-miRNA-214 polyplexes composed of i) P4.12, ii) P4.13, iii) 
P4.14, iv) P4.15, v) P4.16, vi) P4.17, all at N/P 40, vii) PEI and finally with viii) naked anti-miRNA-
214.  
 
Although it can be observed in Figure 5.8, that PEI causes very small degrees of hemolysis, it 
causes extremely large degrees of erythrocyte aggregation, see Figure 5.9. Conversely, the 
polyplexes composed of the p(DMAEMA-co-BMA)-b-PVP (P4.12-14), Figure 5.9 (i-iii), and 
p(DMAEA-co-BMA)-b-PVP (P4.15-17), Figure 5.9 (iv-vi), did not cause high degrees of 
aggregation at N/P ratios as high as 40. Only P4.17 shows a slight amount of erythrocyte 
clustering. However, there are fewer erythrocytes visible for samples incubated with 









The in vitro cytotoxicity was assessed using Annexin V and Sytox® blue. Annexin V is an 
intracellular protein, which binds to phosphatidylerine. In healthy cells, phosphatidylerine is 
located on the intracellular leaflet of the plasma membrane, however, during early 
apoptosis, or cell stress, the membrane loses its asymmetry and the phosphatidylerine can 
also be seen on the external leaflet. When present on the external leaflet, Annexin V is able 
to bind to the phosphatidylerine, and when it is labelled with a fluorophore, it can be used 
to detect early apoptotic cells through flow cytometry. Since cells are capable of recovering 
from early apoptosis, it is also important to detect dead cells. This was performed using 
Sytox® blue, which is a stain with a high affinity for nucleic acids. When cell membranes are 
compromised, i.e. the cells are dead, the stain is able to penetrate the cell membrane and 
reach the nucleic acids. However, when the cells are still viable, the stain is unable to cross 
the cell membrane. Therefore, only dead cells are stained with Sytox® blue.  
Cardiomyocyte progenitor cells (CMPCs) were exposed to polyplexes at various N/P ratios at 
a constant concentration of Cy3-labelled antagomiRs. The results are summarized in Figure 
5.10. No significant signs of cell death are observed. Only at N/P 40 for RGD-labeled 
polyplexes, some apoptosis is observed indicating some cell stress. However, it is notable 
that the pDMAEA complexes (P4.15-17) cause slightly higher cytotoxicity than the 
pDMAEMA complexes (P4.12-14). 
 




Figure 5.10 CMPC viability and induced apoptosis after transfection with polyplexes at various N/P 
ratios composed of a)P4.12, b) P4.13, c)P4.14, d) P4.15, e) P4.16, f)4.17. Controls included cells 
transfected with PEI, naked Cy5-labelled antagomiR, HEPES buffer and non-transfected cells. 
Results are shown as mean ± SD where n=3. 
 
5.2.4 Cellular uptake and transfection efficiency 
The cellular uptake of polyplexes is a crucial step for gene delivery, and therefore, it is 
important to evaluate the cellular uptake efficiency for these polymer systems. CMPCs were 
thus transfected with polyplexes formulated with Cy3-labelled antagomiR-214. The medium 
was changed after four hours. After further incubation for 24 hours, the cells were 
harvested and cellular uptake was quantified by flow cytometry. The results are summarized 
in Figure 5.11. 
The polyplexes were efficiently taken up by the cells at all N/P ratios. A proportional 
correlation between N/P ratio and uptake is expected, since it is well known that higher N/P 
ratios of polyplexes facilitate greater uptake in cells. This relationship was not observed. 
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estimations of the cellular uptake due to quenching effects at higher N/P ratios. (19). This 
means that the tight complexation of the polycations with the RNA at high N/P ratios shields 
the RNA’s fluorescent signal; consequently, generating results that do not always correlate 
to a proportional increase in uptake corresponding to an increased N/P ratio.  
 
   
Figure 5.11 Determination of cellular uptake by flow cytometry. Where complexes composed of a) 
p(DMAEMA-co-BMA)-b-PVP b) p(DMAEA-co-BMA)-b-PVP. Results are shown as mean ± SD where 
n=3. 
 
To further investigate whether this inconsistency of N/P ratio versus uptake was indeed due 
to shielding effects of the polycations, cell lysis and polyplex decomplexation experiments 
were performed before measuring the fluorescent signal, as described previously by Vader 
et al. (19) In short, CMPCs were exposed to polyplexes, and after numerous washing steps, 
the cells were lysed and the polyplexes were disrupted with 2% sodium dodecyl sulfate 
(SDS) in order to release the antagomiR, and subsequently the lysates were centrifuged. The 
fluorescent signal of the supernatant was measured in order to calculate the relative 
quantity of fluorescently-labelled antagomiR. These results have been summarized in Figure 
5.12. From these analyses, it is evident that the cellular uptake of polyplexes is directly 
proportional to the N/P ratio, with an increase in N/P ratio leading to an increase in the 
cellular uptake. It can also be noticed that the uptake is greater for polyplexes that are 
functionalized with the cardioTL (P4.13 and P4.16) than those with RGD (P4.14 and P4.17), 
probably since the tested cell line being of cardiovascular origin. Lastly, polyplexes without 
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the importance of targeting ligands on the surface of polyplexes for enhanced receptor-
mediated uptake. It should be noted that the uptake of polyplexes formulated from 
p(DMAEA-co-BMA)-b-PVP (P4.15-17) show slightly higher uptake than the polyplexes from 
p(DMAEMA-co-BMA)-b-PVP (P4.12-14).  
 
   
Figure 5.12 Determination of cellular uptake by measuring the fluorescent signal in the 
supernatant of cell lysates. Fluorescent values were corrected for the protein content. Where 
complexes were formulated from a) p(DMAEMA-co-BMA)-b-PVP b) p(DMAEA-co-BMA)-b-PVP. 
Results are shown as mean ± SD where n=3. 
 
Confocal microscopy was used as the third method for determining the cellular uptake of 
the polyplexes. Human microvascular endothelial cells (HMECs) exposed to complexes 
formulated from P4.13-14 or P4.16-17 and Cy3-labelled antagomiR-214 were observed 
under the confocal microscope after being stained with Lysotracker and Hoechst. The 
images can be seen in Figure 5.13 where (i) shows the signal from the Hoechst stain, (ii) 
shows the signal from lysotracker, (iii) shows the signal from the Cy3-labelled antagomiR 
and (iv) is a merged image from all three signals. Hoechst is a common stain for DNA, i.e. it 
allows for visualization of the nucleus. Lysotracker is a highly selective dye for acidic 
organelles, thus it is specific for visualization of late endosomes and lysosomes. The 
microscope images again suggest that p(DMAEA-co-BMA)-b-PVP (P4.16-17) polyplexes, 
Figure 5.13 (c) and (d), were taken up more readily by the cells than p(DMAEMA-co-BMA)-b-
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As discussed in Chapter 2, endosomal entrapment is a very serious problem for many non-
viral gene delivery systems. (20, 21) This causes problems in gene regulation, since the 
payload does not reach the cytoplasm, where the RNA therapeutics must perform its end-
application. Therefore, by staining with lysotracker, it was possible to see whether or not 
the complexes were trapped within the endosomal/lysosomal compartment. In Figure 5.13, 
it can be observed that although the majority of the complexes are still within the 
endosome/lysosome, there is some endosomal escape occurring. This escape can be seen 
when the Lysotracker signal, Figure 5.13 (ii), does not overlap with the Cy3 signal from the 
antagomiR, Figure 5.13 (iii). The mechanism of escape does not seem to be very efficient, 
even with the presence of the pH-labile linker between the two polymer blocks. However, 
to fully establish and understand the extent of polyplex delivery and cytoplasmic release of 
the payload, the efficiency of gene expression was investigated.  
 
 
Figure 5.13  Localization of Cy5-labelled antagomiR-214 48 hours after treatment with a) P4.13, b) 
P4.14, c) P4.16 and d) P4.17 complexes, characterized by microscope analysis. Nuclei were stained 
with Hoechst are shown in blue (i) Lysosomal marker, Lysotracker, is shown in green (ii), Cy5 signal 





i) ii) iii) iv)
i) ii) iii) iv)
i) ii) iii) iv)
i) ii) iii) iv)
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5.2.5 Gene regulation efficiency 
Luciferase reporter assays are a common tool utilized to determine the gene expression at a 
cellular level because they provide an easy, inexpensive and quantitative method of 
quantifying the end-function of delivered gene therapeutics. In this way, it is possible to 
assess the efficiency of the gene delivery vehicle.  
pMIR-QKI-3'UTR reporter, a miRNA-214 reporter that expresses luciferase; however in the 
presence of miRNA-214, this expression is inhibited. If anti-miR-214 is present, it is able to 
inhibit miRNA-214 from blocking the luciferase expression, i.e. luciferase expression can be 
detected. HEK293 cells were co-transfected with pMIR-QKI-3'UTR reporter and pMIR-Report 
β-gal control plasmid. The β-gal control plasmid was transfected as an internal control to 
establish the transfection efficiency, and normalize the luciferase expression results. The 
cells were also transfected with pre-miRNA-214 (pre-miRNA-214), a nonsense miRNA (neg 
control), a scrambled miRNA (scrambled RNA), or no miRNA (Luc). The following day, the 
cells transfected with pre-miRNA-214 were further exposed to polyplexes containing anti-
miR-214, as well as a number of controls: naked anti-miRNA-214 (naked anti-miR), 
Lipofectamine 2000-anti-miR-214 (L(+)), Lipfectamine 2000-nonsense miRNA (L(-)) or PEI-
anti-miR-214 (PEI). After incubation for 48 hours, the cells were lysed and the luciferase 
activity was assessed, see Figure 5.14. Lipofectamine 2000 is known to have an extremely 
high transfection efficiency in vitro and therefore served as a posiive control. The pMIR-QKI-
3'UTR reporter (Luc) expresses luciferase and upon the addition of pre-miRNA-214, this 
expression should decrease. If anti-miRNA-214 is effectively transported into the cell, the 
miRNA-214 will be inhibited, re-establishing the luciferase signal.  As expected, the 
Lipofectamine transported anti-miR-214 (L(+)) almost completely re-established the 
luciferase expression. A trend in the gene regulation efficiency can be observed for all of the 
polyplexes, except P4.17, whereby the efficiency increases with an increase in the N/P ratio. 
All of the complexes were equivalent to or out-performed the ‘gold standard’, PEI. 
Interestingly, the p(DMAEA-co-BMA) (P4.15) containing no targeting ligand out-performed 
all of the other conjugates, while in general the p(DMAEMA-co-BMA) systems (P4.12-14) 
performed better than the p(DMAEA-co-BMA) conjugates with targeting ligands (P4.16 and 
P4.17). 






Figure 5.14 Gene silencing activity of P4.12-17 complexes. Luciferase expression of  QKI-3’UTR 
reporter transfected in HEK 293 cells was determined 48 hours after transfection. Complexes were 
prepared using 50 nM anti-miRNA-214 concentration. Lipofectamine 2000 and PEI were used as 
controls. Results shown as mean ±SD for n=3. 
 
In order to ascertain whether it is possible to further re-establish the luciferase signal, a 
higher concentration of anti-miRNA-214 was loaded into the polyplexes, and a higher N/P 
ratio was compared to N/P 20 complexes, seen in the previous experiment to be more 
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Figure 5.15 Gene silencing activity of P4.12-17 complexes. Luciferase expression of QKI-3’UTR 
reporter transfected in HEK 293 cells was determined 48 hours after transfection. Complexes were 
prepared using 100 nM anti-miRNA-214 concentration. Lipofectamine 2000 and PEI were used as 
controls. Results shown as mean ±SD for n=3. 
 
An increased signal was obtained, especially for P4.13 and P4.14, where almost 50% of the 
signal was re-established. Very little difference was seen in the extent of re-established 
signal between the other complexes and the previously obtain results. The most notable 
result is that the pDMAEMA-containing complexes (P4.12-14) show higher expression in 
Figure 5.15 than the de-cationizing pDMAEA-containing complexes (P4.15-17). These results 
contradict previous reports of pDMAEA versus pDMAEMA complexes. (22) Additionally, 
while the p(DMAEMA-co-BMA) conjugates with targeting ligands (P4.13-14) perform better 
than those without targeting ligands (P4.12), the opposite is true for the p(DMAEA-co-BMA) 
system (P4.15 and P4.16-17). This will be discussed further below. 
 
To further explore the versatility of the gene delivery systems, the diblock conjugates were 
complexed with siRNA-luc. Cells genetically modified to express luciferase, Human Epithelial 
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measured. In this case, the delivered siRNA-luc causes a knockdown effect on the luciferase 
expression. Therefore, successful delivery is seen by a decrease in the luciferase expression 
measured compared to cells without siRNA delivery. The results are summarized in Figure 
5.16. 
 
Figure 5.16 Gene silencing activity of P4.12-17 complexes. Luciferase expression of FADU-Fluc cells 
determined 48 hours after transfection. Complexes were prepared using 8 pmol siRNA. 
Lipofectamine 2000 and PEI were used as controls. Results shown as mean ±SD for n=3. 
 
The conjugates were successfully able to deliver siRNA to the cells for luciferase knockdown 
to be observed. As described for the anti-miRNA system, the luciferase knockdown was 
proportional to the N/P ratio, and in general p(DMAEMA-co-BMA) polyplexes (P4.12-14) 
were more efficient in gene regulation than the p(DMAEA-co-BMA) polyplexes (P4.15-17). 
Both systems showed similar knockdown efficiency to PEI. Interestingly, it was hypothesized 
that the RGD targeting ligands would elicit the highest knockdown effect; however, no 
significant difference between knockdown efficiency was seen for the RGD-functionalized 
systems. It was again noticed that the p(DMAEMA-co-BMA) conjugates without targeting 
ligand (P4.12) performed the worst within the p(DMAEMA-co-BMA) group (P4.12-14), 
whereas the opposite was seen for the p(DMAEA-co-BMA) conjugates (P4.15-17). As the 
same effect was seen for the anti-miRNA-214 luciferase expression results, Figure 5.15, it 
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have an effect on the efficiency of the p(DMAEA-co-BMA) system (P4.16-17). If this is the 
case, then it is also possible that the shielding presence of PVP plays a role in lower gene 
regulation efficiency of the p(DMAEA-co-BMA) (P4.15-4.17). It is possible that the 
contradictory results obtained in this study compared to those reported in literature for the 
gene regulation efficiency of pDMAEA versus pDMAEMA is linked to the presence of the 
targeting ligand and/or the PVP. However, further investigation would be necessary to test 
this hypothesis, and elucidate the reasoning behind it.  
In order to assess whether great knockdown efficiency could be obtained by increasing the 
quantity of siRNA delivered to the cells, a siRNA concentration gradient was performed, 
whereby 4, 8 and 32 pmol siRNA were complexed with non-targeted p(DMAEMA-co-BMA)-
b-PVP (P4.12) and p(DMAEA-co-BMA)-b-PVP (P4.15) at N/P ratio of 20. The results are 
summarized in Figure 5.17.  It was seen that as the amount of siRNA-luc complexed with the 
diblock conjugates increases, the knockdown effect also increases.  
 
 
Figure 5.17 Gene silencing activity of P4.12 and P4.15 complexes containing various concentrations 
of siRNA-luc. Luciferase expression of FADU-Fluc cells determined 48 hours after transfection. 


















































The conjugates synthesized in Chapter 4 were investigated as possible gene delivery vectors. 
Their anti-miRNA binding efficiency was established, and all of the conjugates were seen to 
efficiently condense the RNA therapeutics, even at N/P ratios as low as 3. The polyplexes 
were shown to not cause high degrees of erythrocyte aggregation, with the aggregation 
increasing proportional to the N/P ratio. The complexes containing p(DMAEA-co-BMA) 
(P4.15-17) caused more hemolysis than those formulated from p(DMAEMA-co-BMA) (P4.12-
14). No significant cytotoxicity was observed for the complexes, although some signs of 
apoptosis were observed.  
Furthermore, the complexes were seen to facilitate cellular uptake, with uptake increasing 
proportionally to the N/P ratios. The incorporation of targeting ligands improved the cellular 
internalization of complexes, and p(DMAEA-co-BMA) (P4.15-17) was seemingly more 
efficient at enabling uptake. Conversely, the p(DMAEMA-co-BMA) complexes (P4.15-17) 
stimulated higher luciferase expression regulation than p(DMAEA-co-BMA) complexes 
(P4.15-17) and inverse results with regards to the presence of targeting ligands and 
luciferase regulation were observed for p(DMAEMA-co-BMA) (P4.15-17) compared to 
p(DMAEA-co-BMA) complexes (P4.15-17). Further investigation will be needed to resolve 
why the presence of the targeting ligand, and possibly PVP, decreases the gene regulation 
modulation effect of p(DMAEA-co-BMA) (P4.15-17). That said, both systems elicit gene 
regulation efficiency that is equal to or greater than PEI, and thus, these conjugates show 
potential as possible gene delivery vectors. In vivo studies will be conducted in the near 
future in order to investigate the systemic stability, biodistribution and in vivo gene 
regulation efficiency. 




5.4.1 General experimental details 
Unless stated otherwise, all of the chemicals used were purchased from commercial sources 
and used without further purification. 
ζ-potential was measured on Malvern Zetasizer Nano Z. The samples were exposed to 3 V 
maz, and 3 measurement of 100 scans were obtained per sample. Complex size distribution 
was measured using nanoparticle tracking analysis (NTA) with a Nanosight NS500 
nanoparticle analyser (Malvern Instruments) which was equipped with a 405 nm laser. The 
camera level was set to 16 and all post-acquisition settings were set to automatic, except for 
the detection threshold, which was set at 5. Three 30 s videos were recorder per sample 
using the script control function. 
Flow cytometry was carried out on a CytoFLEX Flow Cytometer (Beckman Coulter). Data was 
analyzed using Kaluza Analysis 1.5a. 
5.4.2 Experimental methods 
Complex formation 
Polymers were dissolved in DMSO and mixed with anti-miRNA-214 at various N/P ratios and 
diluted in HEPES buffer (pH 6.7). The solution was incubated at 37 °C for 1 hour. Complexes 
were used immediately. 
Complex characterization 
Complexes containing 550 pmol Cy3-labelled antagomiR-214 with a final volume of 25 μL 
were prepared for agarose gel retardation. 6 μL 6 x loading dye was added to the samples 
prior to loading. 2% agarose gel was prepared and the electrophoresis was performed at 
140 V for 45 min. The gels were then imaged using the Typhoon 9410 Variable Mode Imager 
[Amersham, Biosciences). 




hsa-miR-214  ACAGCAGGCACAGACAGGCAGU 
antagomiR-214: (Cy3)-5’-ACTGCCTGTCTGTGCCTGCTGT-3’-CHOLESTEROL 
Cell culture 
Human Epithelial firefly luciferase (FaDu-Fluc) cells and Human embryonic kidney 293 cells 
(HEK 293) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Introgen, 
Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) and 10% Penicillin 
Streptomycin solution (P/S). Fetal cardiomyocyte progenitor cells (CMPCs) were cultivated 
on 0.1% gelatin in SP++ medium (1 part endothelial cell growth medium-2 (EGM-2), 3 parts 
Medium199 (M199) supplemented with 1% P/S, 1% non-essential amino acids (NEAA) and 
10% FBS). Human microvascular endothelial cells (HMECs) were cultivated on 0.1% gelatin in 
EGM-2.  
Cellular uptake (flow cytometry) 
CMPCs were seeded in 12 well plates and incubated for 24 hours. Medium was removed 
and replaced with 500 µL OptiMem. Cells were transfected with complexes at various N/P 
ratios formulated with 5.5 nmol Cy3 labelled antagomiR-214. After 4 hours, the OptiMem 
was replaced with SP++ medium and cells were incubated for 48 hours. Cells were washed 
twice with PBS buffer to remove non-internalized polyplexes. Cells were harvested using 
Trypsin and centrifuged (350·g, 5 min) and supernatant was aspirated. The cells were 
resuspended in 500 µL PBS buffer containing 10% FBS. Again cells were centrifuged (350·g, 5 
min) and supernatant was aspirated. The cells were resuspended in 500 µL PBS and after a 
final centrifugation step, the cells were resuspended in PBS buffer with 2% FBS (FACS 
medium). The samples were then analyzed on the CytoFLEX flow cytometer. 
Cellular uptake (lysis)  
CMPCs were seeded in 12 well plates and incubated for 24 hours. Medium was removed 
and replaced with 500 µL OptiMem. Cells were transfected with complexes at various N/P 
ratios formulated with 15 nmol Cy3-labelled antagomiR-214. After 4 hours, the OptiMem 
was replaced with SP++ medium and cells were incubated for 48 hours. Cell lysis and uptake 
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measurement was performed according to literature. (19) Method was as follows: Cells 
were washed twice with PBS buffer to remove non-internalized polyplexes. 200 µL lysis 
buffer (2% SDS, 1% Triton X-100 in PBS) was added and the cells were incubated on ice for 1 
hour. Lysates were then centrifuged (14000·g, 15 min, 4 °C) in order to remove the cell 
debris. 100 µL of the supernatant was transferred to a 96-well plate to measure the 
fluorescence using a SpectraMax M2 (Molecular Devices). Data was acquired with SoftMax 
Pro (v5.4.5). The mean fluorescence intensity was normalized to the amount of protein 
present in the sample. The amount of protein was determined using a Micro BCA™ protein 
assay kit (ThermoFisher Scientific), protocol was followed according to manufacturer.  
Cytotoxicity studies 
CMPCs were seeded in 12 well plates and incubated for 24 hours. Medium was removed 
and replaced with 500 µL OptiMem. Cells were transfected with complexes at various N/P 
ratios formulated with 5.5 nmol antagomiR-214. After 4 hours, the OptiMem was replaced 
with SP++ medium and cells were incubated for 48 hours. Annexin V, Alexa Fluor™ 647 
conjugate (Invitrogen) and Sytox Blue (Invitrogen) was used for cytotoxicity assay. Protocol 
was followed according to manufacturer. The cells were analyzed by flow cytometry on 
CytoFLEX Flow Cytometer (Beckman Coulter) directly after staining. Data was analyzed using 
Kaluza Analysis 1.5a. 
Erythrocyte aggregation and hemolysis 
Method was modified from literature. (16) In short, erythrocytes were obtained from 5 mL 
whole human blood by multiple centrifugation steps (1000·g, 10 min, 4 °C), followed by 
aspiration of supernatant and resuspension in PBS buffer until the supernatant was clear. 
Approximately 4 steps were required. 100 µL of the pellet was resuspended in 4 mL PBS. 
160 µL of the final erythrocyte suspension was added to 40 µL polyplex solution with an 
anti-miRNA concentration of 1 µM. Triton X-100 (1%) in PBS and HEPES (pH 7.2) were used 
as reference samples of 100% lysis and 0% lysis respectively. Samples were incubated for 1 
hour at 37 °C. After a further centrifugation step (1000g, 10 min), the absorbance at 550 nm 
was measured of 150 µL of the supernatant to ascertain the degree of hemolysis. The pellet 
was resuspended in 50 μL PBS and observed under the microscope to evaluate degree of 
erythrocyte aggregation. 




HMECs were seeded in an 8-well flow chamber and incubated for 24 hours. The medium 
was aspirated and replaced with 150 µL OptiMem. Cells were transfected with complexes 
(N/P 20) with a final antagomiR-214 concentration of 3 μM. After 4 hours, the OptiMem was 
replaced by EGM-2 medium and the cells were incubated for 48 hours. The medium was 
then replaced to medium containing 1:10000 Lysotracker Red and incubated for 2 hours. 
The medium was then replaced with medium containing Hoechst solution (1 µg/mL) and the 
cells were incubated for 10 minutes. The medium was aspirated and the cells were washed 
twice with EGM-2 medium. 150 μL of EGM-2 was added to the wells and the cells were 
imaged on a ZEISS LSM 700 confocal microscope (Carl Zeiss). 
Luciferase Assay (anti-miRNA-214) 
The method was modified from literature. (5) The conserved miRNA-214-binding sequences 
in the QKI 3’ untranslated region (UTR) were cloned into pMIR-Reporter vector (Ambion). 
HEK293 cells were seeded in 48-well plates and incubated for 24 hours. The medium was 
replaced with OptiMem. The cells were co-transfected with 200 ng of pMIR-Reporter-QKI-
3’UTR Luciferase vector and pMIR-Report β-gal control plasmid. The latter was used to 
assess the transfection efficiency. In addition, 50 nM pre-miRNA-214, ctrl-miRNA or 
scrambled miRNA were also transfected. The transfection was carried out by using 
Lipofectamine 2000 (Invitrogen). After 4 hours, the medium was replaced with DMEM 
supplemented with 10% FBS. After 24 hours of incubation, the medium was replaced with 
OptiMem, and cells were transfected with complexes containing 50 nM anti-miRNA-214 at 
different N/P ratios, or Lipofectamine with either anti-miRNA-214 or ctrl-miRNA, PEI-anti-
miRNA-214 polyplexes or naked anti-miRNA-214. After 4 hours, the medium was replaced. 
The cells were incubated for 48 hours. They were then washed with PBS and lysed with 150 
μL 1 x Luciferase lysis buffer. The cells were incubated for 15 minutes. 10 μL of the 
supernatant was transferred to a white 96-well plate, and the luciferase activity was 
assessed with Luciferase Assay System (Promega). 25 μL of the cell lysis supernatant was 
transferred to a 96-well plate and 25 μL β-galactosidase Enzyme Assay buffer. After 
incubation at 37 °C for 1 hour, the absorbance at 405 nm and 570 nm was measured.  
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Luciferase assay (siRNA-luc) 
FADU-Fluc cells were seeded in 48-well plates and incubated for 24 hours. The medium was 
replaced with OptiMem and the cells were transfected with polyplexes containing 4, 8, 16 or 
32 pmol siRNA. After 4 hours, the medium was replaced and the cells were incubated for a 
further 48 hours. The cells were washed with PBS buffer and lysed with luciferase assay 
buffer (ThermoFischer Scientific). After incubation at room temperature for 20 minutes, 10 
μL of the supernatant was transferred to a white 96-well plate, and the luciferase activity 
was assessed with Luciferase Assay System (Promega) on a Fluoroskan Ascent FL 
(ThermoScientific). Data was acquired with Ascent Software (v 2.6). 50 μL of the 
supernatant was used to assess the protein content using a Micro BCA™ protein assay kit 
(ThermoFisher Scientific), protocol was followed according to manufacturer.  
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Chapter 6: Zwitterionic poly(styrene-co-maleic anhydride) copolymer derivatives for 
application in gene therapy  
 
Synopsis  
Zwitterionic polymers are increasingly being studied as gene 
delivery vectors, as they contain the necessary positive charge for 
gene complexation, while their negative charge acts to balance 
the charge. Hereby, a significant decrease in the cytotoxicity and 
aggregation behaviour is observed compared to their cationic 
counterparts. In this study, novel poly(styrene-co-maleic 
anhydride) (SMA)-derivatives were investigated for their 
efficiency as non-viral vectors in anti-miRNA-214 delivery. After 
complexation, targeted cells did not exhibit significant toxicity, 
hemolysis or aggregation. Their mechanism of cellular uptake was 
investigated and, although active transport is involved, they do 
not follow the usual clathrin–or caveolae–mediated endocytic 
pathways. The exhibited gene delivery efficiency of these SMA-
complexes was equivalent to or greater than that of the current 








Zwitterionic polymers are macromolecules that contain both positive and negative charge. 
These polymers have emerged as a new possibility for non-viral, gene delivery vectors, 
which exhibit characteristics of both cationic polymers and liposomes, while maintaining a 
lower cytotoxicity than their polycation analogues. (1, 2) This lowered cytotoxicity is most 
probably due to their closer-to-neutral zeta-potential (-potential) when complexed to 
nucleotides, brought about by their balance in charge. This lower -potential also resists 
non-specific interactions with blood plasma and serum, a known problem for polycation 
based delivery systems. (3) 
A common amphiphilic polymer employed in biomedical applications is ring-opened 
poly(styrene-co-maleic anhydride) (SMA). SMA is very easy to modify due to maleic 
anhydride’s reactivity towards hydroxyl, sulfhydryl and amine groups. (4-8) When the pH 
decreases, for example upon entering the endosome, the carboxylic acid moiety is 
protonated, which induces a change in the polymer from hydrophilic to more hydrophobic. 
(9) This change in state previously caused the endosomal membrane to destabilize, 
facilitating endosomal escape of the polymer and its payload. (10)  
Although highly used in drug delivery, (11-14) SMA has not been extensively explored for 
gene delivery applications. Stayton and co-workers (15) mentioned the possibility of using 
SMA modified with alkyl amines for gene delivery due to their pH responsive nature. 
However, the first example where SMA was employed as a vector in gene delivery was 
carried out by Duan et al. (16) where they conjugated SMA with low molecular weight PEI 
(800 Da). The SMA-PEI complexes condensed DNA more efficiently than the unconjugated, 
low molecular weight PEI analogue, while the zeta potential of the SMA-PEI-DNA complexes 
was significantly lower than that of high molecular weight PEI (25 kDa) polyplexes. This 
lowered zeta-potential was due to the neutralizing effect of carboxylic acids on the SMA 
block.  Hereby, a higher transfection efficiency and cellular uptake for SMA-PEI complexes 
was observed than for high molecular weight PEI. They hypothesized that this was due to 
the presence of phenyl groups on the SMA which can form π-π stacking interactions with 
the nucleotide base-pairs. Furthermore, the improved cellular interaction was correlated to 
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the amphiphilic nature of the polymer. No results were shown, however, regarding gene 
expression regulation.  
More recently, Alex et al. (9) created a small library of low molecular weight SMA (2:1) 
grafts containing cationic amine functional groups,  including spermine, L-arginine, aromatic 
(isonicotinic acid), aliphatic (glycidyl trimethylammonium chloride) and cyclo aliphatic 1-(2-
aminoethyl)piperazine. The side-chains on the last three SMA-derivatives were quaternized 
in order to infer cationic charge to the system. Interestingly, the L-arginine and spermine 
grafted SMA-derivatives showed enhanced endosomal escape characteristics, while also 
condensing the DNA more efficiently; whereas, the quaternized amine-modified SMAs 
displayed varying positive and negative attributes. The aromatic group on the (isonicotinic 
acid)-modified SMA increased hydrophobicity of the system, which in turn enhanced the 
endosomal rupturing capabilities of the complexes. However, their hydrophobicity caused 
issues in their protection against DNase at physiological pH. Although the aliphatic (glycidyl 
trimethylammonium chloride)-modified SMAs were able to effectively protect against 
DNase, they caused high levels of cytotoxicity. Finally the cyclo aliphatic (1-(2-aminoethyl) 
piperazine-modified SMAs were unable to effectively complex DNA. 
In the present study, 3-(N,N-dimethylamino)propyl-1-amine (DMAPA)-modified SMA was 
investigated as a possible candidate vector for non-viral gene delivery, see Scheme 6.1. The 
ring-opened analogue is zwitterionic and highly water soluble, which is highly desirable 
since it avoids disruption of the cellular environment caused by insoluble complexes. (2) In 
order to evaluate the effect that the amphiphilic and zwitterionic nature imparts, the 
DMAPA-modified SMA was also ring-closed to form poly(styrene-co-N-(3-(N’,N’-
dimethylamino)propyl)-maleimide) (DMAP-SMI), and the two forms were compared with 
each other in terms of complexation efficiency, cellular cytotoxicity, uptake and transfection 
efficiency. 
6.2 Results and discussion 
6.2.1 Polymer synthesis, modification and characterization 
Figure 6.1 depicts the chemical structure of the reversible-addition fragmentation chain-
transfer (RAFT) agent (R6.1) that was utilized in the current study to prepare poly(styrene-
co-maleic anhydride) (P6.1). The RAFT agent was synthesized according to literature, and 
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the 1H NMR corresponded to literature values. (17)  The details of the synthetic protocol of 
the RAFT agent synthesis and polymerization are summarized in Section 6.4.  
 
 
Figure 6.1 Structure of butyl 1-phenylethyl trithiocarbonate (R6.1) 
 
Table 6.1 summarizes the results from the RAFT–mediated polymerization to prepare 
poly(styrene-co-maleic anhydride), P6.1. P6.1 was obtained with control over molecular 
weight and its distribution (Ð = 1.1). A polymer with an Mn of 12800 g.mol
-1 was obtained. 
 





















P6.1 11000 70 R6.1 
Sty:MAnh 
(1:1) 
AIBN MEK 58 12800 12600 14300 1.1 
§Determined by SEC in DMAc relative to PMMA standards.  
*Determined via 1H NMR 
‡Conversion obtained through gravimetric analysis. 
 
Amidation of the SMA was performed post-polymerization in order to obtain DMAP-SMI 
(P6.2), as depicted in Scheme 6.1. 
 




Scheme 6.1 Amidation of P6.1 with DMAPA to obtain ring-open amine-modified SMA (P6.2) and 
subsequent thermally induced ring-closing reaction to obtain P6.3 
 
The success of the modification was confirmed through Fourier transform infrared (FT-IR) 
spectroscopy, as previously reported in our group, see Figure 6.2. (18) In short, the band 
attributed to the carbonyl groups (1858 and 1774 cm-1) and C-O-C stretching bands 
(between 903 and 1220 cm-1) of carbonyl anhydride in P6.1 disappeared upon amidation, 
and the carboxylic acid C=O stretch (1690 cm-1), carboxylic acid O-H stretch (3664-3126 cm-
1) and the two amine peaks (1559 and 1356 cm-1) appeared in P6.2.  A portion of P6.2 was 
then subjected to thermally induced ring-closure to obtain P6.3.  Again, the success of the 
ring-closure could be confirmed via FT-IR (19) by the disappearance of the carboxylic acid 
C=O peak (1695 cm-1) and carboxylic acid O-H stretch (3000-2500 cm-1), as well as a shift in 
the C=O carbonyl anhydride peaks seen for P6.1 to 1769 and 1690 cm-1, as indicated by the 
dotted blue line in Figure 6.2. 
 




Figure 6.2  ATR–FTIR spectra of a)poly(styrene-co-maleic anhydride) (P6.1), b) ring-opened, DMAPA-
modified poly(styrene-co-maleic anhydride (P6.2) and c) ring-closed, DMAPA-modified poly(styrene-co-
maleimide (P6.3). The blue dotted line indicates the shift in the carbonyl anhydride bands due to 
imidation. 
 
6.2.2 Complex characterization 
For complexation to be possible, P6.2 and P6.3 were dissolved in sodium acetate/acetic acid 
buffer (pH 4.2) in order for the tertiary amine functional groups to be positively charged 
which enables them to condense the negatively charged anti-miRNA-214 and Cy3-labelled 
antagomiR-214. If P6.2 is in its zwitterionic state, the overall positive charge of the system 
will be lower than P6.3, since P6.3 has no propensity for zwitterionic properties. Thereby 
P6.3 is potentially more capable of condensing the RNAs. It is also possible that any negative 
charge present on P6.2 could repel the negatively charged RNAs, thus decreasing the 
complexation efficiency. The complexation efficiency of P6.2 and P6.3 was assessed using 
gel electrophoresis at various Nitrogen-to-Phosphorus charge (N/P) ratios, as seen in Figure 
6.3. It was observed that P6.3 was more efficient in complexing with the antagomiR-214 
than P6.2. However, neither of the two systems are very effective at condensing the RNA 
molecule as a significant portion of free RNA is seen running towards the positive electrode. 
Only at an N/P ratio of 100, can P6.3 efficiently complex the RNA. Further investigations 
would be necessary to optimize the systems to increase the complexation efficiency. It 
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would be very useful to measure the pka values and perhaps investigate the effect of 
molecular weight on the RNA complexation. 
 
 
Figure 6.3 Agarose gel electrophoresis of Cy3-antagomiR-214 complexes from P6.2 and P6.3 at 
different N/P ratios. 
 
The complex size distribution was measured using nanoparticle tracking analysis (NTA). The 
results are summarized in Table 6.2. The mean size of the generated particles is relatively 
large compared to that of common polyplex systems which usually range between 40 and 
100 nm. This is possibly due to the low complexation efficiency imparted by the SMA-
derivatives. Additionally, the polymers do not contain amphiphilic properties which promote 
self-assembly; therefore, it is possible that no secondary structures, e.g. micelles, are 
displayed by the complexes.   
 
Table 6.2 Complex size measured by NTA reported in nm. Results are shown as mean ± SD where 
n=3. 
N/P ratio  10 20 50 100 200 
P6.2 346.6 ± 115.7 161.2 ± 32.4 96.8 ± 27.3 119.6 ± 27.7 126.3 ± 14.6 
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The -potential of polyplexes containing P6.2 and P6.3 at different N/P ratios were 
measured in sodium acetate/acetic acid buffer, see Figure 6.4. An anticipated linear 
relationship between -potential and N/P ratio was observed, since the concentration of 
positively charged moieties increases with an increase in the polymer concentration. The 
ring-closed, DMAP-SMI produce polyplexes with higher -potential, which is comprehensible 
since it is conceivable that these polymers contain an overall higher positive charge 
compared to the zwitterionic, ring-opened analogue. 
  
 
Figure 6.4 Zeta potential of complexes containing P6.2 and P6.3 at different N/P ratios. 
 
6.2.3 Erythrocyte hemolysis and aggregation 
For a successful application in gene delivery, formed polyplexes should minimally interact 
with serum proteins, erythrocytes or other blood cells. This interaction can, for example, 
induce erythrocyte aggregation, leading to clearance by the reticulo-endothelial system 
(RES), and hemolysis. After incubation of DMAPA-modified SMA polymers with freshly 
isolated red blood cells for one hour, human full-blood derived erythrocytes were pelleted 
via centrifugation and observed under a microscope, see Figure 6.5 (a), while the 
supernatant was used to measure the degree of hemolysis, Figure 6.5 (b). 
PEI complexes are known to stimulate blood components, as indicated in Figure 6.5 (a) (i), 
and are indeed inducing erythrocyte aggregation. As indicated in Figure 6.5 (a) (ii), the 
exposure of red blood cells to naked anti-miRNA, or  the complexes composed of P6.2 and 
P6.3, Figure 6.5 (a) (iii) and (iv), respectively, did not cause aggregation, even at N/P ratios 
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However, as indicated in Figure 6.5 (b), P6.3 complexes formed some degree of red blood 
cell hemolysis; however, even at N/P ratio of 100, the degree of hemolysis is below 4%, 
which is remarkably lower than the hemolysis in common cationic polyplex systems, like 
Lipofectamine. The slightly higher degree of hemolysis for P6.3 compared to P6.2 is most 
probably due to the more cationic nature of P6.3 due to the ring-closed configuration, 





Figure 6.5 Polyplex-induced erythrocyte aggregation and hemolysis. Polyplexes were incubated 
with erythrocytes for 1 hour at 37 °C. PEI polyplex and Lipofectamine 2000 were used as controls. 
a) Microscopic images of erythrocyte aggregation, whereby aggregates are indicated using arrows. 
i) PEI, ii) naked anti-miRNA, iii) complexes with P6.2 and iv) complexes with P6.3. b) graph 
representing the degree of erythrocyte hemolysis determined by absorbance detection at 550 nm. 
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6.2.4 In vitro cytotoxicity assay 
The in vitro cytotoxicity caused by exposing fetal-derived cardiomyocyte progenitor cells 
(CMPCs) to the nanoparticles at various N/P ratios was tested using Annexin V and 7-amino-
actinomycin D (7-AAD) (apoptotic and necrotic cells, respectively). Flow cytometry was used 
to determine the degree of incorporation of the fluorescent signals within the cells, and 
hence the cellular cytotoxicity caused by the polyplexes. The results of these assays can be 
seen in Figure 6.6 (a) and (b) for complexes containing P6.2 and P6.3, respectively. While 
transfection with Lipofectamine 2000 caused significant apoptosis and necrosis, no 
cytotoxicity was caused by transfection with the SMA-derived complexes, at any of the N/P 
ratios, as detected via apoptosis or necrosis. 
 
Figure 6.6 Cell viability and degree of apoptosis of CMPCs determined for complexes composed of 
a) P6.2 and b) P6.3 at different N/P ratios determined using Annexin V and 7-AAD staining. 
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6.2.5 Cellular uptake and transfection efficiency 
The cellular uptake of the complexes is of utmost importance to facilitate gene delivery. This 
was investigated by transfecting cells with complexes containing Cy3-labelled antagomiR-
214 and thereafter quantified their uptake by flow cytometry and confocal microscopy. 
In the first experiment, Cy5-labelled antagomiR was complexed with P6.2 and P6.3 and 
transfected into CMPCs. After incubation for 48 hours, CMPCs were analysed by flow 
cytometry in order to ascertain the uptake efficiency (summarized in Figure 6.7). 
Lipofectamine 2000 was used as a control. A slightly higher cellular uptake was observed for 
complexes composed of P6.3 compared to those of P6.2, probably due to the cationic 




Figure 6.7 Cellular uptake determined by flow cytometry. Results are shown as mean ± SD where 
n=3. 
 
An overall trend in increased cellular uptake was observed for higher N/P ratios. It is 
commonly accepted that as the N/P ratio increases, the complexation efficiency improves. 
As reported by Vader et al., (20) this causes an increase in the polymer shielding of RNA-
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Thus, as the N/P ratio increases, a linear trend is not seen in the flow cytometry results, 
observed for N/P 100 in Figure 6.7. It was ascertained using agarose gel electrophoresis, 
Figure 6.3, that at N/P 100 for both P6.2 and P6.3, the complexation efficiency was higher 
than for lower N/P ratios. Therefore, it is very possible that the increased binding efficiency 
at N/P 100 is inducing this shielding phenomenon, and decreasing the observed cellular 
uptake.  
Human microvascular endothelial cells (HMECs) were subsequently transfected with 
complexes containing fluorescently labelled antagomiR-214 and observed under the 
confocal microscope after co-staining with Lysotracker, see Figure 6.8. Lysotracker is a dye 
which is highly selective for acidic organelles, i.e. late endosomes and lysosomes. As 
discussed in Chapter 2, endosomal entrapment is a very serious problem for many non-viral 
gene delivery systems, (21, 22) since the payload does not reach its target site. As indicated 
in the micrographs in Figure 6.8, polyplexes were taken up by the cells but more 
importantly, some of the antagomiR’s fluorescent signal, Figure 6.8 (iii), does not overlap 
with the Lysotracker signal, Figure 6.8 (ii). This suggests that some of the internalized 
polyplexes have escaped into the cytoplasm. 
Upon closer examination of the micrographs, interestingly, some of the complexes formed 
with P6.3 remained within the lysosomal compartment, while the fluorescent signal from 
the Cy3-labelled antagomiR delivered by P6.2 did not overlap with the Lysotracker signal at 
all. Therefore, it was hypothesized that either the ring open, DMAPA-modified SMA 
polyplexes were immediately escaping the endosome after endocytosis, or being taken up 
by the cells in a manner different to endocytosis. Based on the zwitterionic properties of 
P6.2, both of these hypotheses are plausible. As the plasma membrane is a bilipid 
membrane, the ring-opened analogue is possibly less repelled by the membrane, and 
therefore, it is possible that the ring-opened polyplexes facilitate direct diffusion through 
the membrane. Since, the mechanism of uptake is a very important aspect for designing the 
delivery vector, it is relevant to investigate this further. 
 




Figure 6.8 Localization of Cy5-labelled antagomiR-214, 48 hours after treatment with a) P6.2 and 
b) P6.3 complexes, characterized by microscope analysis. Nuclei were stained with Hoechst are 
shown in blue (i) Lysosomal marker, Lysotracker, is shown in green (ii), Cy5 signal is shown in red 
(iii), and the images were finally merged (iv) 
 
6.2.6 Mechanism of cellular uptake 
To study the mechanism of cellular uptake, clathrin–mediated and caveolae–mediated 
endocytosis were inhibited, as they are reported to be the major pathways through which 
polyplexes are taken up. (23, 24) Chloropromazine has been used in the past to inhibit 
clathrin–mediated endocytosis, since clathrin and its adapter proteins are translocated from 
the plasma membrane to the intracellular vesicles. Clathrin-coated pits are therefore 
inhibited from forming on the surface of the cell. (25) Genistein is a turosine kinase inhibitor 
known to inhibit caveolae–mediated endocytosis by disrupting the actin network at the site 
of endocytosis, while also inhibiting the enlistment of dynamin II. (26-28) CMPCs were thus 
transfected with P6.2 complexes, in the presence and absence of Genistein and 
chloropromazine. As a reference, cells were also transfected with unformulated (free) Cy3-
labelled antagomiR, Lipofectamine 2000 and only Genistein and chlorpromazine. The cells 
were then analysed by flow cytometry to determine the quantity of cellular uptake 













Figure 6.9 Investigation of mechanism of cellular uptake by inhibiting the clathrin- and caveaolae-
mediated endocytic pathways compared to uptake for uninhibited cells, determined by flow 
cytometry. Control cells were treated with unformulated antagomiR, Lipofectamine 2000, 
endocytic inhibitor (Genistein and chlorpromazine). 3.5 nmol of antagomiR was used for polyplex 
formation. Results are shown as mean ± SD where n=3 
 
Interestingly, the addition of clathrin– and caveolae–mediated endocytic pathway inhibitors 
did not hinder the cellular uptake of P6.2 complexes, but rather enhanced cellular uptake. 
As Genistein (29) and chloropromazine (30) are known to interact and disrupt the plasma 
membranes, it is plausible that while they inhibit endocytic pathways, they may also make 
the membrane more permeable.  Another possibility is that the uptake was enhanced due 
to cross-regulation, (31) i.e. by changing the clathrin– and caveolae–mediated endocytic 
pathway activity, other pathways are enhanced in order to compensate for the cellular 
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The lack of uptake inhibition suggests that the complexes are not taken up via the two main 
endocytic pathways known to be the predominant pathways for polyplex uptake. (21, 23) 
Although it does not exclude the possibility that they are taken up by another endocytic 
pathway, it is more probable that there is a different mechanism by which the complexes 
enter cells.  A possible other hypothesis is that the zwitterionic nature of P6.2 allow the 
complexes to pass through the plasma membrane via direct diffusion, without the need for 
endocytosis, which has been described previously for amphiphathic phospholipid polymers. 
(32) Additionally, the complexes might penetrate the cell through pore formation, described 
previously for poly(amidoamine) dendrimers. (33) However, further exploration of the 
cellular uptake is necessary.  
To further investigate the mechanism by which the complexes are taken up, more inhibition 
pathway experiments were performed. Since active cellular uptake pathways, such as 
endocytosis and macropinocytosis, require energy (e.g. ATRP), a manner in which to see 
whether cellular uptake is occurring via a passive mechanisms is to perform the cellular 
uptake studies at 4 ˚C. (34) As indicated in Figure 6.10, no uptake occurred at 4 ˚C which 
means that cellular uptake of these polyplexes is occurring via an active pathway and not via 
direct diffusion.  
Methyl β-cyclodextrin is a common inhibitor which affects the structure and function of 
cholesterol-rich membrane domains. (35) In addition, 5-(N-ethyl-N-isopropyl)amirolide 
(EIPA) inhibits Na+/H+ exchange which in turn lowers the sub-membranous pH causing an 
inhibition of macropinocytosis. (36) These two chemicals were separately added to the cell 
medium 30 minutes prior to transfection. In Figure 6.10, it can be seen that the number of 
cells transfected increased in the presence of methyl β-cyclodextrin. This means cellular 
uptake of these polyplexes is independent of cholesterol activity. (35) Inversely, the 
presence of EIPA significantly decreased the cellular uptake which thereby suggests that 
macropinocytos is important in the cellular uptake of these complexes. (36) As uptake via 
micropinocytosis still requires escape from the endocytic pathway, it is possible that the 
ring-open polyplexes are very efficient at escaping macropinosome into the cytoplasm due 
to their zwitterionic properties. A further transfection was performed where Genistein, 
chlorpromazine, EIPA and methyl β-cyclodextrin were added to the cell culture medium. In 
this experiment, the cellular uptake decreased slightly; however, uptake was still observed 
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(Figure 6.10). All together, these experiments suggest that there is another active pathway 
by which the polyplexes are transported into the cells, which will require further 
investigation in the future.  
 
 
Figure 6.10 Investigation of mechanism of cellular uptake by inhibiting the macropiniocytotic 
pathway and cholesterol and compared to uptake for uninhibited cells, determined by flow 
cytometry. Control cells were treated with unformulated antagomiR. 5.5 nmol of antagomiR was 
used for polyplex formation. Results are shown as mean ± SD where n=3 
 
6.2.7 Gene regulation efficiency 
As in Chapter 5, the pMIR-QKI-3'UTR reporter was used to determine the luciferase 
expression at a cellular level.  Again, HEK293 cells were co-transfected with pMIR-QKI-3'UTR 
reporter and pMIR-Report β-gal control plasmid. In the same way as in Chapter 5, the HEK 
cells were transfected with pre-miRNA-214 (pre-mir-214), a nonsense miRNA (neg control), 
a scrambled miRNA (scrambled control), or no miRNA (QK-pmiR). The following day, cells 
transfected with pre-miRNA-214 were further exposed to P6.2– and P6.3–anti-miR-214 
complexes as well as controls: Lipofectamine 2000-anti-miR-214 (L(+)), Lipfectamine 2000-
nonsense miRNA (L(-)) or PEI-anti-miR-214 (PEI). After 48 hours incubation, the luciferase 
activity was assessed. The results from the luciferase assay are summarized in Figure 6.11. 
Upon the addition of pre-miRNA-214, the luciferase expression decreased if anti-miRNA-214 















































































Stellenbosch University  https://scholar.sun.ac.za
158 
 
miR-214 (L(+)) almost completely re-established the luciferase expression. A trend in the 
gene regulation efficiency can be seen for both P6.2 and P6.3 complexes, whereby the 
efficiency increases with an increase in N/P ratio. Furthermore, the ring-opened analogues 
(P6.2) outperform the ring-closed polymer (P6.3) which is probably attributed to the 
amphiphilic nature of the ring-open analogue. This improved transfection also correlated to 
their proficiency in intracellular delivery, as discussed above. All of the complexes were 
equivalent to or out-performed the ‘gold standard’, PEI. 
 
 
Figure 6.11 Gene silencing activity of P6.2 and P6.3 complexes. Luciferase expression of  QKI-3’UTR 
reporter transfected in HEK 293 cells was determined 48 hours after transfection. Complexes were 
prepared using 50 nM anti-miRNA-214 concentration. Lipofectamine 2000 and PEI were used as 
controls. Results shown as mean ±SD for n=3.  
 
6.3 Conclusion  
SMA was successfully synthesized using RAFT-mediated polymerization. The polymer was 
modified in order to obtain ring-open DMAPA-modified SMA and ring-closed DMAP-SMI. 
These modified polymers were complexed with anti-miRNA-214 and antagomir-214 and 
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The cellular uptake was investigated by flow cytometry and confocal microscopy. Using 
Lysotracker, it was possible to visualize the transport of the Cy3-labelled antagomiR to the 
cytoplasm, with the ring-open analogue facilitating a greater concentration of RNA to the 
cytoplasm. The mechanism of uptake was investigated by inhibiting the caveaolae- and 
clathrin-mediated endocytic pathways, and it was found that P6.2 complexes are not 
transported into the cell through either of these mechanisms. A cellular uptake study at 4 ˚C 
revealed that the complexes are taken up by active transport. Further inhibition studies 
using methyl β-cyclodextrin and EIPA indicated that while cholesterol activity does not 
impact uptake, the inhibition of Na+/H+ exchange, important in macropinocytosis, does 
affect cellular uptake. This indicates that the ring-open polyplexes are efficient at escaping 
the macropinosome/lysosome. However, further investigation regarding the uptake 
mechanism is necessary, as cellular uptake was still observed upon the combined inhibition 
of all the active pathways described above.  
The gene regulation efficiency was then investigated via a luciferase experiment. Although 
the P6.2 and P6.3 complexes were not as efficient at restoring luciferase expression as 
Lipofectamine 2000, they performed better than or equal to PEI polyplexes.  
These SMA analogues represent a novel, zwitterionic gene delivery vector. Future studies 
will include investigating the effect of molecular weight, polymer structure, modifications 
and copolymerization on RNA binding efficiency, cellular uptake and gene regulation 
efficiency. Furthermore, in the near future, in vivo studies will be conducted in order to 
assess the stability, biodistribution and efficacy of these gene therapy vectors. 




6.4.1 General experimental details 
Unless stated otherwise, all of the chemicals used were purchased from commercial sources 
and used without further purification. 2,2’-Azobis(isobutyronitrile) (AIBN) (Riedel-de Haën) 
was recrystallized from methanol. Subsequently it was dried under vacuum at room 
temperature. Solvents and monomers were dried and distilled before use, unless stated 
otherwise. The progress of the reactions were monitored using thin layer chromatography 
(TLC) with Machery-Nagel Silica gel 60 plates with a UV 254 fluorescent indicator.  
1H and 13C NMR spectra were measured on a Varian VXR-Unity (400 MHz) spectrometer and 
spectra were analyzed using MestreNova 9.0 and chemical shifts were reported in parts-per-
million (ppm) which was referenced to the residual solvent protons. The samples were 
prepared in deuterated solvents (Cambridge Isotope Labs).  
FT-IR spectroscopy was measured using Thermo Nicolet iS10 FT-IR spectrometer, and data 
was acquired using Omnic software (version 6.0a). 32 scans were performed per sample, 
between 650 and 4100 cm-1. 
Size exclusion chromatography (SEC) was measured on a Shamdzu LC-10AT isocratic pump, 
a column fitted with a PSS guard column (50 x8 mm) in series with three PPS GRAM columns 
(300 x 8 mm, 10 µm, 2 x 3000 Å and 1 x 100 Å) kept at a constant temperature of 40 °C, a 
Waters 717+ auto-sampler, a Waters 2487 dual wavelength UV detector and a Waters 2414 
differential refractive index (DRI) detector. The samples were measured in 
dimethylacetamide (DMAc) as the eluent stabilized with 0.05% BHT (w/v) and 0.03% LiCl 
(w/v), at a flow rate of 1 mL.min-1. Sample preparation included filtering the sample 
solutions through a 0.45 µm GHP filter to remove impurities. The results were calibrated 
against PMMA standards (Polymer Laboratories) ranging from 690 to 1.2 x 106 g.mol-1. Data 
acquisition was performed using Millenium32 software, v4. 
ζ-potential was measured on Malvern Zetasizer Nano Z. The samples were exposed to 3 V 
maz, and 3 measurement of 100 scans were obtained per sample. Complex size distribution 
was measured using nanoparticle tracking analysis (NTA) with a Nanosight NS500 
nanoparticle analyser (Malvern Instruments) which was equipped with a 405 nm laser. The 
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camera level was set to 16 and all post-acquisition settings were set to automatic, except for 
the detection threshold, which was set at 5. Three 30 s videos were recorder per sample 
using the script control function. 
Flow cytometry was carried out on a CytoFLEX Flow Cytometer (Beckman Coulter). Data was 
analyzed using Kaluza Analysis 1.5a. 
6.4.2 Experimental methods 
Butyl 1-phenylethyl trithiocarbonate synthesis (R6.1) 
 
Synthesized according to a protocol described in literature. (17) In short, triethyl amine 
(11.2 g, 111 mmol) was added dropwise to a solution of 1-butanethiol (5.00 g, 55.5 mmol) 
and carbon disulfide (8.45 g, 111 mmol) in chloroform (35 mL) with stirring at rt. The 
solution was stirred for 3 h at rt. (1-Bromoethyl)-benzene (10.1 g, 54.4 mmol) was added 
dropwise to the solution and the mixture was stirred for 12 h at rt. Mixture was diluted with  
with chloroform (20 mL) and washed with water (3 x 50 mL), 2 M H2SO4 (aq) (3 x 50 mL), 
water (3 x 50 mL) and brine (3 x 50 mL). Organic layer was dried over anhydrous MgSO4, 
filtered and concentrated to give R6.1 as a yellow oil (14.39 g, 98%). The 1H NMR spectrum 
corresponds well to that in literature. (17) 
1H NMR (300 MHz, Benzene-d6) δ 7.20 – 7.11 (m, 3H), 7.06 – 6.91 (m, 2H), 5.41 (q, J = 7.1 Hz, 
1H), 3.08 (t, J = 7.2 Hz, 2H), 1.52 (d, J = 7.1 Hz, 3H), 1.37 – 1.27 (m, 2H), 1.14 – 1.00 (m, 2H) 
0.64 (t, J = 7.2 Hz, 3H). 
General co-polymerization of styrene and maleic anhydride (P6.1) 
Styrene (2.00 g, 0.0192 mol), maleic anhydride (1.9 g, 0.019 mol), R6.1 (0.224 g, 0.821 
mmol) and AIBN (0.027 g, 0.16 mmol) were accurately weighed off and transferred to a 
Schlenk flask along with MEK (5 mL) and a magnetic stirrer bar. The solution was thoroughly 
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degassed with argon gas for one hour prior to the start of the reaction. The flask was 
immersed in a preheated oil bath at 70 C for 24 hours and P6.1 was retrieved by 
precipitation in diethyl ether (200 mL). P6.1 was allowed to dry in a vacuum oven at room 
temperature for 24 hours.  
FT-IR 3044 (C-H, aromatic), 2928 (C-H, aliphatic), 1858 (C=O), 1774 (C=O), 1495 (C=C, 
aromatic), 1452 (C=C, aromatic), 1220 (C-O-C, cyclo-anhydride), 1081 (C-O-C, cyclo-
anhydride), 959 (C-O-C, cyclo-anhydride), 903 (C-O-C, cyclo-anhydride),  700 (C-H, aromatic) 
Ring-opened DMAPA-modified poly(styrene-co-maleic anhydride) (P6.2) 
For functionalization of the polymers with DMAPA, P6.1 (2 g) was dissolved in a minimum 
amount of DMF (3 mL). DMAPA (1.5 eq. to the maleic anhydride incorporated in the 
polymer backbone) was added dropwise to the polymer solution. P6.2 was retrieved by 
precipitation in Et2O (150 mL). P6.2 was dried in a vacuum oven at room temperature for 24 
hours.  
FT-IR 3664-3126 (O-H, carboxylic acid), 3126-2814 ((C-H, -N-(CH3)2), 1659 (C=O, carboxylic 
acid), 1559 (NH), 1356 (NH), 700 (C-H, aromatic) 
Ring-closed DMAPA-modified poly(styrene-co-maleimide) (P6.3) 
P6.2 (1.0 g) was dissolved in DMF (20 mL) and heated to 120 °C for 24 hours. After cooling, it 
was dialysed against a solution of water and methanol (1:1) for 2 days and a further 2 days 
against 100% water. P6.3 (1.3 g) was isolated by freeze-drying for 24 hours. 
FT-IR 2996-2707 ((C-H, -N-(CH3)2), 1769 (C=O, imide), 1690 (C=O, imide), 1149 (CN), 700 (C-
H, aromatic) 
RNA sequences 
hsa-miR-214  ACAGCAGGCACAGACAGGCAGU 
antagomiR-214: (Cy3)-5’-ACTGCCTGTCTGTGCCTGCTGT-3’-Cholesterol 
  




P6.2/P6.3 were dissolved in sodium ascorbate buffer (pH 4.2) (40 mg/mL) and mixed with 
anti-miRNA-214 (4 mg/mL) at various N/P ratios. The concentration of anti-miRNA was kept 
constant, but concentration varied depending on the experiment in question. The polymer-
anti-miRNA solution was incubated at 37 °C for 1 hour. Complexes were used immediately.  
Complex characterization 
Complexes containing 550 pmol Cy3-labelled antagomiR-214 with a final volume of 25 μL 
were prepared for agarose gel retardation. 6 μL 6 x loading dye was added to the samples 
prior to loading. 2% agarose gel was prepared and the electrophoresis was performed at 
140 V for 45 min. The gels were then imaged using the Typhoon 9410 Variable Mode Imager 
[Amersham, Biosciences). 
Cell culture 
Human embryonic kidney 293 cells (HEK 293) were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) (Introgen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) 
and 10% penicillin streptomycin solution (P/S). Fetal cardiomyocyte progenitor cells 
(CMPCs) were cultivated on 0.1% gelatin in SP++ medium (1 part endothelial cell growth 
medium-2 (EGM-2), 3 parts Medium199 (M199) supplemented with 1% P/S, 1% non-
essential amino acids (NEAA) and 10% FBS). Human microvascular endothelial cells (HMECs) 
were cultivated on 0.1% gelatin in EGM-2.  
Cellular uptake (flow cytometry) 
CMPCs were seeded in 12 well plates and incubated for 24 hours. Medium was removed 
and replaced with 500 µL OptiMem. Cells were transfected with complexes at various N/P 
ratios formulated with 1.5 µM Cy3 labelled antagomiR-214. After 4 hours, the OptiMem was 
replaced with SP++ medium and cells were incubated for 48 hours. Cells were washed twice 
with PBS buffer to remove non-internalized polyplexes. Cells were harvested using Trypsin 
and centrifuged (350·g, 5 min) and supernatant was aspirated. The cells were resuspended 
in 500 µL PBS buffer containing 10% FBS. Again cells were centrifuged (350·g, 5 min) and 
supernatant was aspirated. The cells were resuspended in 500 µL PBS and after a final 
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centrifugation step, the cells were resuspended in PBS buffer with 2% FBS (FACS medium). 
The samples were then analysed on the CytoFLEX flow cytometer (Beckman Coulter). Data 
was analysed using Kaluza Analysis 1.5a. 
In order to inhibit endocytosis, 10 μM final concentration chlorpromazine, 200 μM final 
concentration Genistein, 2 mM or 200 µM methyl β-cyclodextrin or 10 µM EIPA were added 
to the cell medium 30 min prior to transfection. Quantifying cellular uptake by flow 
cytometry was carried out in the manner described above. 
Cytotoxicity studies 
CMPCs were seeded in 12 well plates and incubated for 24 hours. Medium was removed 
and replaced with 500 µL OptiMem. Cells were transfected with complexes at various N/P 
ratios formulated with 5.5 µM anti-miRNA-214. After 4 hours, the OptiMem was replaced 
with SP++ medium and cells were incubated for 48 hours. APC Annexin V Apoptosis 
Detection Kit with 7-AAD purchased from BioLegend was used for cytotoxicity assay. 
Protocol was followed according to manufacturer. The cells were analysed by flow 
cytometry on CytoFLEX Flow Cytometer (Beckman Coulter) directly after staining. Data was 
analysed using Kaluza Analysis 1.5a. 
Erythrocyte aggregation and hemolysis 
The method for investigating erythrocyte aggregation and hemolysis was modified from 
literature. (3) In short, erythrocytes were obtained from 5 mL whole human blood by 
multiple centrifugation steps (1000·g, 10 min, 4 °C), followed by aspiration of supernatant 
and resuspension in PBS buffer until the supernatant was clear, where approximately 4 
steps were required. 100 µL of the pellet was resuspended in 4 mL PBS. 160 µL of the final 
erythrocyte suspension was added to 40 µL polyplex solution with an anti-miRNA 
concentration of 1 µM. Triton X-100 (1%) in PBS and HEPES (pH 7.2) were used as reference 
samples of 100% lysis and 0% lysis respectively. Samples were incubated for 1 hour at  
37 °C. After a further centrifugation step (1000·g, 10 min), the absorbance at 550 nm was 
measured of 150 µL of the supernatant to ascertain the degree of hemolysis. The pellet was 
resuspended in 50 μL PBS and observed under the microscope to evaluate the degree of 
erythrocyte aggregation. 




HMECs were seeded in an 8-well flow chamber and incubated for 24 hours. The medium 
was aspirated and replaced with 150 µL OptiMem. Cells were transfected with complexes 
(N/P 40) with a final antagomiR-214 concentration of  3 μM. After 4 hours, the OptiMem 
was replaced by EGM-2 medium and the cells were incubated for 48 hours. The medium 
was then replaced by medium containing 1:10000 Lysotracker Red and incubated for 2 
hours. The medium was then replaced with medium containing Hoechst solution (1 µg/mL) 
and the cells were incubated for 10 minutes. The medium was aspirated and the cells were 
washed twice with EGM-2 medium. 150 μL of EGM-2 was added to the wells and the cells 
were imaged on a ZEISS LSM 700 confocal microscope (Carl Zeiss). 
Luciferase Assay 
The method was modified from literature. (37) The conserved miRNA-214-binding 
sequences in the QKI 3’ untranslated region (UTR) were cloned into pMIR-Reporter vector 
(Ambion). HEK293 cells were seeded in 48-well plates and incubated for 24 hours. The 
medium was replaced with OptiMem. The cells were co-transfected with 200 ng of pMIR-
Reporter-QKI-3’UTR Luciferase vector and pMIR-Report β-gal control plasmid. The latter was 
used to assess the transfection efficiency. In addition, 50 nM pre-miRNA-214, ctrl-miRNA or 
scrambled miRNA were also transfected. The transfection was carried out by using 
Lipofectamine 2000 (Invitrogen). After 4 hours, the medium was replaced with DMEM 
supplemented with 10% FBS. After 24 hours of incubation, the medium was replaced with 
OptiMem, and cells were transfected with complexes containing 50 nM anti-miRNA-214 at 
different N/P ratios, or Lipofectamine with either anti-miRNA-214 or ctrl-miRNA, PEI-anti-
miRNA-214 polyplexes or naked anti-miRNA-214. After 4 hours, the medium was replaced. 
The cells were incubated for 48 hours. They were then washed with PBS and lysed with 150 
μL 1 x Luciferase lysis buffer. The cells were incubated for 15 minutes. 10 μL of the 
supernatant was transferred to a white 96-well plate, and the luciferase activity was 
assessed with Luciferase Assay System (Promega). 25 μL of the cell lysis supernatant was 
transferred to a 96-well plate and 25 μL β-galactosidase Enzyme Assay buffer. After 
incubation at  37 °C for 1 hour, the absorbance at 405 nm and 570 nm was measured.  
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7.1 General conclusions 
This dissertation focused on the production of non-viral, polymeric gene delivery systems. A 
facile method of producing α,ω-heterotelechelic poly(N-vinylpyrrolidone) (PVP) for the 
incorporation in such systems was described. Thereafter, two types of delivery systems 
were synthesized and in vitro studies were conducted in order to assess their success within 
the gene delivery application. 
In Chapter 1, a general introduction was provided to the pathway a cationic delivery system 
follows in order to deliver its payload to the cell. This discussion included the hurdles that 
delivery systems must overcome in order to successfully encourage gene regulation. 
Thereafter, Chapter 2 gave a more in depth discussion of reported polymeric delivery 
systems, as well as their advantages and disadvantages. It elaborated on the obstacles that 
have been overcome, especially with the advent of reversible-deactivation radical 
polymerization, and those which still need to be addressed, e.g. cytotoxicity, endosomal 
escape and cytoplasmic release.  
In Chapter 3, a new method for synthesizing α,ω-heterotelechelic PVP was described. Using 
this method, PVP with high chain-end fidelity was obtained, which is superior for application 
in biological systems since a greater percentage of the polymer is able to be functionalized. 
Moreover, the synthetic technique allows for RAFT-agents with more reactive leaving 
groups than previously reported, leading to easier post-polymerization modification. An 
added benefit of the system is that NVP can be polymerized without prior purification. 
Different examples of chain end modifications were shown, including the inclusion of 
aldehyde moieties. 
Chapter 4 described the development of a diblock system containing a hydrophobic 
copolymer, either p(DMAEMA-co-BMA) or p(DMAEA-co-BMA), and hydrophilic PVP linked 
via an acid-labile linker to facilitate endosomal escape. The PVP was synthesized using the 
method developed in Chapter 3 facilitated by a xanthate RAFT agent with a linear acetal 
leaving group. PVP of approximately 4600 g·mol-1 (Ð = 1.2) was obtained. Using a one-pot 
post-polymerization functionalization, the PVP end-groups were converted into an aldehyde 
functional group, for further modification with a RGD or cardiovascular targeting ligand and 
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amino-fluorescein, and a thiol end-group, for later conjugation to the hydrophobic polymer 
via a Michael addition. 
The p(DMAE(M)A-co-BMA) blocks were synthesized via RAFT-mediated polymerization using 
2-hydroxyethyl 4-{[(butylthio)carbonothioyl]thio}-4-cyanopentanoate as the RAFT-agent.  
Polymers of approximately 16500 g·mol-1 (Ð = 1.1) were obtained for both copolymers, and 
the trithiocarbonate was removed post-polymerization. Subsequently, the hydroxyl α-chain 
end was reacted with acrylic acid via a 1-ethyl-3-(-3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC) coupling reaction, supplying the final acrylate end group for the 
Michael addition with PVP. After the Michael addition, the conjugated diblocks were 
characterized by size exclusion chromatography. 
 
Chapter 5 explored the use of the conjugates synthesized in Chapter 4 as gene delivery 
vehicles. The complexation efficiency of the conjugates with Cy3-labelled RNA was 
investigated by means of agarose gel retardation, and it was seen that complexation 
occurred at N/P ratios as low as 3. The complex size decreased with increasing N/P ratio, 
and they were shown to be stable in the presence of 20% fetal bovine serum. The 
p(DMAEMA-co-BMA) containing blocks caused less hemolysis than the p(DMAEA-co-BMA) 
containing blocks, although both remained at acceptable levels of hemolysis at N/P ratio of 
20 and below, except P4.15. No significant cytotoxicity was observed for cardiomyocyte 
progenitor cells after transfection for any of the blocks, and their cellular uptake was seen 
to be directly proportional to the N/P ratio. Furthermore, it was seen that the p(DMAEA-co-
BMA) was taken up slightly more than the p(DMAEMA-co-BMA), and the presence of the 
cardiovascular targeting ligand facilitated the highest uptake. Luciferase expression was 
seen to be restored by the diblock conjugates more efficiently than by PEI-polyplexes, 
although not as efficiently as by Lipofectamine 2000. P(DMAEA-co-BMA) without targeting 
ligand was the most effective polyplex at a concentration of 50 nM anti-miRNA-214, 
however, when this concentration was doubled, the p(DMAEMA-co-BMA) polyplexes 
showed higher efficiency. These results are contradictory to those previously reported for 
comparative studies between pDMAEMA and pDMAEA polyplex systems. (1) A hypothesis 
was drawn as a result of the observed results that the presence of targeting ligand and/or 
PVP negatively affects the gene regulation efficiency of pDMAEA polyplexes. However, 
further investigation would be necessary in order to endorse this hypothesis. 
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Chapter 6 investigated the synthesis and use of ring-open and ring-closed 3-(N,N-
dimethylamino)propyl-1-amine (DMAPA)-modified poly(styrene-co-maleic anhydride) (SMA) 
as gene delivery vectors. SMA was synthesized using butyl 1-phenylethyl trithiocarbonate as 
a RAFT-agent, yielding polymer with a number average molecular weight of approximately 
12800 g·mol-1 (Ð = 1.1). The SMA was functionalized with DMAPA using an amidation 
reaction, and a portion of this was thermally ring-closed. The DMAPA modification, ring-
opened and ring-closed structures were confirmed via FT-IR analysis. The complexation 
efficiency was assessed via agarose gel retardation, and it was seen that the ring-closed 
analogue was more efficiently able to complex the RNAs; however, both polymers did not 
show as high complexation efficiency as the diblock conjugate system described in Chapter 
5. The toxicity profiles of both analogues were pristine, with no significant cytotoxicity, 
hemolysis or erythrocyte aggregation detected at any N/P ratio. Although negligible, the 
ring-closed analogue caused slightly higher hemolysis than the ring-open version. This is 
probably due to the slightly higher cationic charge on the ring-closed polymer, since the 
positive charge is offset by the zwitterionic nature of the ring-opened polymer. The cellular 
uptake was measured by flow cytometry, and confocal microscopy was used to track 
whether the polymers were delivering the Cy3-labelled RNA to the cytoplasm or whether it 
was getting trapped within the endosome. It was seen that both analogues delivered the 
RNA to the cytoplasm, although the ring-open polymer was more efficient in this. A question 
arose about the mode through which the ring-open analogue was being taken up by the 
cells, since the RNA’s fluorescent signal was not overlapping with the Lysotracker signal, i.e. 
the RNA was not found within the endosome or lysosome to any significant extent. 
Therefore, some experiments were conducted in which clathrin- and caveolae-mediated 
endocytosis were inhibited. Cellular uptake was still observed, and thus, it was concluded 
that the usual route for polyplexes to be taken up by the cells, clathrin- and caveaolae-
mediated endocytosis, were not employed in the case of the ring-open SMA derivative. 
Further experiments revealed that the polyplexes are taken up by active transport. While it 
was observed that the cellular uptake is independent of the cholesterol activity of cell 
membranes, transfection in the presence of 5-(N-ethyl-N-isopropyl)amirolide (EIPA) 
revealed that the polyplexes are somewhat transported via macropinocytosis. However, 
since significant uptake was still present after inhibition of all of the abovementioned 
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pathways, further investigation is necessary to elucidate the exact mechanism employed in 
cellular uptake of these polyplexes. 
The ring-opened (P6.2) and ring-closed (P6.3) polymer complexes were then tested for their 
efficiency in regulating luciferase expression. A linear relationship was observed between 
the regulation efficiency and the N/P ratio. Furthermore, even though the ring-closed 
construct (P6.3) was more efficiently able to condense the RNAs, the ring-opened polymer 
showed higher regulation efficieny. This was correlated to the zwitterionic nature of the 
ring-open analogue (P6.2), which means that more of the polymer is delivered to the 
cytoplasm than with the ring-closed polycation. Therefore, it is hypothesized that the 
different mechanism of cellular uptake is the driving factor for enhanced regulation. 
 
When comparing the two different gene delivery systems that were investigated in this 
dissertation, it is prudent to keep in mind that results obtain in in vitro studies do not 
directly translate to in vivo studies. Systems that have shown high gene regulation within 
the in vitro setting have gone on to show no results in vivo, and vice versa. That said, the 
cytotoxicity profile of the SMA-derivatives shows great promise. Although the pDMAE(M)A 
systems described in Chapter 5 do not cause worrisome levels of toxicity, the SMA 
complexes are far superior in this aspect, especially at high N/P ratios.  
Furthermore, the mode of uptake for the ring-open SMA system is very exciting, since it is 
possible that the obstacle of endosomal escape could be circumvented. That said, the RNA 
complexation efficiency and cellular uptake of the diblock conjugate systems was far 
superior to that of the SMA derivatives. This is most probably due to the higher charge 
contained within the pDMAE(M)A systems. It is possible that this could be improved in the 
SMA systems by increasing the positive charge. This will be discussed further in Section 7.2.  
7.2 Future perspectives 
Ethical clearance has been obtained for in vivo studies on mice for both gene delivery 
systems reported in this dissertation, and these studies will begin shortly. 
It would be worth-while studying the impact that the molecular weight of PVP has on the 
diblock conjugate system. It is hypothesized that this, like PEG, might have a threshold point 
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between improving the toxicity profile and too much shielding causing a decrease in cellular 
uptake. Furthermore, it would be interesting to study the conjugation of PVP to other 
hydrophobic polycations, via acid-labile linkers. PVPylation has not been extensively 
investigated in gene therapy, but it holds potential for an improved delivery system 
compared to poly(ethylene glycol) (PEG) because of its biocompatibility and the ease with 
which it can be made while maintaining complete control over molecular weight, molecular 
weight distribution, architecture and end-group functionality. 
As metioned above, SMA has not been extensively studied as a polymer for gene delivery. 
Therefore, it would be of interest to study the impact that the molecular weight and 
architecture has on its gene delivery application. Furthermore, amidation with different 
cationic compounds would be interesting, including the use of moieties that can be 
decationized in a similar manner to DMAEA. It would also be on point to investigate the 
effect of co-amidation with different side chains and studying the use of different 
percentages of side-chain funtionalization.  
The incorporation of both hydrophobic blocks, e.g. styrene, and hydrophilic blocks, such as 
PVP, would be interesting. Recently in our group, sequence-controlled styrene-styrene-
maleic anhydride polymers have been synthesized successfully. A study investigating the 
different effect that such a hydrophobic block would have on gene delivery compared to 
more random styrene block lengths would be interesting. For example, as the sequence 
controlled polymer still contains some maleic anhydride, the hydrophobic block would 
retain some of the zwitterionic properties. While the hydrophobic character would enable 
amphiphilic self-assembly, the retained zwitterionic character may act to enhance gene 
delivery, compared to a homopolymeric styrene block. 
Due to the exciting results with regards to the mechanism of uptake of the ring-open SMA 
derivative, it would also be of utmost importance to conduct a full study on the uptake 
mechanism. Furthermore, it would be interesting to also see what effect the inclusion of 
hydrophobic and hydrophilic blocks would have on this mechanism.  
Within our group, SMA derived particles have been synthesized via surfactant-free 
dispersion polymerization with divinylbenzene as the crosslinking monomer. It might be of 
interest to exchange the divinyl benzene with a reducible, disulphide crosslinker, such as the 
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one used within Zentel’s group. (2) These crosslinkers contain amines for RNA complexation. 
The use of such SMA-derived particles is interesting because they are potentially taken up 
by cells via a non-endocytic mechanism. Therefore, this would, like the ring-open SMA-
derivative, render them able to bypass the obstacles associated with endosomal escape. The 
reducible bond would allow the system to release the RNAs within the cytoplasm for gene 
regulation to take place. 
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